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Abstract  
Craniofacial skeletal muscles (CSkM) have a number of properties that distinguish them 
from other skeletal muscles. They have different embryological origin than limb 
muscles and are believed to have different regenerative capacity. In addition, they may 
offer an easy to access source of progenitor cells for tissue engineering applications. 
The aim of this study was to isolate craniofacial muscle progenitor cells based on their 
adhesion properties to tissue culture plastic and investigate their differentiation ability 
compared to cells derived from limb muscles. 
Mononuclear cells were isolated from mouse masseter and hind-limb muscles (LM) 
with a modified enzymatic digestion method. The mononuclear ‘parental’ population 
(PC)  was serially plated through three different cultures to form pre-plate 1, 2 and 3 
(PP1, PP2 and PP3) for correlating with adherent cells at 1 h, 48 h and 120 h of contact 
with tissue culture plastic. Part of the original isolate was kept unsorted for 5 days and 
named PC. 
Early adhered cells from both muscle tissues appeared to be larger and grew faster than 
late adhered cells. They also showed higher stem cell gene expression compared to late 
adhered cells. Moreover, early adhered cells in CSkM showed higher expression of 
neural crest genes compared to all other isolated cells. The myogenic assessments 
indicated PP3 to be comparatively more capable of desmin, Myog and MyoD 
expression, as well as myotube formation in inductive media. In contrast, osteogenic 
differentiation indicated early adhered cells from both muscle groups to have higher 
ability compared to late adhered cells in expression of osteogenic genes, alkaline 
phosphatase protein and extracellular matrix calcium mineralisation.   
A summary conclusion is that the cells that adhere early to tissue culture plastic seem 
skewed to osteogenic commitment compared to the late adherent population, which 
displays myogenic properties. Cells isolated from both muscle tissues seem to have 
similar differentiation abilities despite the documented developmental differences 
between those two sites though the early adhered cells isolated from CSkM have higher 
expression of neural crest genes than LM, and hence indicate a possible connective 
tissue origin. 
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Chapter 1: Introduction 
________________________ 
1.1. Background 
Tissues that are exposed to injury or in continuous turnover (e.g. muscle and blood 
cells) need an internal and immediate replacement and repair of damaged cells. This is 
accomplished in the mammalian body with an ability of tissue regeneration. The cells 
that are believed responsible for this regeneration and repair are commonly known as 
stem cells. 
 
Skeletal muscle shows a remarkable ability to adapt to physiological demands such as 
growth, injury and stress endured in physical or athletic training. Satellite cells are 
believed to play a major role in these adaptive processes. Satellite cells were first 
discovered in 1960s (Mauro, 1961). Since the original description of the myogenic 
satellite cells, considerable interest and research efforts have focused on the 
identification of cells from muscle tissue with stem cell like biology and differentiation 
abilities. 
 
A considerable amount of literature has been published on the differences between 
craniofacial skeletal muscles (CSkM) and other body muscles including limb muscle 
(LM). However, most of muscle derived stem cells studies have focussed on 
mononuclear cells derived from limb and trunk skeletal muscles (Katagiri et al., 1994; 
Bosch et al., 2000; Lee et al., 2000; Li and Huard, 2002; Qu-Petersen et al., 2002; 
Mastrogiacomo et al., 2005); very little data is available regarding isolation and 
characterisation of craniofacial skeletal muscle stem cells (Sinanan et al., 2004).  
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1.2. Muscle Tissue 
1.2.1.  Muscle 
Muscle is a contractile tissue and is derived from the mesodermal layer of embryonic 
germ cells in mammals. Muscle cells contain contractile filaments that move past each 
other and change the size of the cell. They are classified as skeletal, cardiac, or smooth 
muscles. Their function is to produce force and cause motion. Muscles can cause either 
locomotion of the organism itself or movement of internal organs. Cardiac and smooth 
muscle contraction occurs without conscious thought and is necessary for survival. 
Examples are the contraction of the heart and peristalsis which pushes food through the 
digestive system. Voluntary contraction of the skeletal muscles is used to move the 
body and can be finely controlled. Examples are movements of the eye, or gross 
movements such as the quadriceps muscle of the thigh. There are two broad types of 
voluntary muscle fibres: slow twitch and fast twitch. Slow twitch fibres contract for 
long periods of time but with little force while fast twitch fibres contract quickly and 
powerfully but fatigue very rapidly. 
 
1.2.2. Skeletal muscle  
Skeletal muscle is attached to the skeleton through tendons and is found throughout the 
body forming an integrated network responsible for voluntary movements and 
coordination of human body.  The skeletal muscles are adequately vascularised and 
innervated with nerves, which allow them to achieve their function accurately.  
 
Skeletal muscle is composed of abundant muscle fibers closely integrated into a 
functional unit by connective tissue. The entire muscle is separated from surrounding 
tissues and organs by a dense layer of collagenous connective tissue called epimysium. 
The perimysium is a connective tissue that surrounds groups of muscle fibres called 
 4 
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fascicles. It contains blood vessels that maintain blood supply and nerves that innervate 
these fascicles. The endomysium is the connective tissue that envelopes each muscle 
fibre and contains a capillary network that provides the fibre with a ready blood supply, 
nerve fibers, and satellite cells responsible for repair of damaged muscle tissues.  An 
over view of the structure of skeletal muscle segment is presented in figure 1.1.  
 
 
 
 
Figure  1.1 General structure of a muscle segment.  
Figure shows a cross section of skeletal muscle attached via tendon to a bone. The substructures are 
highlighted. The epimysium is the outermost sheet that surrounds the whole muscle. The perimysium is the 
intermediate layer of the extracellular matrix (ECM) that covers each fascicle. The endomysium is the 
innermost layer of the ECM and surrounds each fibre (Figure taken with permission from Tortora & 
Derrickson 2009).  
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The functional unit of skeletal muscle is known as a muscle fibre. It is an elongated, 
cylindrical cell with multiple nuclei, ranging from 10 to 100 µm in width and from a 
few millimetres up to 30 centimetres in length. The cytoplasm of the fibre is called the 
sarcoplasm, which is encapsulated inside a cell membrane called the sarcolemma. It is 
made up of bundles of thick and thin protein filaments known as myofibrils. Theses 
filaments are organised in repeating functional units called sarcomeres (Martini and 
Ober, 2006). The structure of sarcomere unit is shown in figure 1.2.   Each sarcomere 
has dark bands called anisotropic (A bands), consisting of thicker myofilaments made of 
the protein myosin. The light bands are referred to as isotropic (I bands), and consist of 
thin myofilaments made of the protein actin as shown in figure 1.2.  
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Figure  1.2 Structural aspects of muscle fibre.  
Image shows a muscle fibre with constituent structural units: with mitochondria interspersed within a 
longitudinal aggregate of myofibrils enclosed by an outer membranous sarcolemma. Each myofibril is 
composed of repeating structural units called sarcomeres. These are separated from each other by Z discs that 
contain dense actin. The darker middle part of the sarcomere is composed of myosin and is called the A band 
that extends the entire length of the thick filament. Towards each end of the A band is a zone of overlap where 
thick and thin filaments lie side by side; this is the I band. A and Z disc passes through the centre of each I 
band. A narrow H zone presents in the centre of each A band and only contains thick filaments. The thick 
filaments at the centre of H zone are hold together by the M line. (Figure taken with permission from Tortora 
& Derrickson 2009). 
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Muscle proteins can be divided into three groups. These are described below: 
1. Contractile proteins, such as myosin and actin, which generate force during 
contraction. Myosin functions as a motor protein, which push and pull various 
cellular structures to achieve movement by converting the chemical energy in 
ATP to mechanical energy. Myosin is shaped like two golf clubs twisted 
together where the tail points towards the M line. The myosin heads project 
outward from the shaft in a spiralling fashion, each extending towards one of the 
six thin filaments (actin) that surrounds each thick filaments (figure 1.2). 
2. Regulatory proteins, such as tropomyosin and troponin that regulate the process 
of contraction.  
3. Structural proteins, such as titin keep thick and thin filaments in proper 
alignment, confer the myofibril with elasticity, and help in linking the myofibril 
to the sarcolemma and extracellular matrix.  
 
Muscle cells also contain several intermediate filament proteins.  Desmin is one such 
example and is the major muscle-specific intermediate filament protein. It maintains 
muscle cytoarchitecture by forming a three-dimensional scaffold around the 
myofibrillar Z-disk and by joining the entire contractile apparatus to the 
subsarcolemmal cytoskeleton, the nuclei, and other organelles. (Paulin and Li, 2004). 
 
1.2.3. Ontogeny of skeletal muscle   
Skeletal muscle develops prenatally in a pre-programmed multistep process involving 
intrinsic and extrinsic cues that result in the generation of different precursor cell types. 
Nearly all skeletal muscles in body, except some craniofacial muscles, develop from the 
paraxial mesoderm (Hawke and Garry, 2001, Buckingham et al., 2003, Grefte et al., 
2007, Sambasivan and Tajbakhsh, 2007). This process starts in the mouse from 
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embryonic day 8.5 ⁄ 9 and proceeds to 18 days with birth occurring at~19 days. Further 
maturation during the postnatal period takes about 2–3 weeks (Tajbakhsh, 2009). The 
differences exist in the development of skeletal muscle tissue between the trunk and 
limb section and craniofacial locations will be discussed below.  
 
1.2.3.1. Development of Trunk and limb muscles  
The first step of skeletal muscle development is the formation of cell clusters called 
somites which originate from paraxial mesoderm in an anterior-posterior direction. The 
ventral side of the somite forms the sclerotome, which gives rise to the axial skeleton 
whilst the dorsal somite, called the dermomyotome (DM) contains skeletal muscle 
progenitor cells of the trunk, limb and some head muscles and can be divided into 
epaxial and hypaxial parts (Christ and Ordahl, 1995). Figure 1.3 shows the developing 
origin of various body muscles.  
 
The myotome is first formed underneath the epaxial DM and is responsible for the 
formation of trunk musculature (Tajbakhsh and Buckingham, 2000). Structures 
surrounding the DM produce signals that induce myogenic factor 5 (Myf 5) gene 
expression, which in turn activate myogenic differentiation factor (MyoD) gene. Cells 
then start to fuse at somite boundaries and form multinucleated myotubes. At the limb 
level, the muscle progenitor cells delaminate from the hypaxial DM and migrate into the 
limb buds (Buckingham et al., 2003, Gros et al., 2004).  
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Figure  1.3 Diagram showing the developmental origin of various body muscles.  
Figure showing a mouse embryo with the developmental origin of Branchial arch, Extra-ocular, limb, tongue, 
laryngeal and trunk muscle. It also show the location of developing somites (figure taken with permission from 
Rios and Marcelle, 2009)   
 
 
 
 
This delamination and migration process has been described to be mediated by c-met, a 
tyrosine kinase receptor that binds hepatocyte growth factor (HGF), and the paired box 
gene 3 (Pax3) (Bober et al., 1994, Tajbakhsh et al., 1997). These migrated cells will 
then reach the limb where they will start activating myogenic regulatory factors 
(MRFs), a family of basic helix–loop–helix (bHLH) transcription factors that regulate 
myogenesis.  
 
Myogenic cells forming back muscles are initially activated by Myf 5, which then 
activate the MyoD gene. In contrast, myogenic cells forming the limbs activate MyoD 
via pax3 and c-met dependent pathway (Pownall and Emerson, 1992; Braun and 
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Arnold, 1996; Cossu et al., 1996). Both groups of cells then express myogenin (Myog) 
and myogenic regulatory factor 4 (MRF4) to produce their myotubes and myofibres 
(Braun and Arnold, 1996). 
 
MyoD and Myf 5 belong to a family of transcription factors called the myogenic bHLH 
or MRFs. The proteins of this family all bind to similar sites on DNA and activate 
muscle specific genes. Even though limb and trunk require different genetic pathways to 
initiate the myogenic differentiation process, these myogenic transcription factors can 
compensate for the loss of one or the other. Rudnicki and colleagues (1992) showed that 
Myf 5 and MyoD could achieve the same functions. However, when mice lacking either 
MyoD or Myf 5 genes; the resulting mice have normal muscle development but may 
have breathing difficulties due to rib malformation (Braun et al., 1992).  
 
Soon after migration of cells to their target destination, they fuse to form multinucleated 
myotubes through the activation of MRFs. Fusion is initiated when the myoblasts leave 
the cell cycle, stop dividing and secrete fibronectin into their extracellular matrix, 
binding to it through their major fibronectin receptor, α5β1 integrin (Menko and 
Boettiger, 1987). Cell membrane glycoproteins, including several cadherins and cell 
adhesion molecules (CAMs) will then direct cell alignment (Knudsen et al., 1990). 
After alignment is accomplished cells will start fuse together by calcium ionosphere 
activation that carries calcium across cell membrane.  
 
1.2.3.2. Development of Craniofacial muscles  
The genetic regulation of skeletal muscle development in the craniofacial region is still 
subject to study compared to the large amount of knowledge gained concerning the 
transcription factors and signalling molecules driving myogenesis in the limb and trunk.  
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The craniofacial muscles can be divided into three main groups based on their 
developmental origin:  
1. Somite derived tongue and neck muscles 
2. Muscles controlling eye movement or the extra ocular muscles 
3. Branchomeric muscles  
 
Developmentally, craniofacial muscles experience a unique environment compared to 
those in the trunk and limbs. Distinct to muscles of the trunk and limbs, which are all 
somitic in origin, craniofacial muscles developed from three different regions of the 
embryo; namely the occipital somites, precordal (cranial to the notochord) and paraxial 
head mesoderm (PHM). 
 
Extraocular muscles, which control eye movements, are derived from precordal and 
paraxial head mesoderm (PHM). They have metabolic and fibre type compositions 
distinct from most of trunk muscles (Cheng et al., 2004). On the other hand, the 
progenitors of the branchiomeric muscles originate from the PHM, and the first five 
somites (occipital somites) give rise to the muscles that elevate or rotate the skull in 
addition to the tongue and laryngeal muscles (Noden and Francis-West, 2006). 
 
The PHM is unsegmented unlike its trunk counterpart (Kuratani, 2005). Consequently, 
the stem and progenitor cells of most of the head musculature reside in a uniquely 
organised embryonic tissue compared to that of the other muscle progenitors. 
Muscles of the craniofacial region derive their connective tissue component from neural 
crest cells that provide the connective tissue of extrinsic ocular, glossal and all branchial 
arch skeletal muscles. The mesoderm derivatives provide connective tissues for other 
craniofacial muscles (Sperber, 1989).  Neural crest may play a crucial role in migration, 
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patterning, proliferation, and differentiation of head skeletal muscle progenitors (Rinon 
et al., 2007). The migration of neural crest cells and formation of branchiomeric 
muscles are explained in figure 1.4.  
 
 
 
 
 
Figure  1.4 Neural crest cells migration and formation of branchial arch muscles. 
Figure shows transverse views of three stages of avian head and the combined migration and expansion of 
surface ectoderm (green), neural crest (blue) and superficial myogenic paraxial mesoderm (red) populations. 
All population shift and expand in the same dorsal to ventral direction during these stages (Taken with 
permission from Noden and Francis-West 2005).  
 
 
 
 
 
Craniofacial myogenesis has a distinct regulatory programme in the early stages of 
myogenesis, such as the specification and migration stages, compared to other muscles. 
The signals that involved in formation of craniofacial and limb muscles are highlighted 
in figure 1.5. While Wnt and sonic hedgehog (Shh) signals from the surrounding 
structures induce myogenesis in somites and bone morphogenetic protein (BMP) signals 
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from the lateral plate and dorsal neural tube inhibit myogenesis, the antagonist of Wnt 
(Frzb) and BMP (noggin and Gremlin) arising from the neural crest cells and other 
surrounding tissues encourages myogenesis in the somitomeres and branchial arches 
indirectly, by repressing the inhibitory actions of Wnts and BMPs (Munsterberg et al., 
1995, Dietrich et al. 1998, Tajbakhsh et al. 1998, Cossu and Borello, 1999, Linker et 
al., 2003, Tzahor et al., 2003; Yamane, 2005). 
 
 
 
 
Figure  1.5 The differences in myogenesis pathways between CSkM and LM.  
Figure of cross sections of mouse embryo showing regulatory molecules in (A) the somite (dermomyotomes, 
myotomes) and (B) somitomeres (branchial arch) during the early stages of myogenesis. Wnt and sonic 
hedgehog (Shh) signals from the surrounding structures induce myogenesis in somites. While antagonists of 
BMP (noggin and Gremlin) and Wnt (Frzb) promote head myogenesis. (Taken with permission from Yamane, 
2005) 
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Although MRFs are required for craniofacial myogenesis, their upstream regulators 
appear to be distinct from those essential in the trunk and limb myogenesis. Knockouts 
of the transcription factors Tbx1, Pitx2, musculin and transcription factor 21 (TCF21 
also known as capsulin); result in defects in the formation of distinct head muscles (Lu 
et al., 2002, Kelly et al., 2004). By contrast, Pax3 is neither expressed nor required 
during head muscle formation and, consequently, mice that lack both Pax3 and Myf5 
develop craniofacial muscles normally, whereas trunk and limb muscles are largely 
absent (Tajbakhsh et al., 1997, Mootoosamy and Dietrich, 2002).  
 
In addition to the previously mentioned differences between craniofacial and non-
craniofacial muscles, the craniofacial muscles appear to also have different regenerative 
potentials. Pavlath and colleagues found that there is a regenerative difference between 
masseter and limb muscle, which may be related to intrinsic differences between the 
muscle precursor cells in these two anatomically distinct muscle types (Pavlath et al., 
1998). Additionally, satellite cell isolated from masseter muscle are reported to 
proliferate more and differentiated rather later than those from limb muscle (Ono et al., 
2010). However, when transplanted in limb region, masseter-derived satellite cells 
regenerated limb muscles as efficiently as those from limb muscle (Ono et al., 2010). 
 
There are also some reports indicating that craniofacial muscles (masseter muscle) 
continue to express many molecules normally downregulated in adult limb skeletal 
muscle, such as developmental and neonatal myosin heavy chain (Butler-Browne et al., 
1988) and embryonic fibronectin splice variant EIIIA (Price et al., 1998).    
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In addition to the differences in development between these muscle groups, bone 
development also differs between the craniofacial and limb region of a vertebrate. These 
differences are explained in the following section. 
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1.3. Osteogenesis 
1.3.1. Bone 
Bone is a strong anatomical structure that has the ability to provide protective covering 
of vulnerable structures in the body such as brain, rigid internal support for the body 
and the articulation and attachments of muscles. It provides a site of storage of minerals 
and lipids in addition to blood cell production (Martini and Ober, 2006).  
Bone can be divided into two types; compact and spongy bone. These are depicted in 
figures 1.6 and 1.7.  
 
Based on the microscopic features, osseous tissue is a collagen and calcified mineral 
based extracellular matrix (ECM). It is divided into two distinct types based on the 
architecture of the connective tissue ECM; cortical and cancellous (figure 1.6). The 
former is a relatively dense, compact type of osseous forming the outer part of a bone.  
The cancellous type occurs as spongy with a ‘honey comb’ of branching bars, plates and 
rods called ‘trabeculae. This architecture accommodates a higher level of vascular tissue 
compared to cortical bone that nourishes bone marrow and its embedded populations of 
various stem cells (Tortora & Derrickson 2009a).   
 
Cortical and cancellous bones constitute 80 % and 20 % of the adult skeleton, 
respectively. The predominant mineral salt is a combination of calcium phosphate and 
calcium hydroxide called hydroxyapatite, (Tortora & Derrickson 2009a).  
 
Macroscopically, skeletal bones are divided into four types; long, short, flat and 
irregular. A prototypic long bone is composed of seven structural entities: diaphysis, 
epiphyses, metaphysis, articular cartilage, periosteum, medullary cavity and endosteum. 
The initial three constitute the larger bone structure; with the articular cartilage and 
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periosteum forming on the outside, and medullar cavity and endosteum within it. Other 
bones are composed of different combinations of these structural elements. The various 
macro structural attributes of a prototypic long bone are described in figure 1.7 (Tortora 
& Derrickson 2009a).   
 
The vertebrate skeleton is the outcome of cells from three distinct embryonic lineages. 
Cranial neural crest cells are responsible for the formation of craniofacial skeleton, 
whereas the axial skeleton is derived from paraxial mesoderm (somites), and the limb 
skeleton is the product of lateral plate mesodermal cells.  
 
There are three major bone cell types. Osteoblasts are responsible for building up bone 
in a process called osteogenesis. They secrete the collagenous and non-collagenous 
proteins of bone matrix. The osteocytes are mature bone cells that are contained in a 
lacunar space filled with bone fluid, mineralised collagen fibrils and proteoglycans. 
Osteoclasts have the function of bone resorption by degrading old mineral matrix to 
facilitate bone deposition by osteoblasts.     
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Figure 1.6 Microscopic structure of long bone 
Figure shows a cross section along the transverse and sagittal planes of a hypothetical disaphyseal 
segment of bone. (a) The axis from right to left shows periosteum followed by compact cortical bone in 
the middle and spongy bone to the left. An osteon, haversian canal, resident blood and lymphatic vessels 
are surrounded by concentric rings of lamellae. Spaces between lamellae are either lacunae (osteocyte 
sites) or emanating canaliculi, indicated in the magnified representation on the upper right hand side are 
trabecular rods that lamellae are arranged into. (b & c) Magnified views of the cross section of a 
trabecula indicating the irregular arrangement of lamellae. Fig c also depicts osteoblastic and osteoclastic 
activity on the periphery. (Figure taken with permission from Tortora and Derrickson 2009) 
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Figure  1.7 Macroscopic structure of a long bone 
Image shows a long bone (humerus, arm) with structural segments highlighted along a descending vertical axis 
on the left hand side of image; and sub-cortical structures of a transverse section on the right hand side   
(Figure taken with permission from Tortora & Derrickson 2009).  
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An interplay between several molecules leads to the formation of bone. The main ones 
of high significance include bone morphogenic proteins (BMPs), Runx2, alkaline 
phosphatase (Alp) and bone sialoprotein (Bsp). 
 
Several bone morphogenic proteins (BMPs) are capable of acting as potent bone inducer 
factors, including BMP-2, -4, and -7 (Canalis et al., 2003; Ito and miyazono, 2003; 
Chen et al., 2004; Farhadieh et al., 2004). BMP-7 is considered a weaker bone inducer 
than BMP-2 and -4 (Chen et al., 2004). The BMPs initiate their signalling pathway by 
binding to BMP receptors that activate the expression of target genes (Chen et al., 
2004). Runx2 is also involved in this signalling cascade mediating the osteogenic 
differentiation initiated by BMPs (Chen et al., 2004).   Other proteins and hormones 
involved in osteogenic regulation and differentiation include Parathyroid hormone 
(PTH), vitamin D and TGF-β1.     
 
Runt-related transcription factor 2 (Runx2) (a member of a small transcription factor 
family that shares DNA-binding domains of homology with Drosophila Runt ) is a key 
regulator of osteoblast differentiation and function (Ducy et al., 1997, Komori et al., 
1997, Otto et al., 1997, Jonason et al., 2009). It also interacts with and controls the 
expression levels of several osteogenic genes, including osteocalcin (an osteoblast-
specific marker), Bsp, Alp, and type I collagen (Ducy et al., 1997). 
 
Alkaline phosphatase (Alp) is a commonly used osteogenic marker; mature Alp is 
glycolysed and anchored to the cell plasma membrane. Alp is expressed at high levels in 
mineralised tissues and its importance for osteogenic differentiation is well established 
as an inorganic phosphate donor to growing calcium phosphate crystals. Alp is essential 
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for expression of necessary genes to produce osteogenic extracellular matrix (ECM) 
(Golub and Boesze-Battaglia, 2007) 
 
Bone Sialoprotein (Bsp) is first expressed at the onset of bone, cementum, and dentin 
formation. Its expression is restricted to mineralised connective tissues (Chen et al., 
1992; Ogata, 2008). Bsp is believed to initiate calcium deposition by binding calcium 
ions. It is also involved in the regulation of cell attachment to bone matrix (Arnett and 
Henderson, 1998).  
 
1.3.2. Ossification  
Osteogenesis, or bone development takes place through two ways; these are 
intramembranous and endochondral ossification. Intramembranous ossification occurs 
in craniofacial region, in which cranial neural crest cells migrate to the location where 
the skeletal elements will develop and differentiate into osteoblast cells that start bone 
formation by replacement of sheet-like connective tissue membrane with bony tissue 
(Gilbert and Singer, 2006). The endochondral ossification, leading to development of 
limbs and trunk, involves the formation of cartilage tissue from aggregated 
mesenchymal cells, and subsequent replacement of cartilage tissue by bone (Gilbert and 
Singer, 2006). A depiction of this process is illustrated in figure 1.8 and 1.9. 
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Figure  1.8 Schematic diagram of intramembranous ossification.  
(1-2) Mesenchymal cells condense to produce osteoblasts, which deposit osteoid matrix. These osteoblasts 
become arrayed along the calcified region of the matrix. Osteoblasts that are trapped within the bone matrix 
become osteocytes (3) The extracellular matrix develops into trabeculae that fuse one to another to form 
spongy bone. (4) The mesenchyme condenses at the periphery of the bone and develops into the periosteom, a 
thin layer of compact bone will then replace the surface layers of the spongy bone, but spongy bone remains in 
the centre. (Taken with permission from Tortora and Derrickson, 2009).  
 
 
 
The mechanism of intramembranous ossification involves bone morphogenetic proteins 
and the activation of Runx2. Bone morphogenetic proteins from the head epidermis are 
thought to instruct the neural crest-derived mesenchymal cells to become bone cells 
directly (Hall, 1988). The BMPs activate the Runx2 gene in the mesenchymal cells. The 
Runx2 transcription factor appears to be able to transform mesenchyme cells into 
osteoblasts. 
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The process of endochondral ossification starts by the commitment of the mesenchymal 
cells to become cartilage cells (chondrocytes), which proliferate rapidly to form a model 
for the bone. The chondrocytes then stop dividing and increase their volume 
(hypertrophic chondrocytes); they alter the matrix they produce to enable it to become 
mineralised. Finally the blood vessels invade the cartilage model formed.   
 
The hypertrophic chondrocytes die by apoptosis. This space will become bone marrow. 
As the cartilage cells die, a group of cells that have surrounded the cartilage model 
differentiate into osteoblasts. The osteoblasts begin forming bone matrix on the partially 
degraded cartilage (Bruder and Caplan, 1989; Hatori et al., 1995). Eventually, all the 
cartilage is replaced by bone. Thus, the cartilage tissue serves as a model for the bone 
that follows. The skeletal components of the vertebral column, the pelvis, and the limbs 
are first formed of cartilage and later become bone. This process is depicted in figure 
1.9. 
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Figure  1.9 Schematic diagram of endochondral ossification.  
(1-2) Mesenchymal cells condense and differentiate into chondrocytes to form the cartilaginous model of the 
bone. (3) Chondrocytes in the centre of the shaft undergo hypertrophy and apoptosis while they change and 
mineralise their extracellular matrix. Their deaths allow blood vessels to enter. (4) Blood vessels bring in 
osteoblasts, which bind to the degenerating cartilaginous matrix and deposit bone matrix. (5-6) Bone 
formation and growth consist of ordered arrays of proliferating, hypertrophic, and mineralising chondrocytes. 
Secondary ossification centres also form as blood vessels enter near the tips of the bone. (Taken with 
permission from Tortora and Derrickson, 2009) 
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1.3.3. Heterotopic ossification  
Ectopic bone in skeletal muscle has been observed in states of disease and experimental 
conditions. Heterotopic ossification, myositis ossificans and more aggressive diseases 
such as fibrodysplasia ossificans progressive (FOP) and musculoskeletal neoplasms 
exhibit unwanted bone formation in skeletal muscle (Sawyer et al., 1991; Kaplan and 
Smith, 1997; Mahboubi et al., 2001). Several experimental studies have shown that 
ectopic bone formation occurs as a result of microinjuries and subsequent muscle 
necrosis, which leads to macrophage invasion followed by proliferation of chondrocytes 
and osteoblasts. The bone formed in both humans and mice arises via the endochondral 
ossification route (Aro et al., 1991; Kan et al., 2004), but the origin of the chondrogenic 
cells is unknown. FOP, on the other hand, is believed to be a rare genetic disorder of 
connective tissues characterised by congenital malformation of the great toes and by a 
progressive heterotopic osteogenesis (Kaplan and Smith, 1997; Mahboubi et al., 2001). 
These observations have led to the investigation for osteoprogenitor cells within skeletal 
muscle tissues.  
 
1.3.4. Osteogenic potentials of muscle precursor cells 
Despite the fact that mesenchymal stem cells are being widely recognised as a primary 
source of osteoprogenitor cells, non-bone-marrow sources are important to pursue as an 
alternative to bone marrow when patients do not wish to have a bone marrow aspirate or 
when the bone marrow is compromised, as can occur in the elderly or in those with 
bone marrow disease. Non-bone-marrow-derived cells might also be more easily 
obtained when tissues are accessible during a surgical procedure. 
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Most published work is on cells isolated from non-craniofacial muscle (Katagiri et al., 
1994; Gussoni et al., 1999; Bosch et al., 2000; Lee et al., 2000; Asakura et al., 2001; Li 
and Huard, 2002, Qu-Petersen et al., 2002; Mastrogiacomo et al., 2005); only a few 
have investigated the osteogenic efficiency of CSkM (Sinnan et al., 2006).  
 
There is considerable evidence supporting the skeletogenic ability of muscle-derived 
cells (MDCs) both from in vivo and in vitro experiments, as well as from pathological 
conditions. Van de Putte and Urist (1965) and Urist et al., (1970) originally showed that 
demineralised bone implanted intramuscularly could lead to the formation of new bone, 
and that this activity was mediated by BMP (Urist and Strates, 1971). Many researchers 
are challenged to identify and isolate multipotent stem cells from the skeletal muscle. 
This is due to the lack of specific markers to identify cells with osteogenic ability in 
skeletal muscles (Bosch et al., 2000; Levy et al., 2001).  
 
Bosch et al., in 2000 found that cells isolated from hind limb muscles of dystrophic 
neonatal mice (mdx), when treated with BMP2, produced positive Alp stain and 
participated in in vivo bone formation. 
 
On the other hand, Lee et al., (2000) have gone further and isolated a clonal cell 
population from the muscle of mdx mice (mc13). They showed that these cells could be 
induced in vitro by BMP2 to express osteocalcin mRNA (Lee et al., 2000). Furthermore 
they showed that transduced mc13 cells, constitutively expressing BMP2, formed bone 
when implanted subcutaneously into immunocompromised mice. 
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Satellite cells on the other hand also showed to have osteogenic potential when properly 
stimulated with rhBMP4 and/or BMP7. It can express Alp and up-regulated the 
expression of mRNA for osteocalcin and alkaline phosphatase (Asakura et al., 2001).  
 
Based on their differential adherence of human muscle cells to tissue culture plastic; 
Levy and colleagues (2001) isolated two different cell populations from muscles tissue. 
According to them, the cells that adhered to the uncoated flasks form the connective 
tissue compartment of the isolate while suspended cells from their supernatant that 
adhered when transferred to collagen coated flasks, were deemed as satellite cells. They 
found that, alkaline phosphatase activity was detectable at early stages of isolated 
connective tissue cells (adhered to plastic). They concluded that, human skeletal muscle 
connective tissue contains osteo-progenitor cells that may be of pericytes or 
perivascular origin.  
 
In vitro experiments on cells isolated from human masseter muscle have shown that a 
selected pre-myogenic population [NCAM
+
 (neural cell-adhesion molecule), a satellite 
cell marker] can up-regulate osteogenic markers when stimulated with BMPs (Sinanan 
et al., 2004).  
 
In another human study, Mastrogiacomo et al., (2005) found that plastic adhering 
human muscle cells (cells adhered to uncoated flask for 72 hours) showed positive 
staining for Alp, osteopontin and osteonectin in addition to the ability to form bone in 
vivo. They reported the isolation of an Alp
+
/CD34
-
 cell population from the human 
skeletal muscle, which forms both cartilage and bone in vivo. Isolated cells were 85% 
positive for Alp. At the beginning of the culture, skeletal muscle cells expressed 
chondro-osteogenic commitment markers such as Sox9 and Runx2. They demonstrated 
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that these cells isolated and expanded in vitro could undergo osteo-chondrogenic 
differentiation as evidenced by detection of calcium (osteogenic) and proteoglycan 
(chondrogenic) deposition as well as by the expression of master genes characteristic of 
both pathways. 
 
In 2008, Hashimoto and colleagues, isolated human muscle progenitor cells on collagen 
coated flasks, and showed that isolated cells were spontaneously expressing osteoblast-
specific proteins Alp and Runx2 and were able to undergo terminal osteogenic 
differentiation without exposure to an exogenous inductive agents.  
 
These studies strongly suggested that skeletal muscle may contain osteoprogenitor cells 
that can differentiate into bone forming cells both in vitro and in vivo.  
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1.4. Skeletal Muscle Stem cells 
1.4.1. Background 
1.4.1.1. Stem cells 
These are unspecialised cells that have two distinct properties; the ability for long term 
self-renewal and the capability to differentiate into one or more specialised cells.  The 
differentiation ability or so called plasticity decreases with maturity. Cells taken from 
the early divisions of the zygote are totipotent, that is they are able to form any cell type 
in the embryo and the cells of the placenta (Alison et al., 2002).  A few days later, the 
inner cell mass (ICM), a group of cells within the blastocyst, from which embryonic 
stem cells (ES) are derived,  and they are capable of producing any cell product of the 
three germ layers but not the placenta. Hence, these cells are called pluripotent (Alison 
et al., 2002). Postnatally and during adult life tissue specific stem cells, adult stem cells, 
reside in most organs of the developing animal. The role of these cells is to act as a 
source of new cells for postnatal growth and repair or as a mechanism for tissue 
maintenance, growth and repair in later life (Blau et al., 2001).   
 
They are present in various niches throughout the body, such as bone marrow, brain, 
liver and skin, as a mechanism for tissue maintenance, growth and repair in later life 
(Lavker and Sun 2000; Uchida et al. 2000; Vessey and de la Hall 2001; Wagers et a,. 
2002). In addition to the above mentioned tissues adult stem cells were also reported to 
be present in  craniofacial skin, palate, oral mucosa, periodontal ligaments surrounding 
the tooth and dental pulp etc. (Fernandes et al., 2004; Widera et al., 2009; Davies et al., 
2010; Seo et al., 2004; Gronthos et al., 2000).  
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In theory, adult stem cells could be harvested from a patient, differentiated in the 
laboratory and transplanted back into the same individual for tissue repair, thus 
bypassing the need for immunosuppression. However, for some stem cell types, low 
frequency, difficulties in accessing the niche and isolating the cells, restricted lineage 
potential and poor growth in cell culture may render their use impractical for tissue 
engineering purposes. In these cases, ES cells are likely to provide a more appropriate 
cell source (Vogel, 2001). 
 
Until recently, adult stem cells were thought to be committed to regeneration of specific 
lineages associated with their niche, however a growing amount of data suggests these 
stem cells may actually be pluripotent (Alison et al., 2002). Plasticity of the adult stem 
cell was originally investigated by studies on stem cells derived from bone marrow 
(mesenchymal stem cell (MSC)). These studies found, experimentally, that MSCs have 
the ability to differentiate into other cell types including muscle, fat, liver, etc. (Caplan, 
1991; Baddoo et al., 2003; Alhadlaq and Mao, 2004).  
 
Human embryonic and adult stem cells each have advantages and disadvantages 
regarding potential use for cell-based regenerative therapies. One major difference 
between adult and embryonic stem cells is their different differentiation potentials 
compared to adult stem cells. Embryonic stem cells can become all cell types of the 
body while adult stem cells are thought to be limited to differentiating into different cell 
types of their tissue of origin (Strauer and Kornowski, 2003). 
 
Finding an easy reproducible method for isolating and expanding adult stem cells is still 
subject to investigation. Embryonic stem cells, on the other hands, can also be relatively 
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easily grown in culture. This is an important distinction, as large numbers of cells are 
needed for stem cell replacement therapies. 
 
Other main difference would be the immune rejection after transplantation. Adult stem 
cells, and tissues derived from them, are currently believed less likely to initiate 
immune rejection after transplantation. This is because a patient's own cells could be 
expanded in culture, properly treated by necessary agents, and then reintroduced into the 
patient. This represents a significant advantage, as immune rejection can be avoided 
only by continuous administration of immunosuppressive drugs (Strauer and 
Kornowski, 2003).  
 
Biological difficulty is also a challenge for using bone marrow stem cells as patients 
may have compromised bone marrow or simply do not want to have bone marrow 
aspirate (Krebsbach and Robey, 2002). Therefore, work has focused on finding other 
sources of stem cells that may have the same abilities of the MSCs and might also be 
more easily obtained when tissues are exposed as part of surgical procedure. These 
include skeletal muscle which considered being a promising source of stem like cells as 
it is relatively easier to access especially craniofacial muscle (masseter), which can be 
accessed intra-orally under local anaesthesia with no scar formation. 
 
These are unspecialised cells that have two distinct properties; the ability for long term 
self-renewal and the capability to differentiate into one or more specialised cells.  The 
differentiation ability or so called plasticity decreases with maturity. Cells taken from 
the early divisions of the zygote are totipotent, that is they are able to form any cell type 
in the embryo and the cells of the placenta (Alison et al., 2002).  A few days later, the 
inner cell mass (ICM), a group of cells within the blastocyst, from which embryonic 
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stem cells (ES) are derived,  and they are capable of producing any cell product of the 
three germ layers but not the placenta. Hence, these cells are called pluripotent (Alison 
et al., 2002). Postnatally and during adult life tissue specific stem cells, adult stem cells, 
reside in most organs of the developing animal. The role of these cells is to act as a 
source of new cells for postnatal growth and repair or as a mechanism for tissue 
maintenance, growth and repair in later life (Blau et al., 2001).   
 
1.4.2. Muscle derived cells 
1.4.2.1. Background 
Several advances in 1961 provided a fundamental understanding of skeletal muscle cell 
biology. Firstly, the multinucleated skeletal myofibre was demonstrated to be formed by 
the fusion of many mononucleate myoblasts (Cooper and Konigsberg 1961). Later on 
the same year, Katz and Mauro described an apparently quiescent cell located between 
the sarcolemma and basement membrane of the muscle fibre. Mauro gave them the 
name satellite cells for their anatomical location on muscle fibre periphery (Katz 1961; 
Mauro 1961). The satellite cell occupies an identical anatomical position in the majority 
of vertebrates and is responsible for post-natal growth and regeneration of the muscles.   
 
The remarkable capacity of muscle tissue to regenerate following injury highlights the 
potential of these quiescent cells. Satellite cells are activated upon damage to muscle, 
proliferate and become muscle precursor cells (MPCs) that fuse to make myofibres 
thereby regenerating the tissue (Cornelison and Wold, 1997).  
 
MPCs express muscle specific markers (such as desmin) (Seale and Rudnicki, 2000) 
before they start to fuse to form myofibre. This process is mediated by several growth 
factors and genes such as insulin-like growth factor-I (IGF-I), which is synthesised and 
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secreted by muscle cells to enhance proliferation and differentiation (Stewart and 
Rittweger, 2006; Clemmons, 2009), Myof 5, MyoD, Myog, and MRF 4 genes (Stewart 
and Rittweger, 2006).  
 
However, the ratio of satellite cells is different among different muscles.  Renault et al., 
(2002), found that the ratio of satellite cells was slightly higher in limb (biceps brachii) 
muscle than in masticatory (masseter) muscle. In addition, the satellite cells ratio in both 
muscle groups decreased with age. Even though the number of mean nuclei in masseter 
muscle is higher than limb muscle; it has been found that the regenerative capacity is 
reduced in masseter muscle compared to that of limb muscle after exogenous (freeze or 
crush injuries) traumas (Pavlath et al., 1998). These differences might be explained by 
the differences in embryologic origins; myogenic pathways and gene expression pattern 
of craniofacial and limb muscle (Pavlath et al., 1998; McLoon et al., 2007).  
 
1.4.2.2. Types of muscle derived stem-like cells  
In addition to the satellite cells, there are other stem cell-like populations within skeletal 
muscle that may be of interest in the field of skeletal muscle repair and regeneration. 
Potential sources of stem/precursor cells from various tissues in the skeletal muscle 
complex are shown in figure 1.10. 
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Figure  1.10  Potential sources of stem/precursor cells from various tissues in the skeletal muscle complex.  
Skeletal muscle has an intricate anatomy and is composed of multinucleate myofibres arranged into functional 
units called fascicles decorated with peripheral satellite cells and encompassed within three connective tissue 
sheaths, the endo-, peri- and epi-mysium. Each of the component layers contains a variety of different cells: 
Schwann cells, satellite cells, endothelial cells, haematopoietic cells and interstitial mesenchymal fibroblasts. 
Any or all of these cell types could give rise to multipotent cells. The developmental origin of the cells may also 
play a role in defining this multipotentiality. DS, developmental source of the tissue; PNS, postnatal source of 
the tissue. (Taken with permission from Sinanan et al., 2006). “This figure was originally published in Biology 
of the cells. Sinanan and colleagues, muscling on stem cells. Biology of the cells; 2006; 98: 203-214 © Biology of 
the Cell” 
 
 
 
 
 
A variety of methods for isolating MDCs (muscle-derived cells) have been employed, 
with the initial step usually involving the release of mononuclear cells from the host 
tissue, followed by fractionation of the population to isolate stem cell/precursor 
populations (Sinanan et al., 2006). 
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Depending on the isolation method used or described features of the isolated cells, they 
are called either muscle-derived stem cells (MDSCs) (Lee et al., 2000), skeletal muscle 
side population (SMSP) (Asakura et al., 2001), or muscle derived hematopoietic stem 
cells (MD-HSCs) (McKinney-Freeman et al., 2002). Whether these cells are distinct 
populations or the same population of cells at different stages of maturation is still a 
subject to study (Cao and Huard, 2004).  
 
In recent years, several groups have attempted to characterise undifferentiated cells 
situated in skeletal muscles. The identification of muscle stem cells was based on the 
presence of certain surface markers such as: stem cell antigen-1 (sca-1) and CD34 
(marker of hematopoietic and satellite cells), CD45 and c-kit (markers of hematopoietic 
cells) and desmin (a marker of myogenic cells), Oct4 (embryonic stem cell marker 
(Jiang et al., 2002; Romero-Ramos et al., 2002).  However, the level of expression of 
these markers is not consistence between the different studies (Meeson et al., 2004, 
Deasy et al., 2005, Jankowski et al., 2002, Lee et al., 2000), which may suggest that 
several distinct populations of multipotential muscle derived stem cells may exist. 
Proposed markers distinguishing various stages along the myogenic differentiation 
pathway are shown in figure 1.11.  
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Figure  1.11 Markers distinguishing various stages of differentiating myogenic stem cell  
Figure shows the potential markers that can be used to differentiate between muscle derived cells at different 
stages of differentiation. Discrepancies in expression are distinguished as -/+ and highlight the difficulties 
associated with describing distinct cellular phenotypes. Sca-1 and CD34 expressed in muscle derived stem cells 
while myogenic specific markers expressed later along myogenic lineages (Taken with permission from Deasy 
et al., 2001) 
 
 
 
 
The variability in expression profiles reported could be a result of either using different 
methods of protein analysis, the use of different isolation method or be dependent on the 
status of the cells at the time of analysis (for example whether they are quiescent, 
proliferating, differentiating, or apoptotic) (Beauchamp et al., 2000, Royer et al., 2002, 
Mitchell et al., 2005).  
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MDSCs were isolated based on differences in adhesion properties of cells (Qu-Petersen 
et al., 2002). Cells were differentially plated on pre-coated tissue culture flask in a 
systematic time course. Firstly, after enzymatic digestion of tissues, cells were seeded 
on a culture flask for one hour. The non-adherent cells were then transferred to a new 
flask. Non-adherent cells were then sequentially transferred every day to new flask up 
until reach plate 6 which believed to have the myogenic cell fraction. This method was 
called differential pre-plating method, which first described by Yaffe (1968) and Richler 
and Yaffe (1970) to isolate more purified myogenic cells. Recently this method has 
been modified and used to isolate MDSCs (Qu-Petersen et al., 2002). MDSCs cultured 
in vitro differentiate spontaneously into myotubes, but also, when appropriately 
stimulated (by addition of growth factors to the medium or transfection with certain 
genes), these cells can also give rise to osteoblasts (Bosch et al., 2000; Lee et al., 2000), 
chondroblasts (Kuroda et al., 2006), hematopoietic cells (Sherwood et al., 2004) or 
endothelial cells (Arriero et al., 2004). 
 
Skeletal muscle side population (SMSP) cells on the other hand are isolated using flow 
cytometry sorting after staining them with Hoechst dye 33324 (Asakura et al., 2002). 
The dye effluxing is a description of SMSP cells rather than defining certain features or 
functions of these cells. Even though initially associated with a subpopulation of 
hematopoietic stem cells (Kim et al., 2002), side population cells have been found in 
other tissues, in addition to skeletal muscle, such as, mammary gland, lungs, small 
intestines, bone marrow, and cancer cells (Asakura and Rudnicki, 2002, Asakura et al., 
2002, Summer et al., 2003, Jonker et al., 2005, Ho et al., 2007).  
Therefore, side population phenotype is a rather ubiquitous across various tissues 
associated with low level of differentiation than certain features or origin of cells 
(Burdzińska et al., 2008). 
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Skeletal muscle side population cells (show higher efflux of Hoechst dye 33324) are 
spherical, small, and poorly adhered to the tissue culture flask (Gussoni et al., 1999). 
About 90% of them expressed sca-1 and CD34. They also express CD45 and c-kit, but 
not desmin
 
(Asakura et al., 2002, Sherwood et al., 2004, Uezumi et al., 2006). 
Assessment of the differentiation potential revealed that SMSP could give rise into all 
haematopoietic lines both in vitro and in vivo (Asakura et al., 2002, Jackson et al., 
1999). However, their myogenic differentiation abilities are limited. Although SMSP 
cells in myogenic environment can undergo myogenic differentiation, they do so with 
low efficiency (Gussoni et al., 1999, Asakura et al. 2002).  Interestingly, only the 
CD45
-
 subpopulation of SP cells possesses such a capability whereas CD45
+
 SP cells do 
not undergo myogenic specification even when co-cultured with myoblasts (Asakura et 
al., 2002) due to their commitment to haematopoietic lineage. When tested in vivo, side 
population cells contribute to formation of new fiber in damaged muscle and can be 
located in the position of satellite cells after transplantation. However, the CD45
-
 
subpopulation of cells differentiates into muscle fibers in at greater degree than CD45
+
 
cells, confirming in vitro studies (Asakura et al., 2002, McKinney-Freeman et al., 
2002).  
 
Myogenic specification of SMSP does not appear to be dependent on Pax7 as in Pax7
-/-
 
mice, the number and function of SMSP was not different to that of wild type (Asakura 
et al., 2002, Seale et al., 2004). 
 
The origin of SMSP is not known however there are several suggestions that SMSP 
may be considered as a subset of endothelial cells present in capillaries or veins in 
undamaged skeletal muscle (McKinney-Freeman et al., 2003, Peng and Huard, 2004, 
Uezumi et al., 2006); other researchers have suggested a bone marrow origin at least for 
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CD45
+
 subpopulation (Ojima et al., 2004, Uezumi et al., 2006). All this data may 
suggest that SMSP and satellite cells are distinct populations and probably have 
different origin. In each case, many points concerning their origin, potency and 
functions remain to be elucidated.  
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1.5. Statement of thesis     
1.5.1. Observations 
Muscle tissue has a remarkable ability to repair and regenerate implying the presence of 
stem like cells in this tissue. The occurrence of ectopic ossification suggests a 
subpopulation of these stem-like cells possess the ability to differentiate along the 
osteogenic lineage forming osteoblasts that can deposit mineralised osseous deposits in 
muscle. This situation is further complicated by the observed differences in the 
development of the limb and craniofacial muscle and bone tissues in vertebrates, with 
the former arising from mesoderm derived cells and the latter from neural crest derived 
cells  
A variety of in vitro approaches have led to the isolation and partial identification of 
certain stem-like cells from muscle tissue. These studies have mainly focused on stem-
like cells from non-craniofacial sources of vertebrate muscle tissue; ignoring the 
underlying embryonic developmental differences with the craniofacial region. The 
relative accessibility of craniofacial muscle and the possibility of isolating multipotent 
stem-like cells with osteogenic capacity present a potential source of cells for tissue 
engineering applications.    
 
1.5.2. Hypothesis  
Progenitor cells isolated by an approach of differential plating from the limb and 
craniofacial muscle possess different myogenic and osteogenic differentiation 
capacities.  
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1.5.3. Aims  
The aims of the project were to isolate mononuclear cells from the craniofacial and limb 
muscles of neonatal mice; undertake their preliminary characterisation with phenotypic 
evaluations in vitro; and compare their myogenic and osteogenic potentials in vitro.   
 
1.5.4. Objectives  
The specific objectives were as follow: 
1. Isolate mononuclear cells by differential tissue culture plastic adherence and 
assess growth characteristics, morphological differences and expression of 
muscle specific desmin protein.  
2. Assess the expression of four sets of developmental genes in isolated 
mononuclear cells. The genes sets were stem cellness, myogenic, osteogenic and 
neural crest genes.   
3. Compare the myogenic differentiation potentials of isolated mononuclear cells 
by exposing to myogenic inductant supplemented growth media in vitro, and 
assessing myotube formation and expression of myogenic genes.     
4. Compare osteogenic differentiation potentials of isolated mononuclear cells by 
exposing to osteogenic inductants supplemented growth media and assessing 
alkaline phosphatase protein expression calcium mineralisation and gene 
expression. 
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A summary of analyses conducted in this study is presented in figure 1.12 in the form of 
flow chart that indicates the steps taken to address the project hypothesis. 
 
Figure  1.12 Outline of study. 
The sequence of analyses conducted is presented. The experiments were conducted on three occasions of cell 
isolation. CPC, CPP1, CPP2 and CPP3 represent CSkM derived mononuclear cells; while LPC, LPP1, LPP2 
and LPP3 indicate Limb derived mononuclear cells. Cells growth behaviour, size, gene expression profile were 
initially investigated. The myogenic and osteogenic differentiation abilities of the isolated cells were then 
investigated and analysed.     
 
 
Isolate 1 
Cells isolated CPC/CPP1/CPP2/CPP3/LPC/LPP1/LPP2/LPP3 
Cells growth 
and behaviour  
Size analysis 
Gene 
expression 
Differentiation 
experiments 
Myogenic 
Gene 
expression 
Desmin 
staining 
Myotube 
formation 
Osteogenic  
Mineralisation 
Alizarin Red S 
stain 
Calcium 
deposits  
Gene 
Expression 
Alp stain  
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2.1. Isolation of muscle precursor cells 
2.1.1. Animal used 
Normal (wild type) neonatal mice of the breed ICR/CD1 were used in this study. They 
were purchased from Harlan UK Limited laboratory. All procedures were carried out in 
accordance with the Animal (Scientific Procedures) ACT 1986. This strain of mice is 
inexpensive, robust and readily available outbred population. These strands of mice 
were available due to the work by departmental colleagues on bone tissue application 
(Buxton et al., 2008).  
 
2.1.2. Isolation of muscle tissues 
The isolation procedure of muscle tissues was carried out on three occasions with 10 
neonatal mice at each instance. Following sacrifice of mice by cervical dislocation and 
cleaning of skin over the head and back limbs with 70 % v / v ethanol in water, muscle 
tissues were carefully exposed by elevation of the skin with fine scissors. Masseter 
muscles and back limb muscles were carefully detached from underlying bone and 
transferred to a Petri dish containing calcium free Phosphate Buffer Saline (PBS); (PAA 
labs.) until muscles from all mice were isolated.  
 
2.1.3.  Isolation of Muscle cells 
The method applied for mononuclear cells from extracted tissues was a modification of 
Richler and Yaffe, (1970) Rando and Blau, (1994) and Qu et al., (1998). According to 
this approach a single cell suspension would be achieved by dissociating tissue 
fragments with enzymes. Extracted muscle tissues were minced in PBS using surgical 
blades and then homogenised into 2 ml of solution containing 1.2 U / ml dispase II 
(Roche), 0.75 U / ml Collagenase D (Roche) and 2.5 mM CaCl2 at 37ºC with gentle 
mixing every 10 min to break up any large pieces of tissues. Following incubation, 
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equal volumes of foetal bovine serum (FBS) containing medium was added to each cell 
suspension and the mixture filtered through a piece of 70 µm nylon cell strainer 
(Falcon) to remove large pieces of tissue. The filtered tissues were centrifuged for 5 min 
at 1200 rpm forming a dense pellet at the base of a 15 ml tube (Nunc, Switzerland). This 
pellet was resuspended in 5 ml of general growth medium (GM) consisting of low 
glucose Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10 % heat-
inactivated FBS (PAA Laboratories, Linz, Austria), 100 U / ml of penicillin (Gibco) and 
100 µg / ml of streptomycin (Gibco). The suspended cells were transferred to a sterile 
T-75 (75 cm
2 
surface area) polystyrene flask (Nunc, Switzerland) with added GM for 
cell culture.  
 
2.2. Cell culture   
2.2.1. Cell Culture environment 
Cell culture was used for the maintenance, propagation, experimentation and storage of 
adherent primary cells in sterile conditions. This work was conducted in a fully 
equipped tissue culture laboratory. The macro equipment used for tissue culture is 
tabulated in table 2.1. Most tissue culture consumables were acquired sterile. Non-
sterilised items, including micropipette tips, forceps etc. were autoclaved and oven dried 
at 60
o
 C prior to use.  
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Table  2.1 Cell culture environment  
Item 
No. 
Equipment Manufacturer Application 
1 Laminar Flow 
Cabinet 
NUAIRE Class II 
with UV-tube 
Confined clean work environment; pre-cleaned with 70% ethanol spray 
and propanol wipes prior to every use 
2 Incubator  Nuaire NU-5500 
DH AutoFlow Co2 
Incubator 
Set at 5% CO2 and 37
0C for cell incubation; cleaned every fortnight 
with bleaches.  
3 Cryogenic cell 
storage 
Thermo Scientific Liquid nitrogen containing chamber with removable lid and six vertical 
racks, each capable of containing 5 x 96 sample cryo-boxes. Re-
stocked with liquid nitrogen every fortnight.  
4 Water bath ETI 800 series Weekly cleaned 50 L chamber with adjustable thermostat, set at 370C 
5 Inverted 
microscope 
Olympus CXK31 Standard device with fixed binocular observation tube and 4, 10, 40 
and 100x magnification objective lenses.  
6 Haemocytomet
er with trypan 
blue 
Sigma Standard 9x (1 x1 mm) grid with cover slip.  
7 Centrifuge Different Tissue culture purposed large centrifuge. Microcentrifuge for smaller 
samples.  
8 Pipettes Qiagen Calibrated pipette ‘gun’ and 1000, 200, 20 and 10 µl  micropipettes.   
 
 
The general consumables used for cell culture are detailed in table 2.2. The flasks and 
tubes were purchased sterile and were disposed following a single use.   
 
Table  2.2 Cell culture consumables  
Item 
No. 
Equipment Manufacturer Applications 
1 Flasks Nunc Enclosed polystyrene flasks with a negatively charged inner 
substratum for cell culture. Two sizes used in this study: 150 
and 75 cm2 flasks. Inner space accessed through an air-
permeable screw-able cap. 
2 Plates Nunc Treated polystyrene multi-well plates with removable lid. 
Three types used depending on individual well size: 9.6 cm2 6-
well; 1.9 cm2 24-well; and 0.19 cm2 96 well plates. 
3 Tubes Nunc Sterile polystyrene tubes for various cell culture purposes. 
Sizes used: 50, 15, 2 and 1.5 ml. 
4 Microtubes Nunc Sterile plastic tubes of 500 and 100 µl. 
5 Cryopreservation 
tubes 
Nunc Male-screw sterile plastic vials of 2 ml volume for 
cryopreserving cells. 
6 Tube Racks Generic Autoclavable plastic racks of various sizes. 
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The cell culture media and reagents used are tabulated in table 2.3.  
 
Table  2.3 Cell culture reagents  
Abbreviations of reagents used in text are provided in the corresponding row under the applications column.  
Item 
No. 
Reagent Manufacturer Applications 
1 Dulbecco’s modified 
eagle’s medium 
PAA Lab. DMEM; L-Glutamine supplemented basal medium. Also used 
as basal medium for forming osteogenic inductive medium. 
2 Dulbecco’s modified 
eagle’s medium high 
glucose 
PAA Lab. DMEM; L-Glutamine supplemental medium used as basal 
medium for forming myogenic inductive medium. 
3 Trypsin/EDTA Gibco. A solution of 0.05 % / 0.002 % Trypsin/EDTA in calcium and 
magnesium free phosphate buffered saline. 
4 Ca2+ Mg2+ free 
Phosphate Buffered 
Saline 
PAA Lab. PBS; an isotonic solution of NaCl in water used for cell 
washing, and dilutions. 
5 Foetal Bovine Serum 
(FBS) 
Gibco FBS; heat inactivated serum sourced from South America, 
supplemented to basal medium to nourish cells whilst in culture. 
6 Antibiotics PAA Lab. A mixture of Penicillin 10 Units / ml and Streptomycin 10 mg / 
ml in PBS. This was occasionally supplemented with the 
fungicide Amphotericin B at 0.2 % of culture medium. 
7 DMSO Sigma Dimethyl sulfoxide; used as a cryoprotectant for cryopreserving 
cells. 
8 IGF-1 Sigma Growth factor used in myogenic differentiation medium.  
9 β-glycerophosphate Fischer  Water soluble phosphate donor in osteogenic differentiation. 
10 L-Ascorbate-3-
phsphate 
Fluka Metabolite used for collagen synthesis in osteogenic 
differentiation. 
 
 
The instruments and consumables used for the sterilisation of equipment are tabulated 
in table 2.4. 
 
Table  2.4 Sterilisation equipment  
Item 
No. 
Equipment Manufacturer Applications 
1 Alcohols Various Industrial methylated spirit at 70 % in water and used as a 
sterilizing spray. Propanol wipes (Azowipes) were used also 
applied to clean large surfaces. 
2 Autoclave   Pressurised steam sterilizer set at 126 o C for 20 min. 
 
 
 
 48 
 
Chapter 2 Materials and Methods 
Spectrophotometric measurements of optical densities (OD) of samples were conducted 
in a Tecan M200 (Switzerland) multi-plate spectrophotometer. This was equipped with 
a monochromator capable of creating light of a wide range of wavelengths. It was also 
equipped with a NanoQuant (Tecan) plate for ultra violet spectral quantification of 
nucleic acid. Fluorometric measurements were conducted in a Fluoroskan (Fischer UK) 
multi-well fluorometer.  
 
 
2.2.2. Isolation of different mononuclear cell sub-populations   
The cell suspensions from the muscle tissue homogenates achieved from the previous 
step were divided in to two groups; the first group comprise mononuclear cells plated in 
tissue culture flask for about 5 d  and called parent cells (PC) or unsorted cells. The 
second group consisted of suspension serially plated into three different plates; these 
were called pre-plate 1, 2 and 3 (PP1, PP2, and PP3 respectively), based on their 
adhesion differences. PP1 consisted of mononuclear cells that had adhered within 1 h of 
initial plating of suspension in tissue culture flask. The non-adherent cells from the first 
plating were transferred to a new flask for a period of 48 h. The cells that attached 
within 48 h period were called PP2. The non-adherent cells in suspension from PP2 
were transferred to a new flask for 5 d and were designated PP3.  The above described 
process is illustrated in figure 2.1.  
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Figure  2.1 Diagrammatic representation of the isolation process of the different preplates used  
in this study.  
This diagram shows muscle tissue derive cell suspension in a tube one third of this suspension would be plated 
in a tissue culture flask called PC. The other two thirds of the suspension would undergo a series of plating 
leading to the isolation of three separate populations of mononuclear cells. These cells are different based on 
their adhesion potentials and called PP1, PP2 and PP3. 
 
 
The adherent cells in culture after a few days become closely associated with each other 
(confluent). The confluent adherent cells were detached from the surface by incubating 
with trypsin/ethylene diaminetetra acetic acid (EDTA) (0.25 % trypsin, 1 mM EDTA) 
(Gibco) for 5 min at 37ºC, after a gentle wash with PBS. Trypsin activity was 
neutralised by the addition of serum containing culture medium at ratio of 3:1 medium 
to original volume of trypsin used. The cell suspension was centrifuged at 1000 rpm, 4° 
C, for 5 min and supernatant discarded.  The pellet was resuspended in an appropriate 
volume of GM for counting using haemocytometer. A description of counting method is 
provided with figure 2.2. Cells were plated into new tissue culture flask at a density of 
1000 cells / cm
2. 
 
 
 
 
 
 
 
 
 
 
 
 
1h 48 h 
PP1 PP
2 
PP
3 
 
 
 PC 
 
Cells left for 5 days 
Cells left for 5 days 
Cells in 
suspension 
 
2 PP3 
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Figure  2.2 A haemocytometer counting grid.  
The grid contains 9 large squares each with surface area of 1 mm2. The depth of the chamber is 0.1 mm 
equivalent to 10 µl. the average cell count from four large corners squares was taken and multiplied by 104 to 
give the cell density in 1 ml of solution http://commons.wikimedia.org/wiki/Image:Haemocytometer_grid.svgg 
 
 
 
2.2.3. Cryopreservation of primary cell cultures 
The ability to store small aliquots of frozen cells in liquid nitrogen (-196 °C) without the 
loss of proliferative or differentiative capacity provides great advantage in allowing 
replication of experiments and comparative studies. However, the viability of cells can 
be reduced by mechanical damage caused by ice crystal formation. Freezing is therefore 
facilitated by the cryopreservative Dimethylsulphoxide (DMSO). 
 
After trypsinisation and quantification of cells with a haemocytometer, the cells were 
then centrifuged and resuspended in freezing medium (90 % FBS and 10 % DMSO) at a 
density of 1 x 10
6
 cells / ml. cells were then transferred to prelabled cryovials (1 ml) and 
placed in Styrofoam insulator container with isopropanol, which was stored in 
mechanical freezer overnight, to allow a cooling rate of -1° C / min down to - 70° C. 
The vials were then transferred to the liquid nitrogen cryopreservation tank the 
following day.  
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2.2.4. Retrieval and re-suspension of cryopreserved primary cell culture  
Frozen vials of cells were retrieved and thawed in a 37° C water bath with constant 
agitation. The cell suspension was then transferred to a 15 ml centrifuge tube containing 
growth medium and centrifuged at 1000 rpm for 5 minutes. The supernatant was then 
discarded and the remaining pellet was resuspended in growth medium and seeded at a 
density of 1000 cells / cm
2
.  
 
2.3. Analysis of morphological characteristics  
Cells were imaged under light microscopy using a standard camera type, with image 
size calibrated to the grid of a haemocytometer. The image analysis was performed on a 
PC computer using the public domain NIH Image program NIH ImageJ version 1.34e 
software. This software was developed at the U.S. National Institutes of Health 
(available on the Internet at http://rsb.info.nih.gov/nih-image/the NIH ImageJ version 
1.34e software (http://rsbweb.nih.gov/ij/). The parameter measured was cell surface 
area. The outcomes were statistically analysed using ANOVA test to compare the 
surface area of different isolates.  
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2.4. Immunocytochemistry 
2.4.1. Background  
Immunocytochemistry is a valuable technique which used antibodies for identifying 
proteins and molecules in cells and tissues. The specific antibodies used possess highly 
speciﬁc binding to unique sequences of amino acids in proteins, thereby permitting 
visualisation and examination under microscope (Burry, 2010).  
 
There are two main methods of immunofluorescent labelling. The direct method is 
where the antibody against the molecule of interest is chemically conjugated to a 
fluorescent dye. The second method is the indirect immunofluorescence, where the 
specific antibody (called the primary antibody) is unlabelled, and a second anti-
immunoglobulin antibody directed toward the constant portion of the first antibody 
(called the secondary antibody) and is tagged with the fluorescent dye. 
 
Direct immunocytochemistry is simple and labelled primary antibodies from the same 
species can be used for multiple primary antibody experiments.  On the other hand, 
indirect immunocytochemistry technique are less expensive more flexible than the 
direct technique. It also has the advantage of increased labeling because several 
secondary antibodies can bind a single primary antibody (Burry, 2010). 
 
2.4.2. Cell fixation  
The aim of cell fixation is to preserve cell structure and make target antigens available 
to the appropriate antibodies. In this study, a combination of paraformaldehyde and 
methanol was used for this process.  
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A solution of 4 % paraformaldehyde was prepared by diluting a stock solution of 10 % 
paraformaldehyde in PBS. Paraformaldehyde was added to each specimen-containing 
well by pipetting the solution down the side of each well for 10-20 minutes in order to 
lightly fix the cells. After the removal of the paraformaldehyde and transferring the 
solution to the waste solvent bottle, the cells were washed twice with 2 ml of freshly 
prepared PBS. Thereafter, 1.5 ml of cold methanol was added drop wise for further 
fixation for 10 min. The methanol was decanted and the cells were washed twice with 
PBS. The samples were covered in 2 ml of 0.0625 % sodium azide (NaN3) in PBS and 
sealed with parafilm
®
 for storage at 4°C, ready for antibody staining.   
 
2.4.3. Desmin antibody staining 
Desmin is a cytoplasmic intermediate filament protein that is expressed by muscle 
precursor cells (MPCs) and myotubes and therefore used as a myogenic marker for such 
cells.  
 
Prior to application, the optimal dilution was determined for the primary antibody by a 
titration. The following dilutions with antibody diluent were tested: 1:20, 1:50, 1:100, 
1:200 and 1:400. Clear desmin intermediate filament staining was seen in dilutions up 
to and including 1:200, and therefore the 1:200 dilution was used for all the staining 
procedures.  
 
After fixation of cells, coverslips were removed from the wells and placed on custom-
made pedestals. Cells were washed six times with freshly prepared PBS and 
permeabilised by incubation with 0.25 % Triton-X 100 / 0.0625 % NaN3 in PBS for 10-
15 min. A blocking step with 0.5 % bovine serum albumin (BSA) in PBS for 30 min 
was performed in order to prevent non-specific binding of the primary antibody. 
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Thereafter, the cells were washed six times with PBS. The mouse monoclonal anti-
mouse desmin antibody (Isotype: IgG1, Abcam, UK) was diluted at the appropriate 
dilution in antibody diluent (PBS, 10 % heat inactivated FBS, 0.0625 % NaN3, 0.1 M 
lysine).  
 
After overnight incubation, the samples were washed in freshly prepared PBS and 
incubated with secondary antibody for 30 min at room temperature. The anti-mouse 
IgG1 class specific FITC (Abcam, UK) was diluted 1:200 in antibody diluent. The 
nuclei were identified using the fluorescent DNA probe 4',6-diamidino-2-phenylindole 
(DAPI) (Invitrogen, U.K), which was diluted 1:10,000 in the antibody diluent.  
The cells were washed for a final six times with PBS and coverslips then mounted on 
glass slides with anti-fade media (Citifluor Ltd, U.K) with the edges sealed with nail 
varnish. The samples were visualised with epifluorescence using the following filters to 
determine the expression of muscle specific antibody and the degree of cell 
differentiation: FITC (excitation at 485 nm, emission at 520 nm), and DAPI (UV 
excitation at 372 nm, emission at 456 nm). 
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2.5. Phenotypic Differentiation  
The types of phenotypic differentiation undertaking in this study were myogenic and 
osteogenic differentiation. For this purpose cells were plated in triplicate in 24-well 
plates at a density of 25 x 10
3
 cells / cm
2
. Cells were then left in GM until confluence 
was reached. At that point, the GM was removed and substituted with differentiation 
medium. All differentiation experiments included negative control, which are cells in 
GM at the same time points.  
 
2.5.1. Myogenic differentiation 
It was essential to establish the myogenicity of the isolated cells to see if there is any 
difference in myogenic differentiation abilities between cells from different preplates. In 
vitro proliferation is enhanced by high serum levels (10-20 %) whereas low serum 
levels (0-2 %) can promote myotube formation by depletion of growth factors (Ham et 
al., 1988). Cells were plated at a density of 25 x 10
3
 cells / cm
2
 and maintained at 37°C 
in humidified atmosphere of 5 % CO2 in air with GM until confluent reached.   
Culture medium was then replaced with Myogenic medium (MM) containing high 
glucose DMEM supplemented with 2 % FBS and IGF-1 at a final concentration of 10 
ng / ml (Sigma). 
 
2.5.2. Osteogenic differentiation 
This was carried out by culturing cells in osteogenic medium, which comprised  low 
glucose DMEM supplanted with 10 % FBS, 50 µM L-ascorbate 2-phosphate (AsAc) 
(Fluka), 8 mM β-glycerophosphate (β-GP) and 100 ng / ml recombinant mouse BMP-2 
(R&D systems).  
As a positive control, mouse calvarial osteoblasts were used (MOB), which was kindly 
donated by the former second supervisor Dr Paul Buxton. MOB cells were expanded in 
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GM supplemented with ascorbate-2-phosphate (50 μg / ml; Fluka). Early passages were 
then used for osteogenic differentiation experiments in OS medium (Buxton et al., 
2008).  
 
2.6. Alkaline phosphatase protein expression 
Alp activity was assessed with using Alp stain. The method consisted of fixing the cells 
with 10 % formalin for 15 min. Then  the cells were washed three time with distilled 
water and then incubated for 45 min in Tris-HCl Buffer (0.2 M, PH 8.3) with AS-MX 
phosphate (Sigma Chemical Co., Poole, UK) and Fast Red violet (Sigma Chemical Co., 
Poole, UK).The Alp positive cells stained red to purple to the naked eye. Light 
microscope images of the samples were taken at eye piece objectives x 40.  
 
2.7. Calcium mineralisation   
Mineralisation of osteogenic differentiated cells was assessed by measuring calcium 
deposition with Alizarin Red S stain and QuantiChrom assay kit (BioAssay Systems, 
USA).  
 
2.7.1. Assessment of mineralisation with Alizarin red S stain 
A working solution of a 2 % Alizarin Red S stain was prepared by dissolving 1 g 
Alizarin Red S dye in 45 ml ddH2O at a final pH of 4.1-4.3 (adjusted with either 1 M 
HCl or 1 M NaOH). Volume was finalised to 50 ml upon pH stabilisation. Stain was 
prepared fresh each time. For the stain, medium was aspirated from cultures and cells 
washed 1x with PBS. Cells were fixed in 10 % formalin for 10-15 min. After aspirating 
fixative and washing samples with PBS, stain was performed by pouring Alizarin dye at 
0.5 mL per well of a 24 well plate for 10 min. Samples were washed with PBS or 
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ddH2O x4 and allowed to air dry. Alizarin Red positive cells stained red, and density 
was calcium mineral content dependent.  
 
2.7.2. Assessment of mineralisation with QuantiChrom   
Calcium was measured using QuantiChrom calcium Assay kit according to 
manufacturer’s instructions. After washing cells three times with PBS, 500 µl of 1 M 
HCl was added to samples in each well for 45 min. After 45 min, 5 µl of the 1 M HCl 
solution was transferred to a 96 well plate. Equal amount of solution A and B (provided 
in the kit) were mixed and 200 μl of this solution was added to each well containing 5 
µl of HCl cell lysate. Calcium concentration was measured using spectrophotometer at 
610 nm wavelength and expressed as mg / dl.  
 
2.8. Polymerase Chain Reaction (PCR)  
2.8.1. RNA isolation  
Total RNA was extracted from all cells using RNeasy
®
 mini kit (Qiagen, UK). All 
procedures were conducted following the RNeasy
®
 mini kit technical manual. All 
working surfaces and instruments (e.g. centrifuge, pipettes and bottles) were cleaned 
with special wipes (RNaseZap
®
 wipes) which remove RNase enzymes. In addition, the 
tips, centrifuge tubes and water used were also RNase free. 
 
Following the manufacturer’s protocol, chemical disruption was performed using the 
RLT lysing buffer mixed with 2-Mercaptoethanol. Both materials are strong reagents 
that can dissolve proteins to release the RNA from the cells. Furthermore, the RLT® 
buffer included guanidiniumthiocyanate which inhibits RNase activity. The resulted 
solution was further disrupted by repeated pipetting to aid in freeing RNA from cells.  
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To initiate the selective binding of RNA to the silica membrane, the lysate solution was 
mixed with an equal amount of 70 % ethanol. The lysate solution then transferred to a 
clean silica membrane tube and passed through the column membrane by centrifugation. 
The RNA was bound to the filter membrane, while the flow-through supernatant 
containing the DNA and protein contaminants passed through the filter and collected in 
a tube which was then discarded. The filter membrane was then washed and centrifuged 
several times using different buffers to remove any remaining DNA or protein 
contaminants attached to the membrane. The RNA remained attached to the silica 
membrane. The final step was the elution of the isolated RNA, which was done by 
adding 30 µl of RNase free water to the membrane for five minutes at room temperature 
to dissolve the bound RNA. This was followed by centrifugation at maximum speed to 
elute the total RNA in a clean tube. The total RNA was then kept in RNease free tubes 
and stored at – 80 °C for further use. The steps and specific reagents used for this 
purpose are tabulated in table 2.5.  
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Table  2.5 Summary of RNA preparion 
Laboratory steps Materials Volume Settings 
i) Prior to start 
Clean the working bench, pipettes 
and all plastic ware used 
 
-RNaseZap® wipes 
-RNaseZap spray 
 
 
 
 
iii) Disruption and 
homogenisation 
 
 
 
 
 
 
                                             
 
                                               Total  
RLT buffer 
 
Repeated pipetting  
 
Measure lysate  
 
70% ethanol 
 
 
350µl 
 
 
 
 
 
350µl* 
 
700µl 
 
iv) Purification** 
-Use the lysate from the previous 
step 
 
 
Spin column 
 
RW1 buffer 
RW1 buffer 
RPE buffer 
RPE buffer 
New tube open cap 
 
 
~700 µl 
 
350µl 
350µl 
500 µl 
500 µl 
- 
 
 
Centrifuge   15s 10,000 rpm 
 
Centrifuge   15s 10,000 rpm 
Centrifuge   15s 10,000 rpm 
Centrifuge   15s 10,000 rpm 
Centrifuge   2m maximum speed 
Centrifuge   1m maximum speed 
v) Elution** 
 
 
RNase free water 
 
30 µl 
 
Keep            5 min at room T 
Centrifuge   1 min maximum 
speed 
*Measure the remaining lysate after homogenisation and add equal volume of ethanol. ** Following 
the RNeasy
®
 mini kit manual. 
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2.8.2. RNA quality control  
The quantity of RNA was assessed using a spectrophotometer which measures the 
optical density (OD) of the RNA at a wavelength of 260 nm. The purity of RNA was 
routinely assessed by the A260 / A280 ratio that is derived from the spectrophotometer. 
The A260 / A280 ratio is generated from the light absorbance of the genetic material at 
a wavelength of 260 nm and the protein at 280nm. Acceptable RNA purity was 
represented by a ratio of 1.68-2.06. Samples having an A260 / A280 ratio lower than 
1.68 (protein contamination) or higher than 2.06 (DNA contamination) were excluded 
from the experiments. 
 
2.8.3. cDNA preparation 
Total RNA was converted into single-strand cDNA via reverse transcriptase (RT) 
reaction. Two protocols were used, one for the qRT-PCR using high capacity cDNA 
reverse transcription kit (Applied Biosystems, Cheshire, U.K). The other protocol was 
used for the end point RT-PCR reaction following manufacturer’s recommendations.  
 
2.8.3.1. cDNA preparation for end point RT-PCR 
cDNA synthesis was done using M-MuLV Reverse Transcriptase enzyme (Fermantas, 
UK). The table 2.6 summarises the amount used of each reagent for 20 µl reaction and 
thermal cycler program used.  
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Table  2.6 Component of cDNA synthesis for end point RT-PCR 
Component Volume (µl/20µl reaction 
Oligo dt 1 
RNA X 
10mM dNTP 1 
RNase free dH2O To 12 µl 
Heat mixture to 65°C for 5 min and quick chill on ice 
5X First-Strand Buffer 4 µl 
0.1M DTT 2 µl 
RNaseOUT 1 µl 
M-MLT RT 1 µl 
Total 20 µl 
cDNA cycle (One Cycle) 
37°C. 70°C 4°C 
50 min 15 min ∞ 
  
 
 
The amount of cDNA needed was first calculated based on the number of reactions, and 
then the amount of reagents was calculated based on the amounts explained above in 
table. After the addition of the first set of reagents (Oligo (dT)18, RNA, 10mM dNTPs 
mix, and dH2O) into thin walled PCR tube, the mixture was heated to 65°C for 5 min 
and then chilled on ice. The second set of reagents was then added to the same tube 
according to the order explained in table 2.2. The tube was then loaded onto thermal 
cycler and run at 37 °C for 50 min, at 70°C for 15 min, and at 4°C until samples 
transferred to -20 °C for further use.  
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2.8.3.2. cDNA preparation for qRT-PCR  
The cDNA was prepared so that 10 ng of RNA was used in every reaction in subsequent 
PCR. The amount of cDNA required was calculated for the polymerase chain reaction 
(PCR) in order to make up the correct amount of RT master mix. Table 2.7 outlines the 
amount of RT master mix components needed for 20 µl reaction 
 
 
Table  2.7 Componant of RT master mix and their volumes used in this study 
Component Volume (µl/20µl reaction) 
10x RT buffer 2.0 
25x dNTP mix (100mM) 0.8 
10x RT random primers 2.0 
Multiscribe
™
 Reverse transcriptase 1.0 
Nuclease-Free H2O 4.2 
Total 10.0 
 
 
 
For the 20 µl reaction, 10 µl of RT master mix was placed into a nuclease-free 
microcentrifuge tube together with the 10 µl RNA water mixture. The tubes were then 
loaded into the thermal cycler (100™ PTC, MJ Research, Inc, U.S.A) and incubated at 
25 °C for 10 min, 37°C for 120 min, 85 °C for 5 sec, and 4 °C. The samples were then 
collected and stored in -20 °C until further use.  
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2.8.4. End-point and quantitative RT-PCR  
In q-PCR the level of expression of a particular gene is detected by incorporating a 
special fluorescent dye during the cDNA amplification. The gene expression intensity 
can be detected either at the end of the PCR procedure or during amplification; the 
higher the level of expression, the higher the fluorescent intensity. In the standard PCR 
technique, the level of expression is determined at the end of the reaction by running the 
PCR products on an agarose gel; a procedure called end-point measurement while, if the 
level of expression is measured during the amplification phase of the PCR, the 
procedure is said to be in real-time. There is a direct relationship between the level of 
expression of a particular gene and the amplification cycle at which the fluorescence 
will occur (i.e. the earlier the cycle at which the fluorescence will occur the higher the 
gene expression). This relationship cannot be detected by the end-point procedure. 
Therefore, real-time PCR has the advantage of being more sensitive in detecting minute 
variations in the level of expression (Schmittgen et al., 2000). This is achieved by using 
a special thermocycler that is equipped with a sensitive camera and a monitor to display 
the accumulated fluorescence of the gene in each amplification cycle.  
 
Real-time PCR provides a quantitative measurement of the expression of a particular 
gene and it has, therefore, been called the quantitative reverse transcriptase polymerase 
chain reaction (qRT-PCR).  
 
Relative quantification is used to answer most clinical questions and provides a relative 
quantification of the gene expression of one sample compared to a calibrator or a 
control sample, as in time-point experiments or case-control studies. This procedure 
relies on the differences in the crossing threshold (Ct) cycle value between a sample and 
a control. The Ct value is the cycle at which a significant increase in the fluorescence of 
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a particular gene is detected. Therefore, the procedure is called the comparative Ct 
method (Cikos et al., 2007). The relative qRT-PCR (comparative Ct method) was 
adopted for this research. Figure 2.3 shows the Ct relative quantification method used in 
this study.   
 
 
 
 
Figure  2.3 An example of calculating the relative gene intensity value using the 2-∆∆Ct equation 
Both GAPDH and target gene for each sample have been tested in triplicate reactions. These are presented as 
3 lines in close proximity. The background noise is the level where no fluorescence is seen; usually up to cycle 
13.The Ct threshold is the cycle at which a detectable increase in the fluorescence is observed. The later the Ct 
value the lower the gene expression, as in the study group target gene, occurring at almost Ct 30. The Ct 
values obtained from the triplicate reactions are summated to produce the average Ct for each gene .For 
example, to calculate the gene intensity value: 1) Calculate the ∆Ct (study group=30-18=12; calibrator=25-
21=4); 2) Calculate ∆∆Ct(study group=12-4=8; calibrator= 4-4=0); 3) Calculate 2-∆∆Ct(study group=2-
8=0.004; calibrator=20 =1). Interpretation of the data indicates that the study group sample has a relatively 
lower gene expression (0.004 fold change) compared to the calibrator sample.  
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2.8.5. Protocol for end point PCR 
End-point PCR reaction mixture was done following manufacturer’s recommendation 
for 25 µl reaction volume. A master mix was first prepared and then transferred to each 
reaction tube. The specific primers and cDNA was then added to the prelabled PCR 
tubes. The tubes then loaded into the thermal cycler and PCR reaction started according 
to a preoptimised thermal cycles as shown in table 2.8.  
 
PCR products were checked by 2% Agarose-TBE Ethidium bromide gels. To exclude 
genomic DNA contamination RT sample were loaded without reverse transcriptase 
enzyme and to monitor the quality of RNA, amplification of the house-keeping gene, 
glyceraldehyde- 3 phosphate dehydrogenase (GAPDH) was used.   
 
                       Table  2.8 Reagents used for end point PCR and thermal cycles. 
Reagents Volume (µ/25µl) 
10XPCR Buffer+15mM MgCl2 5 
10 mM dNTPs mix 0.5 
Amplification primer (Forward) 0.5 
Amplification primer (Reverse) 0.5 
Tag DNA polymerase (5U/µl) 0.2 
cDNA 1 
Nuclease-free H2O 17.3 
Total 25 
PCR reaction 
Pre-denaturation Denaturation Annealing Extension 
95°C 95°C 55-60°C 70°C 
3 min 1 min 1 min 1 min 
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2.8.6. Protocol for qPCR 
The following sections will describe the materials and methods used for the qRT-PCR 
experiment. The Applied Biosystems 7300 Real Time PCR System and related 
sequence detection software (Version 1.4) was used to carry out the real time 
quantitative polymerase chain reaction (qPCR). Each sample was examined in triplicate 
for expression of the targets genes and endogenous control (GAPDH). To ensure 
accuracy of the singleplex PCR, preparation was undertaken in a specified nuclease-free 
zone utilising nuclease-free equipment on ice. Additionally, high reliable TagMan
®
 
gene expression assays and PCR master mixes (Applied Biosystems, UK) were 
employed to reduce pipetting errors associated with the use of multiple reagents.  
Each reaction was 25µl, which had been optimised previously. All reagents were 
thawed on ice and mixed gently. Reagents were added according to manufacturer 
protocol into nuclease free eppendorf tube and gently mixed (as shown in table 2.9). 
Then 25µl was transferred into each well of a 96 well PCR plate. The 96 well plate was 
then sealed with an optical adhesive film, briefly centrifuged and then place into PCR 
system for commencement of the reaction. 
 
                                      Table  2.9 Reagents used for q-PCR and their volume 
Component Volume (µl) 
TagMan
®
 Universal PCR master Mix 12.5 
TagMan
® 
probes 1.25 
cDNA 2.5 
Nuclease free water 8.75 
Total 25 
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The normalisation process is required to remove any source of variation in RNA 
concentration and cDNA preparations between different samples. This procedure, and 
the calculation of the final gene expression value, is not a direct process and require the 
use of the Ct value in several equations. These equations have been described in detail 
by Livak and Schmittgen (2001) and will be discussed briefly in the following sections. 
All Ct values were exported from the qRT-PCR machine, and were transferred to an 
Excel spread sheet where the gene expression value was calculated using the final 
equation 2
-∆∆Ct
.  Figure 2.3 shows an example of a qRT-PCR amplification plot by 
which the Ct values were derived.  
 
The process of normalisation of q-PCR data was carried out along the following steps: 
 Step 1 (repeatability) 
Objective: To ensure high precision, both the target and the reference genes were 
experimented in Triplicates. This produced several Ct values which were 
summated to produce an average Ct value obtained for both genes. 
Equation: = Average Ct of reference gene 
       Average Ct of target gene 
 
 Step 2 (normalisation)  
Objective: To normalise the average Ct of the target gene in relation to the 
average Ct of the reference gene of the same sample thereby producing the ∆Ct 
Equation: = Average Ct target – Average Ct  reference = ∆Ct 
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 Step 3 (calibration) 
Objective: The control sample was selected as the calibrator sample. This was to 
produce ∆∆Ct for each sample. During calibration, the calibrator sample was 
also calibrated to itself to produce a value of zero. The reason for generating a 
zero value for the calibrator sample was to produce a value of one when used in 
the next equation, and one would act later as a baseline for relative gene 
expression comparison. 
Equation: = ∆Ct target – ∆Ct calibrator = ∆∆Ct 
 
 Step 4 (gene expression value) 
Objective: The fourth equation was derived from the belief that each gene was 
doubled during each amplification cycle, assuming 92-100% amplification 
efficiency (Livak and Schmittgen, 2001). The equation transferred the calibrator 
value into 1 which acted as a baseline for gene expression comparison. The 
generated gene expression values of the other samples which were higher or 
lower from the baseline were considered a fold change. The results were then 
used for further data analysis to assess the significance of the difference. 
 Equation: = 2
-∆∆Ct 
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2.9. Statistical analysis  
The Graphpad Prism version 5.02 statistical package was used for mathematical 
calculation and statistical analyses of raw data. The calculations included (i) basic 
statistics (mean and standard deviation); (ii) Checking for the normality between data 
sets and (iii) evaluation of significance of the difference of means.  
 
Statistical analyses were conducted after generating a data matrix consisting of readings 
from three different isolates with three replicates per isolate (N = 3; n = 3). Data was 
first tested for normality. This was followed by ANOVA measure (analysis of variance) 
with a 2-way or 1-way measures test utilising the Bonferonni post-test comparing all 
variables. 
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3.1. Introduction  
3.1.1. Background 
Skeletal muscle can adapt to physiological and reparative demands due to cells with 
stem-like characteristics that can differentiate and form muscle fibres. These cells are 
further suggested to have multipotential capacity (Lee et al., 2000, Asakura et al., 2001, 
2002, Qu-Petersen et al., 2002) as well as, mainly deduced from the observation of 
heterotopic ossification in muscle tissue in certain disease conditions (Aho et al., 1988, 
Aro et al., 1991, Kaplan and Smith, 1997, Mahboubi et al., 2001). 
 
As there are differences in the embryonic development of skeletal muscle tissue 
between the limb and craniofacial regions of a vertebrate body, it is suggested that stem-
like cells isolated from these anatomical sites would have different differentiation 
capacities or degree of multipotency, and hence may offer various possibilities for the 
design of tissue engineering applications. 
 
Several mononuclear cell types can be isolated from muscle tissue with various 
methods. These are described in section 1.3.2.2. One of the methods reported in (Yaffe, 
1968; Richler and Yaffe, 1970, Rando and Blau, 1994, Qu et al., 1998) separates 
different mononuclear cells based on their adherence properties. This method was 
originally developed to increase the yield of myogenic cells and since its inception has 
been applied with varying modifications to isolate different mononuclear cells from 
skeletal muscle tissue. 
 
3.1.2.  Rationale 
Much of the literature concerning skeletal muscle tissue mononuclear cells have focused 
on cells derived from limb and trunk skeletal muscles (Lee et al., 2000; Li and Huard, 
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2002; Mastrogiacomo et al., 2005). The data available of the isolation and 
characterisation of mononuclear cells from the craniofacial skeletal muscle are 
relatively less (Sinanan et al., 2004). Distinct to muscles of the trunk and limbs that are 
somitic in origin, craniofacial muscles develop from three different regions of the 
embryo; namely the occipital somites, precordal (cranial to the notochord) and paraxial 
head mesoderm (PHM). Additionally, the connective tissues of CSkM muscles are 
derived from neural crest cells (Sperber, 1989). This implies that mononuclear cells 
isolated from skeletal muscle may possess varying differentiation potentials.  
 
3.1.3. Aims and objectives 
This initial section of the thesis hypothesised that mononuclear cells with varying 
phenotypic characteristics can be isolated from skeletal muscles of the cranium and limb 
of a vertebrate animal. The aim was to isolate various mononuclear cells based on the 
principle of adherence per time with a modification of the (Rando and Blau, 1994, Qu et 
al., 1998) pre-plate technique; and evaluate differences between the cell sub-populations 
by assessing differences  in (i) cellular proliferative potentials by comparing population 
doublings in culture; (ii) evaluate morphology and compare parameter of cell surface 
area, (iii) examine the expression of muscle-specific desmin protein; and (iv) evaluate 
the phenotype  of the cells by analysing the expression of (a) potential stem cell markers 
Oct4 (Jiang et al., 2002), Sca-1 (Kafadar et al., 2009) and  CD34 (Lee et al., 2000, 
McKinney-Freeman et al., 2002, Majka et al., 2003 );  (b); myogenic markers MyoD 
and Desmin. (c) osteogenic markers Runx-2 and Alp; as well as the (d) neural crest 
genes Sox10 (Dupin et al., 2007), P75 (Yan et al., 2006, Dupin et al., 2007) and AP2 
(Mitchell et al., 1991, Williams and Tjian, 1991).  The details and significance of these 
genes are tabulated in table 3.1 
 
 73 
 
Chapter 3: Isolation and Characterisation  
 
 
          Table  3.1 Developmental markers analysed in muscle derived mononuclear cells 
            a Gene annotations are derived from NCBI Gene. b annotations derived from (Kafadar et al. 2009). 
Gene Information 
OCT-4  
A transcription factor that forms a trimeric complex with SOX2 
on DNA and controls the expression of embryonic pluripotency 
associated genes
a 
Sca-1  
Cell surface protein that negatively regulates proliferation and 
differentiation of progenitor cells
b 
CD34  
A possible cell surface adhesion molecule expressed selectively 
on hematopoietic stem cells but also myogenic satellite cells
a
 
MyoD1 
 A transcription factor that regulates muscle cell differentiation by 
inducing cell cycle arrest, a prerequisite for  myogenic initiation
a
 
Desmin A class of intermediate filaments found in muscle cells
a
 
Runx-2 Master transcription factor regulating osteogenic differentiation
a
 
Alp 
An osteoblastic enzyme that provides inorganic phosphate to a 
developing calcium phosphate crystal
a
 
P75 
Transcriptional coactivator involved in neuroepithelial stem cell 
differentiation and neurogenesis
a
 
AP-2c 
AP2 isoform c; transcription factor involved in the activation of 
several genes important for eye, face and neural tube 
development
a 
Sox10 
Transcription factor involved in the regulation of neural crest 
development and in the determination of the cell fate
a
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3.2. Experimental protocols   
3.2.1. Isolation of mononuclear cells  
3.2.1.1. Animals  
Normal (wild type) neonatal mice of the breed ICR / CD1 were purchased from Harlan 
UK Limited laboratory. All procedures were conducted in accordance with the Animal 
(Scientific Procedures) ACT 1986. A description of the methods carried out is provided 
in section 2.1.1.  Isolation of muscle tissues from craniofacial and hind limb region was 
conducted on three occasions with 10 neonatal mice in each instance. 
 
3.2.1.2. Isolation of muscle tissue  
Required tissues were extracted with surgical scissors and transferred to petri-dishes for 
enzymatic digestion, as described in section 2.1.2 and 2.1.3.  
The extracted tissues were digested to a cell suspension that was subjected to the 
modified pre-plating method described below.  
  
3.2.1.3. Adherence based fractionation of mononuclear cell isolate 
The method used to separate the different sub-types of cells in suspension is described 
in section 2.2.2. In brief, the cell suspension achieved from the digestion of muscle 
tissue was divided in to two groups; group one was plated in a T75 tissue culture flask 
for 5 days and designated as the parent or unsorted cells (PC). The second aliquot of 
suspension was serially plated through three different plates; pre-plate 1, 2 and 3 
represented by PP1, PP2, and PP3 respectively. Cells were fractioned based on their 
adherence properties to tissue culture plastic per time. PP1 constituted cells that had 
adhered within 1 h of contact with culture plastic. The non-adhered cells were 
transferred to a clean culture flask and adherent cells by 48 h were called PP2. The non-
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adherent cells in suspension from PP2 cultures were then cultured with a new flask for 5 
d and the resulting adherent cell population was the PP3. Cells were sub-cultured and / 
or cryopreserved as described in sections 2.2.2 and 2.2.3, respectively. Three batches of 
each population were conducted in this study.       
 
3.2.2. Assessment of proliferative differences between cell fractions 
The growth behaviour of isolated cells was investigated by recording cell numbers at 
the start and end of a passage during routine serial sub-culture performed till 
senescence, which is the point of a lack of cell replication. Earliest passage cells would 
be trypsinised according to the method described in section 2.2.2. These detached cells 
were counted as described in section 2.2.2. They were seeded at a density of 1000 cells / 
cm
2 
in T75 tissue culture flasks in GM and incubated in humidified conditions. Cell 
numbers were recorded at the end of culture. These were used to arithmetically 
determine the population doubling value. A population doubling is an increase of two-
fold in the total number of cells during the exponential phase of growth in culture. The 
formula used to calculate the population doublings (PD) in a passage was: PD = Log (N 
- No) / log2, where: N is number of cells counted at the end of growth period, No is the 
original number of cells plated. Results were calculated as cumulative population 
doubling (PD) number against time.  
 
3.2.3. Assessment of differences in morphological parameters 
Light microscopic images of cell cultures in T75 flasks were used to assess 
morphological differences. Images were taken and analysed with Image J software, as 
described in section 2.3. In general, two images per flask were taken at x40 objective 
with a standard microscope-mounted camera. A total of 7 cells per image were selected 
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and analysed for surface area. This experiment was conducted on each of the three 
occasions of cell isolation and for each cell subpopulation.  
 
3.2.4.  Assessment of muscle specific desmin protein expression  
An Immunocytochemistry analysis for the muscle-specific desmin protein was 
conducted on all isolated cells. For this purpose, 25 x 10
3
 cells were seeded on sterile 
glass cover slips immobilised in a well of a 24-well plate in GM. Each sample was 
assessed in triplicate on each of the three occasions of cell isolation. The method 
applied for this experiment is described in section 2.4. Cells were first fixed and then 
stained for desmin using mouse monoclonal anti-mouse desmin antibody (Isotype: 
IgG1, Abcam, UK). Cells were then incubated with secondary antibody (anti-mouse 
IgG1 class specific FITC (Abcam, UK)) for 30 minutes at room temperature. The nuclei 
were identified using the fluorescent DNA probe DAPI (Invitrogen, U.K). 
 
3.2.5. Polymerase Chain Reaction analysis of phenotypic genes  
The genes tabulated in table 3.1 were examined due to their association with 
multipotent cell phenotypes.  
Two variants of PCR were used for this experiment. End-point PCR was used to assess 
the presence or absence of gene expression; and qPCR was used to evaluate fold 
differences in the level of expression between samples. This experiment was conducted 
in triplicate (n = 3) on each of three occasions of cell isolation (N = 3). The methods for 
PCR applied are described in section 2.8. The different steps undertaken are highlighted 
below. 
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3.2.5.1. RNA isolation  
This was conducted with Qiagen Total RNA kit as described in section 2.8.1. Cells were 
homogenised with buffer RLT. Homogenates were mixed 1:1 with 70 % v / v ethanol in 
water and passed through a silicon membrane-column. RNA was eluted in RNase free 
water. 
3.2.5.2. RNA quantification  
RNA was quantified by spectrophotometry according to the method described in section 
2.8.2. A 2 ul aliquot of the RNA isolate was checked for concentration and integrity 
with spectrophotometer Tecan, M200 (A260 : A280).  
 
3.2.5.3. Reverse transcription  
This step was conducted according to the method described in section 2.8.3. A total of 
100 ul cDNA was prepared with the equivalent of 10 ng RNA per 2.5 ul of reverse 
transcribed product. 
 
3.2.5.4. End point PCR 
This was performed by amplifying target genes in cDNA by conventional PCR and 
running the product on a 2 % agarose gel, according to the method described in section 
2.8.5. The primers and the physical parameters for this are stated in table 3.2. Three 
replicates representing one of each of the three occasions of cell isolation were analysed 
simultaneously to omit any errors.  
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                       Table  3.2 Conditions for end-point PCR analysis 
                          Table indicates the genes, primer sequences, and physical conditions used for end-point PCR analysis. (C= Celsius, min= Minutes, sec= Seconds, F= Forward, R= Reverse)    
 
Primers and PCR conditions for End-point PCR 
Gene Primer Primer sequence 
PCR condition PCR product size  
(pb) Denature Annealing Extension Final extension  No. of Cycles 
   
1 OCT-4 
F TGTGGACCTCAGGTTGGACT 
94℃,2 sec 55℃,30 sec 72℃,1 min. 72℃,5 min. 35 201 
R CTTCTGCAGGGCTTTCATGT 
2 Sca-1 
F TCTGAGGATGGACACTTCTC 
94℃,2 sec 55℃,30 sec 72℃,1 min. 72℃,5 min. 35 384 
R CTCAGGCTGAACAGAAGCAC 
3 CD34 
F TTGACTTCTGCAACCACGGA 
94℃,2 sec 60℃,30 sec 72℃,1 min. 72℃,5 min. 35 300 
R TAGATGGCAGGCTGGACTTC 
4 MyoD1 
F AGGACACGACTGCTTTCTTC 
94℃,2 sec 55℃,30 sec 72℃,1 min. 72℃,5 min. 35 360 
R GCACCGCAGTAGAGAAGTGT 
5 Desmin 
F TGATGAGGCAGATGAGGGAG 
94℃,2 sec 55℃,30 sec 72℃,1 min. 72℃,5 min. 35 250 
R TGAGAGCTGAGAAGGTCTGG 
6 Runx-2 
F GAACCAAGAAGGCACAGACA 
94℃,30 sec. 55℃,10 sec 72℃,1 min. 72℃,5 min. 35 452 
R AACTGCCTGGGGTCTGAAAA 
7 ALP 
F GCCCTCTCCAAGACATATA 
94℃,30 sec. 58℃,10 sec 72℃,1 min. 72℃,5 min. 35 372 
R CCATGATCACGTCGATATCC 
8 GAPDH 
F ACCACAGTCCATGCCATCAC 
94℃,30 sec. 55℃,10 sec 72℃,1 min. 72℃,5 min. 30 451 
R TCCACCACCCTGTTGCTGTA 
9 P75 
F GTGCGGGGTGGGCTCAGGACT 
94℃,30 sec. 60℃,10 sec 72℃,1 min. 72℃,5 min. 35 422 
R CCACAAGGCCCACAACCACAGG 
10 AP-2c 
F CCTGGATTTAACTGGCGACT 
94℃,30 sec. 55℃,10 sec 72℃,1 min. 72℃,5 min. 35 676 
R CCTCCAGCCCTGAAATATGG 
11 Sox10 
F GGAGGTTGCTGAACGAAAGTG 
94℃, 1min. 60℃,1min. 72℃,1 min. 72℃,5 min. 35 444 
R TCCATGTTGGACATTACCTCG 
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3.2.5.5. QPCR analysis for developmental genes  
This was performed with 2 
-∆∆Ct
 method according to the methods described in section 
2.8.5. The Taqman probes used in this experiment are presented in table 3.3.  
 
                               Table  3.3 TagMan probe catalogue number for q-PCR analysis 
Gene Probe ID 
Sca-1 Mm00726565_s1 
CD34 Mm00519283_m1 
MyoD1 Mm00440387_m1 
Desmin Mm00802455_m1 
Runx-2 Mm00501580_m1 
ALP Mm00475834_m1 
GAPDH Mm99999915_g1 
P75 Mm01309635_m1 
AP-2c Mm00493473_m1 
Sox10 Mm01300162_m1 
 
 
3.2.6.  Statistical analysis  
Variations in gene expression and surface area comparisons were statistically assessed 
with a 1-way ANOVA using the Graphpad Prism v5.02. A p-value of ≤ 0.05 was 
considered to be statistically significant. The growth data were analysed using 2-way 
ANOVA and a p-value of ≤ 0.05 was considered to be statistically significant.  
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3.3. Results 
3.3.1. Isolation of mononuclear cells from muscle tissue 
Mononuclear cells were isolated with the absence of infection. The neonatal mice were 
de-skinned and target tissues homogenised with digestive enzymes. The resulting pellet 
of cells was re-suspended in GM and tissue fragments removed by passing through a 
sieve. The filtrate was collected. Cells were counted and then seeded to form the 
parental cells population and the first pre-plate (PP1), with non-adhered cells removed 
to achieve the PP2 and PP3 population of cells. Light microscopy revealed cells were 
mononuclear. Aseptic techniques ensured no infections developed in the extraction 
process. An average of 2,000,000 cells were isolated on each of the three occasions of 
isolation.  
 
3.3.2. Assessment of proliferative differences between cell fractions 
Expansion potentials of muscle-derived cells were determined by calculating the 
population doublings (PD) that the cells could achieve before senescence. Population 
doublings for all CSkM and LM cells (PC, PP1, PP2, and PP3) from three different 
isolates were measured. The mean of the PDs for the three isolations was plotted against 
the time. The results of this experiment are shown in figure 3.1 for CSkM cells and 3.2 
for LM. Cells, from both CSkM and LM that adhered within the 1st hour of initial 
plating (PP1), cells that adhered within 48 h (PP2) and unsorted cells (PC), showed 
significant increases in growth rate for 5 w compared to late adhered cells (PP3), which 
displayed a relative lag in proliferation during this time. Moreover, late adhered cells 
(PP3) demonstrated an increase in growth rate after 5 w. From 7 w to 15 w, no 
significant differences in growth behaviour were found between cells from different 
pre-plate. A comparison between the muscle groups showed that the PC, PP1 and PP2 
populations from CSkM differed significantly from their counterparts isolated from LM 
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at 3 to 9 week of culture. The PP3 populations did not differ significantly at any time 
points. 
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Figure  3.1 Mean population doublings for CSkM derived mononuclear cells.  
Figure shows bar chart with the mean and SD of the population doublings (PDs) of cells plotted against time in 
culture (Weeks). Bars show mean with standard deviation, n= 3. * represent p < 0.05, PC vs. PP-type. Cell 
types displayed differences in the initial 7 w of culture. PP1 seemed highly replicative due to a higher 
cumulative PD value by 3 and 7 w. PP3 displayed a significantly lower PD rate compared to PC from 1 to 5 w 
in culture. All cultures displayed similar PD values from 9 to 15 w.  
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Figure  3.2 Mean population doublings for LM derived mononuclear cells.  
Figure shows bar chart with the mean and SD of the population doublings (PDs) of cells plotted against time in 
culture (Weeks). Bars show mean with standard deviation, n= 3. * represent p < 0.05, PC vs. PP-type. PC, PP1 
and PP2 proliferated at similar rates. PP3 displayed a significant lag in PD counts till 9 w in culture. All 
cultures displayed similar PD values from 11 to 15 w.  
 
 83 
 
Chapter 3: Isolation and Characterisation  
3.3.3. Assessment of differences in morphological parameters  
Cells isolated from both CSkM and LM were analysed for morphological size 
differences. Images were taken from each pre-plate with light microscope mounted 
camera and images analysed using image J software for surface area of cells. 
 
The analysis showed gradual decrease in cell size from the early adhered cells (PP1) 
toward the late adhered ones (PP3) in all samples. Examples of the images obtained in 
this experiment are shown in figures 3.3 for CSkM and 3.4 for LM. The mean value of 
surface area obtained for the different cultures are illustrated in a box-whisker plot in 
figure 3.5. 
 
The CSkM derived PC cells seemed large and irregularly shaped. The CPP1 cells 
displayed similar characteristics. Their morphology differed from PP2 and PP3, which 
seemed to skew towards a more rounded shape. Similar was the case for LM derived 
cells. This trend was supported by the measurements of mean surface area, which 
indicated PC and PP1 to be significantly largely than PP2 and PP3. 
 
A comparison between CSkM and LM derived cells indicated that although small, the 
differences between the surface area of the two types of muscle derived cells were 
significant. 
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Figure  3.4 Images of LM derived mononuclear cells.  
Figure shows grey-scaled images taken at x40 magnification of (A) PC, (B) PP1, (C) PP2, and (D) PP3 LM cells 
in tissue culture flasks at 1 d after cultures had settled. (a) PC and PP1 cells appeared similar as irregularly 
shaped cells. (c) The PP2 appeared elongated but flattened while (d) the PP3 appeared somewhat satellite or 
rounded. Bar equal 100 µm.    
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Figure 3.3 Images of CSkM derived mononuclear cells.  
Figure shows grey-scaled images taken at x40 magnification of (A) PC, (B) PP1, (C) PP2, and (D) PP3 cells in 
tissue culture flasks at 1 d after cultures had settled. (A) PC cells appeared elongated in shape as were cells of 
(B) PP1. (C) The PP2 appeared elongated and flattened while (D) the PP3 appeared somewhat satellite or 
rounded.  Bar equal 100 µm.  
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Mean surface area of cells isolated from CSkM and LM
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Figure  3.5 Mean surface area of cells isolated from CSkM and LM.  
A box and whisker plot indicating readings (n = 42) obtained for surface area of CSkM and LM muscle 
derived cells with minimum to maximum range represented by vertical bars. *, #, + represent p < 0.05, PC vs. 
PP1, PP2 and PP3, respectively. Comparisons between the sub-types of both tissues are annotated by a, b, c, d, 
which represent p < 0.05, PC vs. PC, PP1 vs. PP1, PP2 vs. PP2 and PP3 vs. PP3, respectively. CPP1 and LPP1 
had a larger surface area than PC while PP2 and PP3 had smaller surface areas. Comparisons between the 
muscle types indicated differences between respective pairs to be significant for all except PP3. LPC cells are 
significantly bigger than CPPC. LPP1 and LPP2 cells were significantly smaller than their counterpart cells 
from CSkM (CPP1 and CPP2). There is no significant difference in size between CPP3 and LPP3.  
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3.3.4. Assessment of muscle specific desmin protein expression 
The different cultures were assessed for the expression of muscle specific desmin 
protein as a percentage of desmin positive cells in a culture of 25,000 cells on glass 
cover slips. It was found that cells displayed different degrees of desmin 
immunoreactivity. The images obtained of desmin stained cultures in this experiment 
are shown in figure 3.6 and 3.7 for CSkM and LM, respectively. The determined 
percentages of desmin positive cells from all samples are shown in figure 3.8.  
 
The percentage of desmin positive cells was calculated by counting green fluorescence 
desmin positive cells against DAPI blue positive total cells. Desmin positive cells 
counting were performed in three random fields at objective x 40. 
 
The images indicate a presence of desmin in all cultures. The relative intensity of the 
protein stain was least in PP1 and then PP2 compared to PC and PP3 for both muscle 
groups. Moreover, PP3 stain was highest in the case of either muscle type.  
The analytical data supported these findings by clearly indicating a stark difference 
between PP1 and PP2 with PP3 in expression of desmin. There was no significant 
difference between the muscle types.  
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Figure 3.6 Confocal immuno-fluorescence based images of CSkM isolated cells. 
Nuclei are stained blue and desmin green. PC (A) and PP3 (D) displayed high intensity of 
desmin fluorescence. (B) PP1 and (C) PP2 displayed absence of any significant levels of the 
protein. Bar equal 100 µm. 
Figure 3.7 Confocal immuno-fluorescence based images of LM isolated cells.  
Nuclei are stained blue and desmin green. PC (A) and PP3 (D) displayed high intensity 
of desmin fluorescence. (B) PP1 and (C) PP2 displayed absence of any significant levels 
of the protein. Bar equal 100 µm. 
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Figure  3.8 Mean percentage of desmin expression in muscle derived mononuclear cells isolated from CSkM 
and LM.  
A box and whisker plot indicating readings (n = 9) obtained for the percentage of desmin expression in CSkM 
and LM muscle derived cells, with minimum to maximum range represented by vertical bars. *, #, + represent 
p < 0.05, PC vs. PP1, PP2 and PP3, respectively. The PP3 fractions displayed highest expression of desmin 
compared to the rest. The PP1 and PP2 fractions displayed the least positive cells for desmin. Comparisons 
between tissue types showed no significant differences between any of the tissues. 
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3.3.5.  PCR analysis of phenotypic genes 
The general trend seen was that early adhered cells PP1 and PP2 showed higher 
expression of stem cell, neural crest cell, and osteogenic markers compared to PP3 cells. 
In contrast, the PP3 expressed myogenic genes at significantly higher levels than the 
remainder. The results of this analysis are described in the following sub-sections. 
 
3.3.5.1. End-point RT-PCR 
The data from this analysis is shown in figure 3.9. It shows the bands obtained 
following agarose gel electrophoresis. The GAPDH house keeping gene was detected in 
all samples analysed. The Oct4 gene seemed non-transcribed in any of the samples. A 
band for Sca-1 was detected in all samples analysed. The CD34 band intensity was 
higher for PP1 and PP2 compared to PC and PP3 for both muscle types. The AP2c, 
Sox10 and P75 gene bands displayed high intensity for PP1 and PP2 of CSkM derived 
cells compared to others. The Runx2 band intensity was higher in PC, PP1 and PP2 
cells from both muscle tissues while the gene seemed non-transcribed in PP3 cells. The 
Alp gene was found expressed in all samples. The MyoD gene seemed transcribed in all 
samples, while desmin gene was mainly expressed by PP3 compared to others. 
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Figure  3.9 End-point gene expression of CSkM and LM derived cells.  
Three isolates of each of the four mononuclear cell-fractions were analysed in parallel for the expression of 
developmental genes. Potential stem cell genes (Oct-4, Sca-1 and CD34); myogenic genes (MyoD and Desmin); 
osteogenic genes (Runx-2 and Alp); neural crest (NCC) genes (Ap2c, Sox 10 and P75). In brief, oct4 genes 
seemed non-transcribed in all samples. The early adhered cells expressed stem cell genes and osteogenic genes 
whereas the late adhered cells expressed Sca-1 gene and myogenic genes. Early adhered cells from CSkM 
expressed neural crest specific gene.  
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3.3.5.2. QPCR analysis for developmental genes  
The qPCR was conducted with 2 
-Δ
 
ΔCT
 method with the CT readings of CPC cells used 
as the calibrator. 
The result for Sca-1 and CD34 gene expression are presented in figure 3.10. Sca-1 was 
expressed at a significantly higher fold value in PP1 and PP2 cells compared to their 
respective PC samples. It displayed a similar pattern of expression in CSkM and LM 
derived cells and sub-populations. CD34 was expressed at a significantly higher fold 
value by PP1 and PP2 cells and in both tissue types, compared to respective control. 
There were no significant differences between the two muscle groups. 
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Figure  3.10 QPCR analysis of stem cellness markers 
Figure shows fold values plotted against cell type for (A) Sca-1 and (B) CD34. The bars represent mean±1SD, 
N = isolation attempts = 3; n = replicates = 3. (A) PP1 and PP2 genes expressed significantly higher levels of 
Sca-1 compared to rest. (B) PP1 and PP2 genes expressed significantly higher levels of CD34 compared to the 
rest. *= p < 0.05, PC vs. PP-type. 
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The results of the myogenic genes MyoD and Desmin gene are shown in figure 3.11. 
The MyoD gene was expressed at significantly higher levels in PP3 cells of both 
isolates compared to PC or other sub-populations.  The Desmin gene was similarly 
found expressed at significantly higher levels in PP3 cells compared to PC and other 
sub-populations. The PC cells expressed the gene at a relatively higher level than PP1 
and PP2. No significance difference was found between the two muscle groups. 
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Figure  3.11 QPCR analysis of myogenic genes  
Figure shows fold values plotted against cell type for (A) MyoD and (B) Desmin. The bars represent mean 
±1SD, N = isolation attempts = 3; n = replicates = 3. (A) PP3 cells expressed the gene at significantly higher 
levels compared to rest. (B) PP3 cells expressed the gene at significantly higher levels compared to rest. There 
was no expression of the gene in the early adherent cells. * = p < 0.05, PC vs. PP-type. 
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The results for Runx2 and Alp are shown in figure 3.12. Runx2 was expressed at a 
significantly higher value in PP1 and PP2 from both muscle origins, compared to PC 
cells. The Alp gene was expressed significantly higher in PP1 and PP2 cells from both 
muscle isolates, compared to their respective PC samples. No significance difference 
was found when comparing CSkM cells with their equivalent isolates from LM tissue.  
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Figure  3.12 QPCR analysis of osteogenic genes 
Figure shows fold values plotted against cell type for (A) Runx2 and (B) Alp. . The bars represent mean ±1SD, 
N = isolation attempts = 3; n = replicates = 3 (A) PP1 and PP2 expressed significantly higher levels of Runx2 
compared to all other samples. Late adherent cells did not express the gene (B)  PP1 and PP2 expressed 
significantly higher levels of Alp compared to rest. PP3 did not express the gene.* = p < 0.05, PC vs. PP-type. 
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The expression of AP-2 was found to be similar to P75 and Sox10. The results are 
presented in figure 3.13. AP-2 gene was expressed at significantly higher values by 
CSkM derived PP1 and PP2 cells only. The LPP1 and LPP2 displayed a difference with 
LPC but this was insignificant. The differences between CPP1 vs. LPP1 and CPP2 vs. 
LPP2 were found to be significant. The Sox10 gene was expressed at significantly 
higher values by CSkM derived PP1 and PP2 cells only. The differences between CPP1 
vs. LPP1 and CPP2 vs. LPP2 were found to be significant (p < 0.05). The P75 gene was 
similarly expressed at significantly higher values by CSkM derived PP1 and PP2 cells 
only. The differences between CPP1 vs. LPP1 and CPP2 vs. LPP2 were found to be 
significant (p < 0.05).  
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Figure  3.13 QPCR analysis of neural crest markers  
Figure shows fold values plotted against cell type for (A) AP-2, (B) Sox10, and (C) P75. The bars represent 
mean ±1SD, N = isolation attempts = 3; n = replicates = 3 (A) The CSkM derived PP1 and PP2 expressed 
significantly higher levels of P75 compared to all samples. * (B) The CSkM derived PP1 and PP2 expressed 
significantly higher levels of Sox10 compared to all samples. (C)The CSkM derived PP1 and PP2 expressed the 
gene significantly higher levels compared to all samples. * = p < 0.05, PC vs. PP-type; a, b = p < 0.05, CPP1 vs. 
LPP1 and CPP2 vs. LPP2 respectively.  
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Table 3.4 summarises the gene expression profile of all isolated cells. It shows that 
early adhered cells from both muscle groups express stem cell (Sca-1 and CD34) and 
osteogenic (Runx-2 and Alp). The late adhered cells from both muscle groups only 
express the myogenic genes (MyoD and desmin) and to a lesser extent stem cell gene 
Sca-1. The early adhered cells from CSkM uniquely expressed the neural crest markers 
genes (Ap-2, P75 and Sox10).   
 
Table  3.4  Summary of genes expressed by isolated cells 
 
 
 
 
 
 
 
Cells Sca-1 CD34 MyoD Desmin Runx-2 Alp Ap-2 P75 Sox10 
CPP1 + + - - + + + + + 
CPP2 + + ± ± + + + + + 
CPP3 ± - + + - - - - - 
LPP1 + + - - + + - - - 
LPP2 + + ± ± + + - - - 
LPP3 ± - + + - - - - - 
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3.4. Discussion 
3.4.1. Isolation of mononuclear cells from muscle tissue 
A modification of the preplate method developed by Yaffe (1968), Rando and Blau 
(1994), Qu et al., (1998) was applied here to isolate mononuclear cells from muscle 
tissue. The modifications included (i) the use of non-coated tissue culture plastic dishes 
for cell attachment in contrast to collagen coated substrates as used by others and (ii) 
alternate contact durations of 1 h, 48 h and 5 d compared to the day-wise pre-plating 
applied by Rando and Blau 1994 and Qu et al., (1998). In addition, comparisons 
between the CSkM and LM derived mononuclear isolates have been conducted to a 
relatively lesser extent. As the developmental origins between these tissues differ, a 
requirement of a comparison between pre-plate isolates from both anatomical locations 
was deemed necessary. In this part of the study, mononuclear cells were successfully 
isolated from the two anatomically different skeletal muscle tissues. The isolated cells 
displayed differences in the various parameters assessed here. 
 
3.4.2. Proliferative assessment 
A comparison of the replicative potential of the cells indicated differences between the 
early and late adhered cells. The replicative potential of early adherent PP1 and PP2 
sub-populations was significantly higher than the late adherent PP3 cells. The later 
adherent cells displayed a relative lag in proliferation in the initial period of culture, 
extending from 1 to 9 w.  
This initial finding is suggestive of a difference in the isolated cells phenotypic 
capacities. Replication in cells is phenotype dependent; terminally differentiated cells 
tend to be post-mitotic whilst those that is of a less committed nature display a relatively 
greater capacity to multiply. This is in contrast to cancerous cells, which may be highly 
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replicative but whose aberrant phenotype would disqualify it from the context of normal 
developmental processes.  
 
The comparative proliferation of the early adherent sub-populations compared to the 
slow proliferative rate displayed by later adherent PP3 substantiate, within limits, the 
phenotypic characteristics of the differentially plated cells. Accordingly, the replicative 
nature of the early adherent sub-populations could be indicative of their 
multipotentiality compared to the restricted nature of proliferation in PP3, which 
reflects it’s somewhat committed, if not differentiated, nature. In agreement with 
Pavlath et al., (1998) early adhered cells from CSkM showed slower growth rate 
compared to their equivalent cells from LM during the period from 3 to 9 weeks in 
culture. This different may be due to the developmental differences documented 
between those two muscle sites.  
 
3.4.3. Morphological assessment 
The differences between the sub-populations were further evaluated by examining 
morphology and comparing mean surface area of cells attached to tissue culture plastic. 
This analysis also showed differences between the isolates, with the early adherent PP1 
and PP2 cells seemingly fibroblast like with a significantly larger surface area than the 
late adherent PP3, which appeared rounded in shape and of a very small surface area 
when attached to plastic.  
 
The methodology applied to assess cellular morphological characteristics could have 
been elaborated to incorporate additional parameters, which in turn may have added 
contrast to the initial findings presented here. A method that may have served well to 
this purpose would have been flow cytometry, as it would have allowed the three 
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dimensional view of the cell; hence providing an assessment unadulterated by physical 
topography of tissue culture plastic. Additionally, flow cytometry would have provided 
a view of cellular granularity; an important factor that may reflect cytoplasmic 
differences. Such an assessment may have elaborated the morphological differences to a 
further extent.  
 
However, the relatively larger fibroblastic morphology of the early adherent cells 
renders them comparable to multipotent cells isolated from other body segments, such 
as the bone and adipose tissue derived mesenchymal stem cell. In a similar manner, the 
restricted replicative potential and smaller size of the PP3 cells emphasises a difference 
in cellular function, if not multipotential abilities, of the sub-populations.         
 
3.4.4. Muscle-specific desmin expression 
This experiment further elaborated the phenotypic difference between the isolates. The 
expression of desmin in early adherent PP1 and PP2 was negligible. Though these cells 
were found to express the protein, the levels were several folds in magnitude lesser than 
the late adherent PP3, which were strongly desmin positive. This experimental finding 
strongly emphasises the phenotypic differences between cells by suggesting that the 
later adherent PP3 cells may be committed or differentiating myogenic precursors. This 
experimental finding is particularly important as it sums the preceding results by 
indicating that the phenotypic difference observed between the pre-plates.  
 
3.4.5. Gene expression analysis with PCR  
The phenotypes of isolated cells from an early passage were assessed initially with end-
point PCR. The aim of this experimental approach was to validate the presence or 
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absence of certain genes that represent four possible facets of a stem-like cell, i.e. 
multipotentiality, myogenic, osteogenic capacities, and neural crest origin.  
 
The first group of genes indicated that Oct4, a gene normally assigned to embryological 
pluripotency, was not expressed in these isolates. Sca-1, which is reported to be 
associated with several stem like cells in mice, was detected in all samples but its 
expression was relatively higher in the early adherent cells than late. Interestingly it was 
paralleled by CD34, yet another gene associated with multipotent cells from mice, but 
in the early adherent cells only. These suggest the multipotent nature of cells, compared 
to a pluripotent one that may be easily perceived due to the neonatal source of the mice; 
as well as that the early adherent cells may be more ‘plastic’ than the late adherent cells.   
This notion was supported by the findings of the myogenic and osteogenic genes. In 
brief, the early adherent cells displayed expression of osteogenic genes but lack 
myogenic gene expression. The converse was true for the late adherent PP3 cells, which 
expressed myogenic genes but lacked osteogenic genes. These findings indicate the 
early adherent cells were likely multipotent that expressed transcripts of genes, the lack 
of expression of these genes in the late adherent cells, complemented by the strong 
expression of myogenic genes, is highly indicative that PP3 were committed and/or 
differentiating myoprecursor cells.  
 
The assessment of neural crest genes was conducted to determine if the different 
development origin of these muscles contributed to an altered phenotype, and also to 
attempt to distinguish the origin of early adherent cells between the muscle and 
connective tissues.  This analysis indicated the expression of neural crest related 
markers in early adherent CSkM cells but not the remaining samples. The importance of 
this result is twofold; it clearly indicates the developmental and hence physiological 
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difference between muscle from these two anatomical regions, and it also shows that the 
early adherent cells may have a connective tissue origin. Though, comparable markers 
for connective tissue of the limb muscle region, or general connective tissue markers 
that may overlap both anatomical regions were not evaluated the positive expression of 
osteogenic with lack of myogenic gene expression support the notion of their neural 
crest derived connective tissue origin.  
 
3.4.6. Significance of findings 
The different pre-plate isolated cells displayed differences in their phenotype, which 
may possibly extend to their differentiation potentials. The early adherent PP1 and PP2 
were found to be large, fibroblastic cells with a strong replicative potential that lacked 
desmin expression. These expressed the stem cell markers Sca-1 and CD34 at a higher 
level with Runx2 and Alp gene transcripts; and displayed a lack of myogenic gene 
expression. The findings clearly indicate that the early adherent cells may not have been 
committed muscle precursor-like cells.  Instead, the proliferative and morphological 
assessments suggest that these were multipotential possibly capable of differentiating to 
osteogenic, adipogenic or chondrogenic cells.  
 
The late adherent PP3, in contrast, displayed characteristics that suggest it may be a 
muscle-precursor or of least, a mononuclear cell committed to the myogenic lineage. 
This is deduced from their relative shape and size compared to the early adherent cells, 
but more so from the observation of desmin positive cells in this sub-population.  
The desmin molecule is a muscle specific cytoskeletal protein and can only be detected 
in cells that are committed myogenic precursor cells. The relatively reduced expression 
of Sca-1 and CD34 transcripts with the lack of expression of osteogenic genes but 
strong expression of myogenic MyoD and Desmin clearly support its suggested identity 
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as a committed myoprecursor cell (Rando and Blau, 1994; Lee et al., 2000; Jankowski 
et al., 2001; Qu-Petersen et al., 2002; Deasy et al., 2005; Rouger et al., 2007).   
 
A finding of interest is the expression of neural crest markers in the early adherent cells. 
It is shown here that cells originating from the neural crest retain the expression of 
certain genes within cells isolated from CSkM, which in turn implies that the origin of 
the early adherent cells may have been of a connective tissue type.  
 
3.4.7. Conclusion  
Based on the observations from the experiments conducted in this section, it is indicated 
that mononuclear cells can be isolated from muscle tissue. These cells, when separated 
based on duration of contact with tissue culture plastic, can be divided into at least three 
different sub-populations. The sub-populations that adhered very early to culture dishes 
were similar; but not exactly alike. These collectively differed from the later adherent 
PP3 sub-population in proliferative capacities, morphology and the expression of 
desmin. The differences were shown to extend to the expression of stem cellness, 
myogenic and osteogenic genes. The differences between the two muscle groups were 
evident in the expression of neural crest markers in early adherent cells of the CSkM, 
indicating their difference in developmental origin, and hence physiological properties 
with LM; which also shows that early adherent cells may have a connective tissue 
origin and the late adherent cells seem to be myogenic precursors. These differences 
were also seen as proliferative differences between the early adherent cells of the two 
muscle types at 3 to 9 wk. 
 
.  
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3.5.  Summary of the results 
 Mononuclear cells can be isolated from muscle tissue.  
 The initially isolated suspension can be fractioned into sub-populations based on 
the factor of ‘adherence per time’.  
 Proliferative potential of early adherent cells is higher than the late adherent 
cells, which display an extended lag.  
 There are some differences in growth behaviour between early adhered cells 
together with parent population isolated from CSkM and their equivalent cells 
isolated from LM from week 3 to week 9.  
 There were no differences between late adhered cells from both muscle groups.   
 Morphology and cell-surface area differ between the pre-plates, with early 
adherent cells appearing fibroblastic and larger in surface area than later 
adherent cells. 
 Early adherent cells display minute levels of desmin expression but the later 
adherent cells display a strong desmin expression. 
 Early adherent cells strongly express stem cell and osteogenic genes. 
 Later adherent cells strongly express myogenic genes. 
 Early adherent cells from CSkM, but not LM, express neural crest markers.  
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4.1. Introduction 
4.1.1. Background 
Skeletal muscle is an organ that has the ability to regenerate following trauma or 
physical activity. Myogenic differentiation is the default developmental pathway of 
skeletal muscle precursor cells, which enables the repair of damaged tissues, as well as 
adaptation to physical changes.  
 
The process of myogenesis is orchestrated through a series of transcription factors 
controlled by the myogenic regulatory factors (MRFs). MyoD, a basic helix–loop–helix 
(bHLH) transcription factor is the founding member of the MRF family, which also 
includes the closely related Myf5, myogenin (Myog), and MRF4 proteins (Buckingham 
2001). The activity of these factors leads to phenotypic change, characterised in part by 
the expression of muscle-specific desmin protein. Myogenic differentiation progresses 
through irreversible cell cycle arrest of muscle precursor cells (MPCs) that display a 
gradual increase in the expression of muscle specific genes, which in turn lead to the 
fusion of myoblasts into multinucleate myofibres. This conversion process can be 
recapitulated in vitro with high efficiency in well-established models. 
 
Based upon the different adherence properties of cells obtained from freshly dissociated 
muscle, pre-plating has been used to obtain myogenic populations of cells that have 
slow adhesion characteristics (Rando and Blau, 1994). These cells have been shown to 
possess greater and promising efficiency to regenerate dystrophin-positive myofibres 
when injected intramuscularly in mice models (Jankowski et al., 2002; Qu-Petersen et 
al., 2002).  
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4.1.2. Rationale of study  
As shown in the previous sections, the isolated cells from both muscles and their sub-
populations may have different myogenic differentiation abilities. This is strongly 
evident in the differential expression of cytoplasmic desmin in PP3 cells compared to 
PC or PP1 or PP2 from either muscle type. Furthermore, it was shown that PP1 and PP2 
express various developmental genes except for MyoD and Desmin.  Incidentally, these 
genes are expressed in PP3 cells, which simultaneously show little or no expression of 
the remaining developmental markers. These findings strongly imply a difference in the 
potentials of the various cell isolates to differentiate along the myogenic lineage.  
 
4.1.3. Aims and objectives  
The aim of the present section of the thesis was to assess and compare the potential of 
CSkM and LM cells to undergo myogenic differentiation. Based on the observation 
presented in their preliminary characterisation, it is hypothesised that the late adherent 
PP3 sub-population of muscle derived mononuclear cells is relatively more myogenic 
than the early adherent fractions. The objectives were to induce myogenic 
differentiation in the different cell types to (i) conduct a light microscopic comparison 
for myotube formation; (ii) assess myotube formation and multi-nucleation by 
examining the expression of muscle-specific desmin at 14 d culture in differentiation 
medium; and additionally (iii) examine the expression of myogenic genes (MyoD, 
Desmin, Myog) in cultures at different time points over the course of 21 d. 
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4.2. Experimental protocol  
4.2.1. Cell culture  
Mononuclear cells were isolated from CSkM and LM as described in sections 2.1 and 
2.2. The stock suspensions were fractionated based on adherence to plastic per time to 
form the sub-populations PP1, PP2 and PP3 as described in section 2.2.2.   
 
4.2.2. Myogenic differentiation 
The differentiation experiments were carried out in 24-well plates as described in 
section 2.5.1. Cells were seeded at an initial seeding density of 25 x 10
3
 cells / cm
2 
in 
GM. At confluence, GM would be replaced by myogenic medium (MM). Myogenic 
differentiation was achieved by incubating a confluent monolayer of cells with MM. 
This medium comprised high glucose DMEM supplemented with 2 % FBS, 1 % 
antibiotics and 10 ng / ml IGF-1 (Sigma). Culture medium was replaced every three 
days.  
 
4.2.3.  Assessment of myogenic differentiation  
4.2.3.1.  Bright field light microscopic evaluation for myotube formation 
This was performed to visualise myotube formations in confluent CSkM and LM cells 
cultured in MM for 14 d. For this purpose, cultures were viewed at x40 magnification 
under bright field of a phase contrast light microscope. Images were taken as described 
in section 2.3.  
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4.2.3.2. Immunocytochemical examination of myotube formation using 
muscle-specific desmin protein expression 
This was performed similar to the description in section 3.2.4 with a detailed 
methodology provided in section 2.4. Cells were grown in GM till confluence on sterile 
glass coverslips, which were immobilised in 24 well plates. GM was then replaced with 
MM. After 14 d in MM, cells were first fixed with 4 % paraformaldehyde and then 
stained for desmin with a mouse monoclonal anti-mouse desmin antibody (Isotype: 
IgG1, Abcam, UK). Cells were then incubated with secondary antibody (anti-mouse 
IgG1 class specific FITC (Abcam, UK) for 30 minutes at room temperature. The nuclei 
were stained with the fluorescent DNA probe DAPI (Invitrogen, U.K).  
 
4.2.3.3.  QPCR analysis for muscle-specific MyoD, Desmin and Myog genes 
The expression of myogenic genes MyoD, Desmin and Myog were examined in 
cultures of confluent cells in MM over the course of 21 d. The specific time points 
examined were 1, 7, 14 and 21 d. The methods used for this experiment are described in 
section 2.8. Sample cultures comprising confluent monolayers were setup in GM and 
MM in 24-well plates. The two media were evaluated due to their differential effects on 
cell growth; as the GM supports replication but may not have the necessary 
differentiation queues of MM. At the required time, monolayers were washed x3 with 
PBS and lysed with buffer RLT. RNA was processed as described in section 2.8.1. 
Reverse transcription was performed as in section 2.8.3.2. The qPCR reactions were 
carried out as described in section 2.8.6. The table 4.1 shows the details of the genes 
and qPCR probes used.  
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Table  4.1 QPCR Gene probes for myogenic differentiation 
Gene Taqman Probe Function 
MyoD Mm00440387_m1 Master transcription factor 
Desmin Mm00802455_m1 Muscle-specific cytoskeletal protein 
Myog Mm00446194_m1 Muscle-specific transcription factor 
 
 
The CT values were normalised to the GAPDH gene, and resulting ∆CT values 
calibrated to CPC 1 d in GM.  
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4.3. Results 
4.3.1. Bright field light microscopic evaluation for myotube formation  
The confluent cultures were observed at 14 d with bright phase light microscopy for the 
formation of myotubes. The results of this experiment are shown in figures 4.1 for PP1 
and 4.2 for PP3 from both muscle types. PP3 showed the highest ability for myotube 
formation. Moreover, cells in PP1 showed the least myotube formation.   
 
 
   
Figure  4.1 Observation for myotube formation in PP1 cells.  
Images are x40 objective views of (A) CSkM and (B) LM derived PP1 cells 14 d in MM.  These indicate a lack 
of myotube formations. Bar equal 100 µm. 
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Figure  4.2 Observation for myotube formation in PP3 cells.  
Images are x40 objective views of (A) CSkM and (B) LM derived PP3 cells 14 d in MM.  They clearly show the 
formation of fibre-like myotubes. Bar equal 100µm.  
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4.3.1.1. Immunocytochemical examination of myotube formation using 
muscle-specific desmin protein expression  
This analysis was used to seek the expression of desmin (fluorescent green) against 
nuclei (DAPI blue) in CSkM and LM derived cells cultured in MM for 14 d. The results 
of this experiment are presented in figure 4.3 and 4.4 for the early and late adherent sub-
populations respectively.  
 
The analysis revealed early adherent PP1 sub-population did not express any desmin by 
this time. The PP2 cells from both muscle types expressed very small quantity of 
desmin positive cells, as shown in figure 4.4. The late adherent PP3 cells from both 
muscle types displayed strong desmin expression.  In addition, these cells isolated from 
both tissue types displayed multi-nucleation, as shown in the figure 4.4 
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Figure. 4.3 Desmin immunocytochemistry staining of early adherent cells 
Images are views at objective x63 for (A) CSkM PP1 and (B) LM PP1; x40 for (C) CSkM PP2 and (D) LM 
PP2. The PP1 sub-population (A) and (B) did not express any desmin protein. The PP2 sub-population from 
(C) CSkM and (D) LM showed few desmin positive cells at 14 d in MM.  Multi-nuclei due to myotube 
formation were not observed in any of these cells. Bar equal 100 µm. 
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Figure  4.4 Desmin immunocytochemistry staining of late adherent cells  
Images are confocal microscopic views at objective x63 of late adherent cells from (A) LM and (B) CSkM after 
14 d in MM. The two PP3 populations displayed strong expression of desmin with multi-nuclei apparent. Bar 
equal 100 µm.  
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B 
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4.3.2. QPCR analysis for muscle-specific MyoD, Desmin and Myog genes 
The muscle tissue specific genes MyoD, Desmin and Myog were examined in CSkM 
and LM derived cells cultured in GM and MM for 1, 7, 14 and 21 d. The results of this 
experiment are shown in figures 4.5, 4.6 and 4.7 for MyoD, Desmin and Myog, 
respectively.  
 
The MyoD gene was detected in all samples at 1 d. In GM, the PC and PP3 cells from 
both muscle types displayed a progressive increase in the expression of this gene over 
the course of culture. The gene was found expressed significantly higher by PP3 than 
PC at all-time points analysed. The PP1 cells did not exhibit any change in expression 
over the course of culture. The PP2, however, did seem to increase expression of the 
gene by 14 d and 21 d.  
 
In MM, MyoD expression was detected in all samples at 1 d but was significantly 
higher in PP3 than the rest. Its expression increased by 7 d in all samples except the PP1 
fractions. The PP3 cells significantly increased expression of MyoD by 14 d compared 
to the other cell types. At 21 d, expression of the gene had increased in all samples. It 
was expressed at a higher fold value by PP3 followed by PP2; while PC and PP1 shared 
a small difference at a much lower fold. No significant difference was found when 
comparing cells isolated from CSkM and their equivalent cells from LM.  
 
The results indicate the differential effects of media in the form of differences in the 
magnitude of relative fold values, which indicate MM caused a significantly higher 
upregulation of MyoD expression than GM. No significant difference between cells 
from the two muscle groups.  
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Figure  4.5 QPCR analysis for myogenic MyoD expression 
Figure shows the relative fold values of expression of MyoD in CSkM and LM cells 
Specimen were cultured in 24-well plates in GM or MM. (A and B) In GM, PP3 of both muscle types express 
significantly higher levels of MyoD followed by PC and then PP2, while PP1 do not express the gene. (C and D) 
In MM, expression of the gene increased in all samples through the course of culture. It was upregulated to a 
high level earlier by PP3 at 14 d. At 21 d, expression in PP3 and PP2 was many folds higher than PC and PP1. 
The expression of the genes was found stronger in MM compared to GM. Bars indicate mean±1SD, N = 3, n = 
3. * = p < 0.05, PC vs. PP-type. No significant difference between cells from the two muscle groups.  
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The desmin gene was found to be almost-selectively expressed at significantly high 
relative fold values by PP3 from both muscle types and in both media. The remaining 
samples upregulated Desmin expression in MM; but this was very small compared to 
PP3. In MM, the PP2 cells displayed an upregulation at 14 d. This increased slightly in 
value along with PC cells by 21 d. The PP1 did not seem to have significant increase in 
the expression of desmin through the course of culture in either media. There were 
small but significant differences between PC and PP2 from CSkM and their equivalent 
from LM tissues.  
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Figure  4.6 QPCR analysis for myogenic Desmin expression 
Figure shows the relative fold values of expression of Desmin in CSkM and LM derived cells. Specimen were 
cultured in 24-well plates in GM or MM. (A and B) In GM, PP3 of both muscle types express significantly 
higher levels of Desmin. PC cells display a small fold upregulation of the gene by 21 d. (C and D) In MM, 
expression of the gene increased in all samples through the course of culture. It was upregulated relatively 
faster and to a high level earlier by PP3 from both muscle types. At 21 d, PP3 was many folds higher than PC, 
PP1 and PP2. PC and PP2 displayed a steady upregulation of Desmin but PP1 did not display any stark 
upregulation of the gene. The expression of the genes was found stronger in MM compared to GM. Bars 
indicate mean±1SD, N = 3, n = 3. * = p < 0.05, PC vs. PP-type. a,b p<0.05, CPC vs. LPC and CPP2 vs. LPP2.  
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The Myog gene displayed a similar pattern of expression to Desmin. It was detected at 
very low levels in all samples at 1 d. The PP3 cells from both muscles significantly 
expressed higher levels of the gene at all time points in the two media conditions. The 
other cells displayed a steady increase in Myog expression but were many fold lesser 
than PP3. The PC cells and PP2 cells expressed higher levels of the gene at 21 d 
compared to PP1, which displayed a comparative delay in upregulating the gene. A 
comparison between the media types indicates the expression of the gene to be highly 
increased by MM than GM. No significant difference between cells from both muscle 
groups.  
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Figure  4.7 QPCR analysis for myogenic Myog expression 
Figure shows the relative fold values of expression of Myog in CSkM and LM derived cells. Specimen were 
cultured in 24-well plates in GM or MM. (A and B) In GM, PP3 of both muscle types express significantly 
higher levels of Myog. PC and PP2 cells display a small fold upregulation of the gene by 21 d. PP1 display a 
delay in Myog upregulation. (C and D) In MM, expression of the gene increased in all samples through the 
course of culture. It was upregulated relatively faster and to a higher level earlier by PP3 from both muscle 
types. At 21 d, PP3 was many folds higher than PC, PP1 and PP2. PC and PP2 displayed a steady upregulation 
of Myog but PP1 displayed an obvious delay in upregulation of the gene. The expression of the genes was 
found stronger in MM compared to GM. Bars indicate mean±1SD, N = 3, n = 3. * = p < 0.05, PC vs. PP-type. 
No significant difference between cells from both muscle groups.   
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4.4. Discussion 
4.4.1. Evaluation of myotube formations 
This experiment showed the early adherent cells were not capable of forming myotubes, 
while the PP3 sub-populations from both muscle groups displayed positive myotube 
formation. The initial findings made with bright field microscopy were supported by 
immunocytochemical stains of fixed 14 d cultures of cells in MM, which clearly show 
the presence of multinuclear myotubes in late adherent cells. The comparison of the 
myogenic ability of the late adherent cells suggests these may be committed 
myoprecursor cells. 
 
4.4.2. QPCR analysis of myogenic genes 
The analysis of genetic change of MyoD, Desmin and Myog were evaluated over the 
course of 21 d. It positively supported the initial findings by indicating the late adherent 
PP3 to strongly express myogenic genes compared to other specimen (Rando and Blau, 
1994; Lee et al., 2000; Jankowski et al., 2001; Qu-Petersen et al., 2002; Deasy et al., 
2005). MyoD gene is essential for the acquisition of myogenic identity it also involved 
in the transcriptional activation of other muscle specific genes (Buckingham, 2001). 
Desmin was used because of its characteristic appearance in myoblasts as muscle-
specific marker gene and its common use to detect cells with myogenic potential. The 
increased expression of desmin shows the myogenic potential of the late adhered cells. 
On the other hand Myog promotes conversion of myoblasts to myotubes and is 
expressed exclusively in myotubes (Blais et al., 2005); therefore it is also used as a late 
marker of muscle differentiation.  
 
The early adherent cell type PP2 displayed a small upregulation of myogenic genes 
towards the end of the experiment; but this significantly small in value. The expression 
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of stem cell genes by these cells may suggest their ability to differentiate towards 
myogenic differentiation. It might be also as a result of possible contamination of 
culture with some muscle committed cells.  
 
4.4.3. Significance of findings 
The results suggest that the late adherent cells isolated on plastic using differential 
adherence method from two different muscles are highly myogenic. The early adherent 
cells do display some myogenic tendencies but that is restricted to the PP2 sub-
population, while the PP1 is apparently have very limited tendency. The observed 
differences in cell behaviour can be ascribed to the different origin of cells suggested by 
the positive expression of neural crest related markers in the early adherent cells of the 
CSkM suggesting a connective tissue origin of the early adherent cells. Though an 
overlapping set of genes representing connective tissue origins of both muscle groups 
may have been beneficial, the relative lack of any myogenic potential in the early 
adherent cells supports the notion of their non-myogenic nature.  
 
The ability of the PP3 cells to differentiate is seemingly high. These cells were shown in 
the previous section to express myogenic genes and in particular, to express desmin 
gene right at the onset of isolation. The experimental findings in this section support the 
previous suggestion that these may represent committed and/or early differentiated 
muscle precursor cells (Lee et al., 2000; Qu-Petersen et al., 2002; Rouger et al., 2007).  
 
There were no differences observed between cells isolated from CSkM and their 
equivalent cells isolated from LM in term of myogenic differentiation abilities.  
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4.4.4. Conclusion 
Based on the previous results; the late adhered cells from both muscle groups appeared 
to be more myogenic as evident by the formation of myotubes and the increased 
myogenic gene expression compared to late adhered cells. There were no significant 
differences between cells isolated from CSkM and their equivalent cells from LM in 
term of myogenic differentiation ability.    
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4.5. Summary of the results 
 The later adherent PP3 sub-population of muscle derived mononuclear cells can 
form myotubes in myogenic medium. The early adherent PP1 and PP2 lack the 
ability to form myotubes. 
 The myotubes formed by late adherent cells were multi-nucleated with a high 
intensity of desmin expression. 
 The myogenic gene expression profile conducted on cells cultured in MM for up 
to 21 d showed the PP3 were expressing higher levels of myogenic genes at all 
times and both media conditions.  
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5.1.  Introduction 
5.1.1. Background  
In addition to the differences in the embryonic origin and myogenic development, 
osteogenic development in the craniofacial region is different from that in long bones. 
Bone in CSkM develops through intramembranous ossification mediated by cranial 
neural crest cells, whereas long bone in limb region develops through the endochondral 
ossification.  
 
Despite the fact that bone marrow stem cells have been generally recognised as the main 
source of osteoprogenitor cell, evidence exists that in a number of pathological 
conditions ectopic bone formation occurs in sites other than the anatomically correct 
ones (Smith and Triffitt, 1986; Sawyer et al., 1991). Heterotopic ossification, myositis 
ossificans and more aggressive diseases such as fibrodysplasia ossificans progressiva 
and musculoskeletal neoplasms exhibit unwanted bone formation in skeletal muscle 
(Kaplan and Smith, 1997, Mahboubi et al., 2001, Aho et al., 1988, Aro et al., 1991). 
 
5.1.2. Rationale of study 
Over the previous chapters, it has been shown that based on differential adherence to 
plastic, at-least three sub-populations of cells can be separated from a muscle tissue 
derived mononuclear cell isolates that have distinct properties. These are the PC, and 
sub-population PP1, PP2 and PP3 designated sub-populations of cells under study here. 
In experiments conducted, the early adherent PP1 and PP2 sub-populations displayed 
high proliferative capacities and fibroblastic morphologies compared to the less 
proliferative, rounded, late adherent PP3 cells. The early adherent cells were mainly 
desmin negative as opposed to PP3 and displayed a higher expression of stem cell 
markers and osteogenic gene transcripts. The late adherent population exhibited 
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myogenic characteristics, which were shown in the section 4 to be due to a relatively 
higher capability of myogenic gene expression and the formation of multi-nucleated 
myotubes compared to the early PP1 and PP2. These observations indicate the relative 
myogenic nature of PP3 cells; but also indicate a possible mesenchymal 
multipotentiality of the early adherent populations, particularly in regard to the higher 
expression of Runx2 and Alp transcripts found in chapter 3.  
 
5.1.3. Aims and objectives 
The aim of this section of thesis was to evaluate and compare the potential of isolated 
mononuclear cells from CSkM and LM to undergo osteogenic differentiation in vitro. 
This was assessed by culturing cells with osteoinductive medium and analyse (i) the 
genetic expression of osteogenic markers Runx 2, Alp and Bsp; (ii) compare the 
expression of alkaline phosphatase protein; and (iii) assess matrix calcification. The 
experiments were carried out in 24-well tissue culture plates and analyses conducted in 
the later phase of a 28 d culture period that parallels the process of osteogenic 
differentiation of a cell.  
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5.2. Experimental protocols  
5.2.1. Cell culture 
Mononuclear cells had been isolated from CSkM and LM as described in sections 2.1 
and 2.2. The stock suspensions were fractionated based on adherence to plastic per time 
to form the sub-populations PP1, PP2 and PP3 as described in section 2.2.2.  
Mouse calavarial osteoblasts (MOB) were used as a positive control for osteogenic 
differentiation. These were isolated from calavarial bone of sacrificed mice that had 
been used for the extraction of muscle specimen. The osteoblasts were cultured as 
described in section 2.5.2. These were cultured in GM with ascorbic acid at a 
concentration of 50 µM (Sigma).  
   
5.2.2.  Osteogenic differentiation 
The differentiation experiments were carried out in 24-well plates as described in 
section 2.5. Cells of an early passage were seeded at an initial seeding density of 25 x 
10
3
 cells / cm
2 
in GM. At confluence, GM would be replaced by osteogenic medium 
(OM). It comprised low glucose DMEM supplemented with 10 % FBS, 50 µM L-
ascorbate 2-phosphate (Fluka), 8 mM β-Glycerophosphate (Fischer) and 100 ng / ml 
BMP-2 (R&D systems).  
 
5.2.3. Assessment of osteogenic differentiation 
This was carried out at various times during a 28 d culture period in cells cultured in 
OM. The experiments were conducted in triplicate on each of the three occasions of cell 
isolation and were performed on cells that were of an early passage.  
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5.2.3.1. QPCR gene expression analysis for osteogenic genes  
This was carried out for Runx2, Alp and Bsp genes in cells cultured for 10, 21 and 28 d. 
The analysis was conducted in GM and OM due to the differential effects of the media 
on cell function; GM promotes replication whereas OM induces osteogenic 
commitment and differentiation. The methods used here are detailed in section 2.8. 
Cells monolayers were homogenised with buffer RLT. RNA was extracted as in 2.8.1 
and quantified (2.8.2) and then reverse transcribed as in 2.8.3.  
 
The qPCR was carried out as described in section 2.8.5. The CT values of target genes 
were normalised to GAPDH housekeeping gene and the ∆CT values calibrated to 
CSkM PC 1 d. The details of the probes used are in table 5.1.  
 
 
Table  5.1 Taqman probes for osteogenic markers 
Gene Probe catalogue number Function 
Runx2 Mm00501580_m1 
Master transcription factor 
Alp Mm00475834_m1 
Inorganic phosphate donor 
Bsp Mm00492555_m1 Bone matrix protein 
 
 
 
5.2.3.2. Assessment of Alp expression by staining 
This was conducted according to the methods described in section 2.6. Samples 
consisted of confluent monolayers cultured in OM for 28 d. After fixing the cells with 
10 % formalin for 15 min, the cells were washed three times with distilled water and 
then incubated for 45 min in Tris-HCl Buffer (0.2M, PH 8.3) with AS-MX phosphate 
(Sigma Chemical Co., Poole, UK) and Fast Red violet (Sigma Chemical Co., Poole, 
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UK). The Alp positive cells would be stained red/purple. This experiment was 
conducted on isolates from the three attempts of cell isolation.  
 
5.2.3.3. Semi-quantitative assessment of mineralisation   
This was assessed in cells cultured in OM for 28 d with 2 % Alizarin Red S Staining. 
The method used for this experiment is described in section 2.7.1. For this analysis, 
samples were fixed and then stained with 2 % working solution of dye. Samples were 
washed several times and air dried. Images of samples were taken at objective x40 as 
described in section 2.3. This experiment was conducted on cells from each of the three 
occasions of cell isolation.  
 
5.2.3.4. Quantitative assessment of mineralisation  
This was conducted with the aid of the QuantiChrom Calcium kit (BioAssay Systems, 
USA) according to the method described in section 2.5.2. Samples consisted of cells 
cultured in OM for 28 d. Samples were assayed by initially washing x3 with PBS and 
then homogenising monolayer with 500 µl of 1 M HCl. A 5 µl aliquot of homogenate 
would be transferred to a 96-well plate and to it added 200 ul of a 1:1 mixture of 
working reagents A and B. Coloration was measured with a spectrophotometer at 610 
nm wavelengths. Absorbance values were interpolated from a standard curve and 
expressed as mg / dl.  This experiment was conducted in cells isolated from the three 
attempts at cell isolation from tissue; and at three replicates per cell type per attempt.  
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5.3. Results 
5.3.1.  QPCR gene expression analysis for osteogenic genes 
The expression of osteogenic master transcription factor Runx2 was investigated in 
cultures of cells in GM and OM at 10, 21 and 28 d. The results of this experiment are 
presented in figure 5.1. It shows that Runx2 was detected in all cells at 10 d in both 
media. Its expression was higher in PP1 and PP2 cells compared to PC and PP3. The 
fold expression of the gene remained at a higher level in the early adherent sub-
populations compared to the remaining samples through the remainder of culture. The 
early adhered CSkM cells appeared to have significantly higher expression of the gene 
in 21 d compared to same cells isolated from LM. 
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Figure  5.1 QPCR analysis of osteogenic Runx2 
Figure shows the relative fold values of expression of Runx2 in CSkM and LM derived cells. Specimens were 
cultured in 24-well plates in GM or OM. (A and B) In GM, PP3 of both muscle types express significantly 
lower levels of Runx2. PP1 and PP2 cells displayed a small fold upregulation of the gene by 21 and 28 d. PP1 
and PP2 display a level of expression comparable to the positive control MOB. (C and D) In OM, expression of 
the gene increased in PP1 and PP2 from 10 to 21 d and then decreased by 28 d. Runx2 was not modulated at 
any time in culture by PP3 cells. A comparison between the muscle groups indicated the CSkM early adherent 
sub-populations to express the gene significantly more than LM derived equivalents. The expression of the 
gene was found stronger in OM compared to GM. Bars indicate mean+1SD, N = 3, n = 3. * = p < 0.05, PC vs. 
PP-type. a, b, c = p < 0.05, CPC vs. LPC, CPP1 vs. LPP1, and CPP2 vs. LPP2 respectively.  
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The Alp gene was detected in all samples at 10 d in GM and OM. In GM, its expression 
increased in PP1 and PP2 by 21 d and further by 28 d. The difference was significantly 
higher for PP1 than PP2 by the final time point. PP3 displayed a small change in 
expression but its fold values of expression were very low than the early adherent sub-
populations. A comparison with positive control MOB showed the early adherent sub-
populations were expressing the gene at a significantly higher level. In OM, Alp 
displayed a similar trend to GM. The gene was upregulated several fold by early 
adherent cells than PC and late adherent PP3. This difference is obvious for both muscle 
types. At 21 d, the PP1 expressed Alp at a significantly higher level than PP2. The PP1 
and PP2 levels of Alp expression decreased by 28 d. The MOB expressed Alp at a 
smaller fold value than the early adherent fractions. A comparison between the media 
types indicated similar range of expression values with the temporal difference in the 
upregulation of the genes by the early adherent cell fractions, which showed earlier 
modulation in OM than GM as shown in figure 5.2.  
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Figure  5.2 QPCR analysis of osteogenic Alp 
Figure shows the relative fold values of expression of Alp in CSkM and LM derived cells. Specimens were 
cultured in 24-well plates in GM or OM. (A and B) In GM, PP1 and PP2 displayed a higher level of expression 
than PC, PP3 and the positive control cells (MOB) at 21 and 28 d. The PP3 did not modulate the gene to a 
significant level. (C and D) In OM, PP1 and PP2 displayed heightened expressed of Alp at 10 and 21 d. The 
expression of Alp decreased in the early adherent cell populations by 28 d. It was significantly lower in PP3 
than the rest. The expression of the gene was found stronger in OM compared to GM. Bars indicate 
mean+1SD, N = 3, n = 3. * = p < 0.05, PC vs. PP-type. 
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The results for Bsp are shown in figure 5.3. Bsp gene was detected in all samples at 10 
d. Its expression was many folds higher in OM than GM. In either medium, the gene 
was expressed at significantly higher levels by PP1 and PP2 cells compared to the rest. 
The PP3 cells did not express Bsp early but had upregulated it several fold by 28 d. 
There were no differences in the expression of Bsp between the early adherent cells. 
These differed from the positive control in GM, where the early adherent populations 
were significantly lower than the MOB. A comparison between the muscle groups 
indicated Bsp expression was significantly higher in CSkM derived PP1 and PP2 cells 
compared to their LM derived equivalents.  
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Figure  5.3 QPCR analysis of osteogenic Bsp 
Figure shows the relative fold values of expression of Bsp in CSkM and LM derived cells. Specimens were 
cultured in 24-well plates in GM or OM. (A and B) In GM, PP1 and PP2 displayed a higher level of expression 
than PC and PP3 cells at all time points. The positive control (MOB) showed significantly higher expression 
than all other cells. (C and D) In OM, PP1 and PP2 displayed a progressive increase in the expression of Bsp 
over the course of culture. This was significantly higher than the positive control MOB cells. The PC and PP3 
cells increased expression from 21 to 28 d. But PP3 expressed the least Bsp compared to all samples. A 
comparison between the muscle groups indicated the CSkM early adherent sub-populations to express the 
gene significantly more than LM derived equivalents. The expression of the gene was found stronger in OM 
compared to GM. Bars indicate mean+1SD, N = 3, n = 3. * = p < 0.05, PC vs. PP-type. b, c = p < 0.05,CPP1 vs. 
LPP1, and CPP2 vs. LPP2 respectively. 
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5.3.2. Alkaline phosphatase activity  
The results of this analysis are shown in figures 5.4 and 5.5 for CSkM and LM derived 
cells. These show that osteogenic Alp was positively detected in all samples. The 
intensities of expression varied. The PP1 and PP2 cells from both muscle types 
displayed highest intensity of stain. These were followed by PC and MOB osteoblastic 
cells. The PP3 displayed least intensity of staining.  
 
 
 134 
 
Chapter 5: Osteogenic Differentiation  
 
Figure  5.4 Alp staining for CSkM derived cells 
Images were view and taken at objective x40 of Alp stained monolayers of different cell types of three different 
isolates at 28 d. The PP1 and PP2 cells displayed highest intensity of stain. PC and MOB displayed 
intermediate intensities of stain. The PP3 displayed a very small degree of staining.  
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Figure  5.5 Alp staining for LM derived cells 
Images were view and taken at objective x40 of Alp stained monolayers of different cell types of three different 
isolates at 28 d. The PP1 and PP2 cells displayed highest intensity of stain. PC and MOB displayed 
intermediate intensities of stain. The PP3 displayed a very small degree of staining.  
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5.3.3.  Semi-quantitative assessment of mineralisation   
The results of the Alizarin Red S staining of monolayers are shown in figures 5.6 and 
5.7 for CSkM and LM cells. These indicate that PP1 and PP2 cells stained the highest 
and were followed by PC cells. The PP3 and MOB were similar and seemed much less 
intense compared to the rest. These differences were observed for cells isolated from the 
two muscle types.  
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Figure  5.6 Alizarin Red S staining of CSkM derived cells 
Images were viewed and taken at objective x40 views of stained cultures from three different isolates at 28 d in 
OM. PP1 and PP2 stained the highest followed by PC. PP3 and MOB formed lesser stained monolayers.  
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Figure  5.7 Alizarin Red S staining of LM derived cells 
Images were viewed and taken at objective x40 views of stained cultures from three different isolates at 28 d in 
OM. PP1 and PP2 stained the highest followed by PC. PP3 and MOB formed lesser stained monolayers.  
 
 
 
 
                                                                    
   
 
 
 
 
      
    
 
 
 
 
      
     
 
 
 
 
 
                   
    
 
 
 
 
        
    
 139 
 
Chapter 5: Osteogenic Differentiation  
5.3.4. Quantitative assessment of mineralisation  
Cells from CSkM and LM were examined for their mineralisation capabilities after 
treatment with OM for 21 and 28 d.  The results of this analysis are shown in figure 5.8. 
It shows that cells had deposited detectable levels of calcium mineral by 21 d in culture, 
which increased to significantly higher levels by 28 d. A comparison between the sub-
types of cells indicated a similar level of calcium mineralisation in PC, PP1 and PP2 
cultures by 21 d that was significantly higher than that detected for PP3 cells and MOB 
positive control cells. The 28 d readings indicate a higher deposition of calcium mineral 
by PP1 and PP2 compared to all others. PP3 displayed an increase in calcium mineral 
by this point but its final readings were significantly lower than the other cell types. A 
comparison between cells isolated from CSkM and their equivalent isolated from LM 
shows no significant difference in calcium mineralisation.  
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B. Calcium detection analysis in LM cells
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Figure  5.8 Calcium mineral detection in CSkM and LM cultures  
Graph shows bar chart with mean±1SD, N=3, n=3 of calcium concentration in mg / dl. (A) = CSkM, (B) = LM. 
Mineral was detected in cells from both muscle groups. It was detected lower in PP3 sub-populations from 
both muscle types. PP1 and PP2 displayed highest concentration of calcium deposition.  * = p < 0.05, PC vs. 
PP-type.  
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5.4. Discussion  
5.4.1.  QPCR gene expression analysis for osteogenic genes 
This analysis examined the genes Runx2, Alp, and Bsp in cells cultured in GM or OM 
for up to 28 d. The early adherent PP1 and PP2 expressed each of these genes at a 
significantly higher level than later adherent PP3. In the case of Alp, this relative high 
fold of expression was starkly evident in both media types. In comparison, the late 
adherent PP3 did not express these osteogenic genes at a higher level. Instead, the 
expression of these genes was found at a baseline that did increase by 28 compared to 
10 d but this incremental raise was very small in value.  
In addition, small yet significant differences were observed in the expression of these 
osteogenic genes over time between the CSkM and LM derived specimen. This is an 
indication of the differential influence that developmental origin may bear on adult stem 
cell characteristics. The phenotypic significance of these gene expression patterns are 
discussed below.  
 
5.4.2.  Assessment of Alp expression by staining 
The staining indicated a higher expression of the alkaline phosphatase enzyme in the 
early adherent PP1 and PP2 cells compared to PP3 and even the MOB. This was 
particularly interesting as the last cell type is a dedicated mature osteoblast that would 
have been thought to differentiate and function at a relatively higher level. Interestingly, 
the PP3 cells displayed expression of the protein, albeit at significantly lower levels. 
These cells were considered as committed precursors due to their relative strong 
potential to differentiate to the myogenic lineage with the expression of myogenic genes 
and myotube formations. The observation that these cells express alkaline phosphatase 
after sufficient duration in inductive medium indicates its possible potential to deviate 
from the myogenic lineage.  
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5.4.3.  Assessment of osteogenic mineralisation 
The formation of a calcified extra-cellular matrix is the hallmark of osteogenic 
differentiation. The analyses conducted here indicated clearly that the early adherent 
cells were relatively osteogenic by forming more calcified matrices than the remaining 
specimens, including mature osteoblasts. In a manner similar to the osteogenic alkaline 
phosphatase expression, the late adherent PP3 cells displayed some mineralisation at 28 
d. The increase observed from the initial to final time point indicates that these cells 
may have adopted an osteogenic profile. A comparison between the muscle groups 
indicated a slight difference in the concentration of calcium, which was insignificant.  
 
5.4.4.  Significance of findings  
The findings indicate that the early adherent PP1 and PP2 sub-populations possessed a 
higher capacity to differentiate along the osteogenic lineage. These cells expressed the 
osteogenic genes at a higher level, expressed abundant levels of alkaline phosphatase 
and displayed higher matrix calcifications compared to PC, PP3 and MOBs. The 
findings support the presence of osteoprogenitor cells within skeletal muscle tissue as 
shown in previous work of Urist and colleagues (1970); Khouri et al., 1991; Bosch et 
al., 2000; Lee et al., 2000; Levy et al. 2001; Mastrogiacomo et al., 2005; Hashimoto et 
al., 2008.  
 
Interestingly, the PP3 cells displayed a degree of change with the presence of osteogenic 
inductive medium with an increase in gene expression, alkaline phosphatase expression 
and calcium mineralisation at 28 d compared to 10 d in culture. This is an important 
implication for the plasticity of PP3, as the findings of the previous sections suggested 
these were committed myogenic precursors, and hence were likely to not be capable of 
responding to inductants of a different lineage. The findings suggest that these cells 
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while being myogenic on the onset, my have the potential to ‘trans-differentiate’ from 
early myogenic commitment to that of an osteogenic phenotype. This can be seen in the 
long duration of culture with strong osteo-inductive medium; with time the defining 
factor that drives the change of fate in these cells. It may also be a suggestive of partial 
contamination of the late adhered cells with the more osteogenic cells from rely adhered 
ones (Bosch et al., 2000).  
 
5.4.5. Conclusion 
The results presented here showed that early adhered cells from both muscle groups 
appeared to be more osteogenic than late adhered cells and the positive control MOB 
cells. This was evident by the higher expression of Alp and Alizarin Red stains. This 
was further confirmed by the higher expression of osteogenic genes (Runx2, Alp and 
Bsp) and detectable calcium depositions by early adhered cells from both muscle 
groups. Early adhered cells from CSkM showed slightly higher Runx2 and Bsp genes 
expression at 21 d. however, this change was faded by 28 d and cells from both muscle 
groups behave similarly again. Therefore, there were no significant differences in term 
of terminal osteogenic differentiation between cells isolated from CSkM and their 
equivalents cells isolated from LM.   
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5.5. Summary of the results 
 The early adherent PP1 and PP2 express higher levels of Runx2, Alp and Bsp 
genes in OM compared to the late adherent PP3 cells at all times in a 28 d 
culture.  
 PP3 display an increase in osteogenic gene expression at the end of 28 d in OM.   
 PP1 and PP2 expressed alkaline phosphatase protein at a higher intensity than 
PP3.  
 The PP3 cells express the protein at the end stages of a 28 d culture in OM. 
 Calcium mineralisation assessed by Alizarin Red S stain followed the trend 
observed for alkaline phosphatase expression being higher in the early adherent 
sub-populations than late adherent PP3. 
 This was confirmed by the quantitative analysis of calcium deposition. 
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6.1.  The hypothesis  
The present study was based on the hypothesis that neonatal mouse muscle tissue from 
the head and limbs contains mononuclear cells that may, in turn, bear differences in 
their capacity to differentiate along the osteogenic and myogenic lineages.  
 
Analytical methods have been developed to isolate mononuclear cells with stem cell 
like characteristics; these have been described in section 1.4.2.2. The pre-plate method 
that was originally developed by Yaffe (1968),  Richler and Yaffe, (1970) and Rando 
and Blau, 1994,  uses ‘contact duration’ as a method to fraction a total cell isolate into 
sub-populations, different in their adherent properties and hence possibly phenotypic 
characteristics. This method has been applied with varying modifications to isolate 
mononuclear cells with a capacity to differentiate to different lineages. Many such 
studies have mainly focused on late adherent cells and evaluated their multilineage 
potentials whilst the initial isolates have not been paid much attention. 
 
Developmentally, CSkM and LM originate from two distinct parts of the embryo. Most 
of the head muscles arise from prechordal and paraxial head mesoderm (PHM) (Noden, 
1983) but the connective tissues are neural crest derived (Noden and Trainor, 2005). 
The progenitors of tongue and posterior neck muscle arise from the occipital somites 
whereas branchiomeric muscles progenitors arise from the unsegmented PHM 
(Kuratani, 2005; Noden and Francis-West, 2006). On the other hand, trunk and limb 
musculature derive from the pre-somitic paraxial mesoderm, which runs parallel to the 
body axis flanking the neural tube. Accordingly, most of head muscle progenitor cells 
reside in a distinct embryonic tissue compared to limb and trunk muscle progenitors.  
The connective tissue compartment of CSkM develops from NCC in contrast to LM 
muscle tissues that are of mesodermal origin.  
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The signals that regulate myogenesis in the head vary to those that operate in trunk and 
limb regions. Early transcription factors that control early somitic muscle development 
are not expressed in the developing CSkM (Mootoosamy and Dietrich, 2002). All the 
somitic muscles, including limb muscle, that migrate from somites, are Pax3-positive 
and express homebox factor Lbx1 during early myogenesis, but craniofacial muscles are 
Pax3 and Lbx1 negative (Tajbakhsh et al., 1997; Buckingham, 2001; Brown et al., 
2005; Mootoosamy and Dietrich, 2002). Postnatally there are differences in their 
regenerative potentials. Pavlath and colleagues found that there is a regenerative 
difference between masseter and limb muscle, which may be related to intrinsic 
differences between the muscle precursor cells in these two muscles (Pavlath et al., 
1998). There are also some report that indicate that craniofacial muscles (masseter 
muscle) continue to express many molecules normally downregulated in adult limb 
skeletal muscle, such as developmental and neonatal myosin heavy chain (Butler-
Browne et al., 1988)  and embryonic fibronectin splicing variant  EIIIA ( Price et al., 
1998). Additionally, satellite cells isolated from masseter muscle reported to proliferate 
more and to differentiate rather later than those from limb muscle (Ono et al., 2010). 
However, when masseter-derived satellite cells transplanted in limb region; the 
masseter-derived satellite cells regenerated limb muscles as efficiently as those from 
limb muscle (Ono et al., 2010). 
 
Furthermore, bone formation in craniofacial region and other parts of the body 
experience different pathways. Craniofacial ossification follows the intramembranous 
pathway which is differs from the endochondral pathway occurs in long bones.    
 
The above-mentioned studies have documented differences between CSkM and LM 
development and regeneration. However, whether these differences positively or 
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negatively affect the proliferation and differentiation abilities of cell population isolated 
from these tissues remain to be evaluated. 
 
6.2.  Overview of the thesis 
The current study was divided into three main levels: firstly, to isolate and characterise 
muscle derived mononuclear cells from CSkM and LM tissues; secondly, compare the 
myogenic differentiation abilities of the isolated cells; and thirdly, examine differences 
in their osteogenic differentiation potentials. 
 
6.2.1.  Isolation of mononuclear cells 
In this study, mononuclear cells were isolated from both CSkM and LM tissue based on 
their adhesion properties to plastic. These populations were named, PP1, PP2 and PP3, 
which represented the adherent portion of a total cell isolate by 1 h, 48 h and 120 h on 
plastic. 
 
A modification of the preplate method developed by Yaffe (1968) and Rando and Blau 
(1994), was applied here to isolate mononuclear cells from muscle tissue. The 
modifications included (i) the use of non-coated tissue culture plastic dishes for cell 
attachment in contrast to collagen coated substrates as used by others and (ii) various 
contact durations, comprising 1 h, 48 h and 5 d. The different substrates and contact 
intervals used by other researchers are tabulated in table 6.1. It shows the differences 
between method used in this study and same method used by most of the other studies. 
Most of work undertaken so far has been on non-craniofacial sources of muscle tissue, 
with the use an extracellular matrix protein as a substrate, and a main focus on the late 
adherent cells isolated with variable time points for cell attachment procedure. Hence 
 149 
 
Chapter 6: Discussion 
this was the first attempt to investigate and compare cells isolated from CSkM and LM 
based on their adhesion properties to tissue culture plastic. 
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Table  6.1 Various modes of muscle derived cells isolation by the pre-plate method 
 HMM-MAA (high-molecular-weight melanoma-associated antibody), VWF (Von Willebrand factor), MPT (Modified preplate technique), PT (preplate technique), αSMA (Alpha sarcomeric 
actin), h (Hour). MDSC (Muscle derived stem cell), c-Met (Tyrosine kinase receptor), MNF (Myocyte nuclear factor), Flk-1 (Foetal liver kinase-1), Bcl-2 (B-cell lymphocytic-leukaemia proto-
oncogene), Sca-1 (Stem cell antigen 1), P75 (Nerve growth factor receptor), Sox10 (SRY-box containing gene), AP2c (Transcription factor AP2 gamma), Alp (Alkaline phosphatase)   
Muscle origin species Isolation method 
Cells 
investigated 
Substrate Lineage potential Markers used Main differences  
Main 
similarities 
References 
Limb Mice 
MPT (1h, 2h) (PP1, PP2) PP1 
discarded 
Late adhered 
cells 
Collagen Hematopoietic Hoechst 33342/ Ly-5.1/ c-Kit/ Sca-1 
Method/ substrate/ Lineage 
potential/markers 
N/A 
Jackson et al., 
1999 
Limb Mice 
PT (2h, 24h until PP6) PP1 
discarded 
EP (PP2-5), LP 
(PP6), MDSC 
subpopulation of 
PP6 
collagen 
Muscle/ neural/  
endothelial  
Desmin/  Sca-1/  CD34 
Method/ substrate/ Lineage 
potential/markers/ cells used 
(MDSC) 
EP higher desmin than MDSC 
initially 
Expanded 
MDSC are 
95% 
desmin+ 
Qu- Petersen et 
al., 2002 
Limb Mice 
MPT (1h, 2h, 18h, 24h), PP1 to 
PP4-6. 
All cells Collagen  Myoblast  Desmin  
Method/ substrate/ Lineage 
potential/markers 
late adhered 
more 
myogenic 
Qu et al., 1998 
Limb Mice 
MPT (1h, 2h, 18h, 24h), PP1 to 
PP4-6. 
Late adhered 
cells 
Collagen Myoblast Sca-1/ CD33/  desmin 
Method/ substrate/ Lineage 
potential/markers/ cells 
investigated 
PP4-6 more Sca-1 and CD34 
late adhered 
more 
myogenic 
Jankowski et al., 
2001 
Limb Mice 
MPT (1h, then when 30% to 
40% of cells attached) PP1 to 
PP5-6.  
Late adhered 
cells 
Collagen 
Myogenic/ 
Osteogenic 
Sca-1/  desmin/  CD34/  Bcl-2/  Flk-1/  
c-Met/  MNF 
Method/ substrate/ Lineage 
potential/markers/ cells 
investigated 
no comparison made 
Late adhered 
myogenic 
and 
osteogenic  
Lee et al., 2000 
Limb Mice 
PT (2h, 24h until PP6) PP1 
discarded 
PP1, PP3 and late 
adhered  MDSC  
Collagen Bone formation Desmin 
Method/ substrate/ Lineage 
potential/markers/ cells 
investigated 
Late adhered (MDSC) more 
osteogenic 
MDSC 
higher 
desmin 
expression 
  
Shen et al., 2004 
Limb Mice 
PT( selective pre-plating by 
trypsinisation) 
Late adhered Collagen Myogenic Desmin 
Method/ substrate/ Lineage 
potential/markers/ cells 
investigated 
Late adhered 
cells higher 
desmin 
expression 
Rando and Blau, 
1994 
Limb Mice  
MPT (1h, 2h, 24h), PP1 to 
PP3-6. 
All cells No coating Myogenic Sca-1/  CD34/ Desmin 
Method/ substrate/ Lineage 
potential/markers/ PP6 more 
Sca-1 and CD34.  
PP4 and PP5 
cells higher 
desmin 
expression 
Torrente et al., 
2001 
Limb Mice 
PT (2h, 24h until PP6) PP1 
discarded  
Late adhered 
cells 
Collagen Osteogenic N/A 
Method/ substrate/ Lineage 
potential/markers/ cells 
investigated/ no comparison 
N/A Usas et al., 2009 
Limb Mice PT (2h, 24h until PP6)  
Late adhered 
cells 
Collagen Smooth muscle  αSMA/ CD34/ Sca-1 
Method/ substrate/ Lineage 
potential/markers/ cells 
investigated/ no comparison 
N/A 
Nolazco et al., 
2008 
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Muscle origin species Isolation method 
Cells 
investigated 
Substrate Lineage potential Markers used Main differences  
Main 
similarities 
References 
Limb Mice 
MPT (1h, 2h, 18h, 24h), PP1 to 
PP4-6. 
Late adhered 
cells and MC13 
clone 
Collagen 
Muscle cell 
expansion  
N/A 
Method/ substrate/ cells 
investigated 
N/A Deasy et al., 2002 
Limb Mice 
PT (2h, 24h until PP6) PP1 
discarded 
Late adhered 
cells 
Collagen Muscle dystrophy N/A 
Method/ substrate/ Lineage 
potential/ cells investigated 
N/A 
Ambrosio et al., 
2009 
Limb Mice PT (2h, 24h until PP6)  
Late adhered 
cells 
Collagen Chondrogenic N/A 
Method/ substrate/ Lineage 
potential 
N/A Kubo et al., 2009 
Limb  Rat MPT (1h, 2h, 3h, 1d, 2d, 3d).  
Late adhered 
cells 
Collagen Osteogenic  CD44/ CD45 
Method/ substrate/ Lineage/ 
species/  potential/markers/ 
cells investigated/ no 
comparison 
N/A Kim et al., 2008 
N/A Human PT (1h, 24h interval until PP5)  All cells Collagen Osteogenic  Desmin 
Method/ substrate/ Lineage 
potential/markers/ PP3 more 
desmin expression/ PP3 
higher Alp production/ PP1 
higher BMP-2 secretion 
Early 
adhered cells 
less desmin 
expression 
Musgrave et al., 
2002 
Head and 
neck 
Human 
Brief culture (1h (discarded), 
24h used) 
24h adherent 
cells 
No coating Hematopoietic  CD45/ CD31 
Method/ substrate/ Lineage /  
potential/ species/ markers/ no 
comparison 
N/A 
Dell'Agnola et al., 
2002 
N/A Human PT (2h, 24h until PP6)  CD34+ cells Collagen 
Adipogenic, 
myogenic, 
osteogenic and 
chondrogenic 
CD34 
Method/ substrate/ Lineage  
potential/ species/ markers 
N/A Lu et al., 2009 
Limb Mice 
MPT (1h, then when 30% to 
40% of cells attached) PP1 to 
PP6 
Late adhered 
cells 
Collagen Osteogenic Desmin 
Method/ substrate/ Lineage 
potential/markers/ cells 
investigated/  
Late adhered  
cells higher 
desmin 
expression 
Bosch et al., 2000 
gracilis and 
semitendinosus 
Human 
Brief culture (1h uncoated then 
transferred supernatant to 
coated flask) 
 
Uncoated 
Collagen 
Osteogenic 
HOP-26/ αSMA/ Desmin/ CD31/ 
VWF/ HMM-MAA/  
β nonmuscle (NM) actin  
Method/ substrate/ Lineage 
potential/ species/ markers/ 
cells investigated 
Early 
adhered 
more 
osteogenic 
Levy et al., 2001 
Limb and 
craniofacial 
Mice MPT (1h, 48h, 5d)  Uncoated 
Myogenic and 
osteogenic 
Sca-1/ CD34/ P75/ Sox10/ AP2c/ Alp/ 
Runx2/ MyoD/ Desmin 
  This study 
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Cells that adhered within the 1h of attachment, PP1, from both muscle tissue sites, 
showed higher growth rate initially compared to other sub-populations. These cells also 
appeared to be larger and with no desmin expression. The PP2 on the other hand, 
showed similar growth behaviour to PP1, however, their size was smaller and cells had 
minimal expression of desmin.  
 
Late adhered cells, PP3, showed less growth rate compared to PP1 and PP2 and were 
significantly smaller in size. They were also highly positive for desmin expression.  
These observations were similar in both muscle tissues. Comparing isolated cells from 
CSkM to its counterpart equivalent from LM revealed that early adhered cells, PP1 and 
PP2, were slightly larger in size compared to PP1 and PP2 from LM. In contrast PP3 
seemed to be similar from both muscles.   
    
The multilineage potentiality of isolated cells was indicated by the expression of 
potential stem cells genes (Oct4, Sca-1 and CD34). The early adhered cells from both 
muscle tissue expressed both Sca-1 and CD34 in contrast to the late adhered cells which 
only expressed Sca-1.  
 
The assessment of myogenic gene expression for MyoD and desmin indicated their 
selective expression in later adherence cells. This may suggest that those cells are 
residing in muscle tissue and therefore express muscle specific genes.   
 
Heterotopic ossification in muscle tissue led to investigating the early osteogenic 
markers in isolated cells. These markers were osteogenic specific Runx2 and Alp that 
had the high chance of being detected, if expressed at all in the mononuclear cells  
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The expression of osteogenic markers in only early adhered cells, PP1 and PP2, from 
both muscle tissues indicates that they had the potential to differentiate to an osteogenic 
lineage. This may indicate their non-muscle origin, such as connective tissue origin and 
have multipotentiality towards osteogenic lineage. 
 
As documented in developmental studies such as Noden and Francis-West, (2006), 
Noden and Schneider, (2006); Evans and Noden, (2006); Noden, (1983); Grenier et al., 
(2009). CSkM connective tissue is believed to originate from neural crest cells whereas 
connective tissue of LM has a mesodermal origin. Therefore, the expression of three 
NCCs specific markers namely Sox10, P75 and AP-2 was assessed in these cells. The 
expression of those genes in only PP1 and PP2 of CSkM strongly support available 
evidence of NCC involvement in CSkM development. It also suggests that early 
adhered cells are present in the connective tissue of CSkM muscle. The use of 
connective tissue specific markers for other muscle origin would have provided a 
clearer picture of the origin of early adhered cells from LM. 
  
6.2.2.  Myogenic capacity of isolated mononuclear cells 
An investigation of the myogenic differentiation abilities was carried out in order to 
further elaborate the phenotypic differences between the cells observed in the initial 
analysis. 
 
In this study, early adhered cells, especially PP1, form both muscle tissues have a very 
limited ability to differentiate along myogenic lineage as clearly observed from bright 
field microscopy and desmin immune staining compared to late adhered cells.  
PP2 cells shows relatively more myogenic gene expression than PP1 but lesser than 
PP3. This could be due to the stemness of those cells as they express stem cell specific 
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genes, Sca-1 and CD34. They also present in the muscle niche and may have the ability 
to differentiate to myogenic lineage, which in the in vitro method used may require 
longer time in culture. This is ascertained from the pattern of genetic expression, which 
indicates a possibility that early adhered cells especially PP2 may form myotubes if 
allowed further culture. On the other hand, PP3 showed increase in myotube formation 
and gene expression by 7 days.  
 
The PP2 cells seemingly more myogenic than PP1 cells; this difference was small 
initially but presented as a progressive increase in transcription level of myogenic 
genes. However, absence of myotube formation may require further examination as this 
may suggest the ability of these cells to trans-differentiate from a seemingly non-
myogenic phenotype to a myogenic one. 
 
6.2.3.  Osteogenic differentiation of isolated mononuclear cells 
In this section we aimed to evaluate and compare the osteogenic potentials of isolated 
cells. Based on previous findings, cells showed different phenotypic and myogenic 
potentials. These could be complicated by the different origin of cells with and the 
difference in bone formation between craniofacial and long bones.  
Early adhered cells, PP1 and PP2, from both muscles showed higher osteogenic 
potential compared to PP3 cells. This can be seen from Alp, Alizarin Red S stain, and 
calcium measurement assay presented in chapter 5. 
 
Based on the findings PP1 cells from both muscle groups seemed to have a relatively 
higher osteogenic potential than PP2. The late adhered cells, PP3, from both muscle 
tissues showed gradual increase in osteogenic gene expression towards the end of 28 d 
of culture. They also show a minute amount of Alp stain. The Alizarin Red S staining 
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also confirmed the presence of few points of calcium deposition, which was further 
confirmed by the increase of calcium deposition from 21d to 28 d. This finding may be 
due to a sub-population of osteogenic cells present within the PP3 fraction of 
mononuclear cells. However, the early passaged cells used in this study and the time 
needed for the fibroblastic cells to expand and contribute to these readings may rule out 
the possibility of contamination. On the other hand, the expression of stem cells gene, 
Sca-1, by these cells and the gradual increase in osteogenic genes, Alp and Alizarin Red 
S stains and calcium deposition may indicate their ability to trans-differentiate from a 
myogenic cell to an osteogenic lineage. All these findings show that PP3 can 
differentiate towards osteogenic lineage but to an obviously lesser extent than PP1 and 
PP2.  
Even though, differences were notices between CSkM PP1 and PP2 and their equivalent 
cells isolated from LM in term of osteogenic gene expression (Runx2 and Bsp) at 21 d; 
there were no significant differences at later time point (28 d). This transient different 
may be related to the developmental differences in muscle and bone formation between 
those two sites.   
 
6.3.  Significance of findings and agreement  
Cells isolated in this study based on their ability to adhere to uncoated tissue culture 
plastic. In addition, the time selected for cells to plastic contact was different among 
other published work in this field (Rando and Blau, 1994; Lee et al., 2000; Jankowski et 
al., 2001; Qu-Petersen et al., 2002; Deasy et al., 2005). Few studies have used the 
criteria of adherence to plastic in order to isolate osteogenic faction of muscle derived 
mononuclear cells (Levy et al., 2001; Mastrogiacomo et al., 2005, Gharaibeh et al., 
2008). A direct comparison of isolated cells in this study to same cells isolated in 
previous studies is not applicable.  However, the data confirmed previous work that 
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mononuclear cells can be isolated from muscle tissue based on their adhesion 
characteristics. Also the late adhered cells appear to be more myogenic compared to 
early adhered cells. The cellular isolation process of preplating was originally developed 
to enrich cell culture preparations for myogenic cells used in muscle transplantation 
experiments (Rando and Blau, 1994; Qu et al., 1998). Early adhered cells (PP1) on 
collagen had been reported by several researchers to be mainly fibroblast and discarded. 
However, Levy and colleagues (2001) have suggested that cells that adhered to plastic 
initially had more osteogenic potentials than late adhered cells or cells that adhered to 
collagen coated plastic.  The findings support that early adhered cells to uncoated tissue 
culture flask appeared to have more growth potentials initially, low desmin expression 
and high osteogenic differentiation ability.  
 
Sca-1 genes appeared to be present in all cells with higher expression in early adhered 
cells compared to late adhered ones. This supports the idea that all sub-population may 
have undifferentiated cells present in the culture with varying degrees of multipotency.  
The expression of CD34 mainly in early adhered cells from both muscles may suggest 
that those cells may have the ability to differentiate into non-myogenic cell types.  
Taking into consideration the expression of all genes we can suggest that early adhered 
cells from both muscles share the same expression profile, which may indicate the 
multipotent nature of those cells. Expression of NCC genes by early adhered CSkM also 
suggests that those cells may originate from the connective tissue compartment of the 
muscle hence may have the ability to differentiate into non-myogenic lineages. 
However, further investigation of the other stem cell, connective tissue and 
multipotential genes may be of great help in understanding the identity of those cells.  
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Regarding osteogenic potential, the data in this study is in agreement with previous 
reports supporting the existence of osteoprogenitor cells within skeletal muscle. Prior 
work on this subject includes the diffusion chamber and muscle pouch implantation 
experiments of Urist et al., (1970), muscle flap experiments by Khouri et al., (1991), 
and numerous in vitro experiments using both muscle-derived cell lines (Katagiri et al., 
1994) and primary muscle cell preparations (Bosch et al., 2000, Lee et al., 2000; Levy 
et al., 2001, Mastrogiacomo et al., 2005; Hashimoto et al., 2008). However, prior to this 
report, any efforts to isolate an enhanced population of osteoprogenitor cells from 
primary craniofacial skeletal muscle samples were not readily available; as was not a 
comparison between equivalent cells isolated from limb muscle. As researchers strive to 
improve fracture healing or bone formation at a cellular level, procurement of 
progenitor cells from a variety of sources may prove to be significant. 
 
Recently, several groups of researchers were interested in identifying and isolating 
multipotent stem cells from the skeletal muscle but as of today, due to the lack of 
specific markers, the identity of the cells giving rise to osteoblasts within skeletal 
muscles has not been determined (Bosch et al., 2000; Levy et al., 2001). A number of 
candidates have been proposed: satellite cells, for example, have been found to be early 
progenitors of the muscle cell and also to retain the ability to undergo osteo-
chondrogenic differentiation in vitro.  Asakura et al., (2001) have provided evidence in 
vitro that isolated mouse muscle satellite cells, in the presence of rhBMP4 and/or 
BMP7, can express alkaline phosphatase, an early marker of osteoblast differentiation 
and osteocalcin gene 
 
Lee et al., (2000) showed that muscle cells could be induced in vitro by BMP2 to 
express osteocalcin mRNA. Furthermore they showed that transduced cells, 
 158 
 
Chapter 6: Discussion 
constitutively expressing BMP2 formed bone, when implanted subcutaneously into 
immune-compromised mice. Levy et al., (2001) also provided evidence of a cell 
population isolated from skeletal muscle expressing in culture high levels of osteocalcin 
mRNA after 24 h of induction with vitamin D.  
 
Among potential contaminant cells from skeletal muscle, pericytes are particularly 
interesting as the possible source of osteoprogenitor cells for ectopic bone formation. 
Others have shown that pericytes isolated from other tissues are capable of 
mineralisation and behave phenotypically similarly to osteocytes in response to 
different oxygen tensions and growth factors in vitro (Reilly et al., 1998; Schor et al., 
1995). These data support a widely believed connection between angiogenesis and 
osteogenesis (Reilly et al., 1998; Schor et al., 1995). Urist refers to pericytes as the cells 
induced by demineralised bone matrix or BMP to form bone within muscle tissue 
(Urist, 1965; Urist et al., 1983, Nilsson et al., 1986). Based on available data, the 
relative contribution of pericytes to the early adhered cells population is not clear. It is 
not mutually exclusive for osteoprogenitor cells within skeletal muscle to be associated 
with satellite cells and pericytes. 
 
A stem cell population should fulfil several criteria in order to be used for tissue 
engineering applications. These criteria include: 
• Should be found in abundance.  
• Can be easily collected and harvested.  
• Can be reproducibly differentiated along multiple cell lineage pathways. 
• Can be safely and effectively transplanted to either an autologous or allogeneic host.  
Several researchers have used, with some limitation, MDSC in the treatment of several 
diseases such heart failure, urological disordered, muscular dystrophies, orthopaedic 
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applications (Menasche, 2008; Huard et al., 2002; Rando and Blau, 1994, Qu-Petersen 
et al., 2002; Gussoni et al., 1999; Bosch et al., 2000; Lee et al., 2002).  
The cells isolated in this study have both the ability to differentiate in to myogenic and 
osteogenic lineages. After being investigated in 3D model; early adhered cells could be 
utilised in bone and/ or cartilage repair and regeneration. While the late adhered cells 
could be used in repair and regenerate damaged muscle tissues and other diseases such 
as DMD. 
 
Two different strategies are pursued for application of stem cells in regenerative 
medicine. The one and easier way is simple injection of cell suspension into the blood 
circulation or the target tissue a procedure called “cell therapy,” the second approach 
(tissue engineering); utilising the use of tissue-like construct consisting of a three-
dimensional matrix colonised by cells is engineered in vitro and subsequently implanted 
into the tissue defect of the recipient. Mostly, addition of growth factors is necessary for 
proliferation and differentiation of stem cells in vitro (Ehnert et al., 2009). 
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6.4.  Conclusions 
The experimental findings presented in this thesis reveal that mononuclear cells can be 
isolated from muscle tissues of the mouse cranium and limbs. This initial isolate can be 
differentially fractioned into at least three populations based on their variable adherence 
to tissue culture plastic. Phenotypically, the early adherent cells seem to be relatively 
multipotent compared to the late adherent cells, which display characteristics of 
committed myogenic precursors. The osteogenic differentiation ability of the early 
adherent cells is higher than the late. Conversely, the ability of myogenic differentiation 
is higher in late adherent than early adherent cells. Interestingly, the different cells 
display varying degree of trans-differentiation. Accordingly, the early adherent cells 
display progressive increase in myogenic differentiation while PP3 exhibit an increase 
in osteogenic parameters after 21-28 day stimulation in inductive media. Cells isolated 
from both muscles displayed certain differences. These pertained mainly to cell size as 
surface area being larger in early adherent cells from CSkM than LM, but also due to 
the positive expression of neural crests specific genes in the former. No significant 
differences were observed in myogenic differentiation ability between CSkM and LM 
isolated cells. There was transient difference in osteogenic differentiation ability 
between early adhered cells from CSkM and their equivalent from LM by 21 d. 
However, this difference was small and faded by 28 d. Therefore, cells isolated from 
both muscle tissues seem to have similar differentiation abilities despite the documented 
developmental differences between those two sites.  
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6.5.  Future directions 
Presented in this study are the preliminary findings of a promising shift in bone tissue 
engineering where muscle tissue, due to the presence of cells capable of osteogenic 
differentiation, may offer a suitable source of multipotent cells.  Before moving to more 
advanced in vivo investigation of the ability of the cells isolated in this study, a full 
understanding of the biological behaviour and characteristics is required.  
 
An initial examination would be to use a substrate other than plastic. This may include 
extracellular matrix molecules, such as collagen and fibronectin, as well as biomaterial 
substrates, such as modified titanium implant surfaces or polymeric substrates. The 
mechanism of cell adhesion depends on the type of cell surface molecules and the 
ability of these molecules to interact with extracellular matrix components. Tissue 
culture plastic is a widely used substrate but is non-native to the body and, while 
bearing the chance of fractionating a heterogeneous population as seen in the result 
provided here, it may fail to divide cells based on subtle molecular differences.  
As it hasn’t been done before, a comparison between cells isolated from both muscle 
groups adhered to plastic and cells adhered to other substrate such as collagen would 
give more insight into their biological characteristics and potential applications.    
Multipotent cells can differentiate along several lineages. Some lineages tested 
successfully in cells that can undergo osteogenesis include, adipogenic differentiation, 
chondrogenic differentiation and neurological differentiation. These cells types form the 
organ and represent fates that local stem cells may adapt in cases of injury or 
physiological regeneration. Evidence exists that adult stem cells isolated from different 
anatomical sites exhibit multipotentiality. Hence, it may have been advantageous to 
assess the potential of isolated cells to differentiate and trans-differentiate along these 
lineages.  
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A method that is relatively accessible and can be conducted with ease is analysing the 
transcriptional activity of genes key to multipotentiality of cells. This could be achieved 
using mouse pluripotency stem cell arrays from Applied Biosystems. The gene content 
on these arrays is a result of the work of the I.S.C.I consortium: Characterization of 
human embryonic stem cell lines by the International Stem Cell Initiative (Adewumi et 
al., 2007). (https://products.appliedbiosystems.com/ab/en/US/adirect/ab?cmd=  
catNavigate2&catID=604089&tab=DetailInfo). The genes can characterise cellular 
phenotype with respect to stem cellness, and with a careful experimental design, can 
allow the assessment of differentiation to different mesenchymal lineages, as well as 
trans-differentiation between these lineages. Furthermore, the cells isolated here, and 
their potential comparatives isolated from a substrate other than plastic, may be further 
evaluated with flow cytometry. This is a powerful method to delineate phenotypically 
different cells in a heterogeneous cell isolate. A point of interest is the possibility of 
assigning a biological identity to the different isolated cells using flow cytometry, a feat 
that has not been wholly achieved in the case of the human mesenchymal stromal cell, 
for example.  
 
However, it is the possibility of the isolated cells to be used in treating some muscle 
diseases (such as Duchenne muscular dystrophy (DMD) and heterotopic ossification) or 
bone defects (tumour, large infections). An animal model with some of these diseases 
would give a more definitive answer of the cells abilities. This could be achieved by 
using the late adhered cells from both muscle groups in a DMD mouse model assessing 
the outcome in craniofacial and limb muscle areas. The osteogenic abilities would be 
investigated by creating a bone defect in craniofacial and long bone regions. Injecting 
the isolated cells from both groups into the same area where they were isolated from 
and to the opposite site. i.e. isolated CSkM cells will be injected into craniofacial bone 
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defect and long bone defect. Same will be adopted for the cells isolated from LM. This 
experiment would assess if CSKM and LM cells would lead to a beneficial treatment of 
muscle or bone loss. The outcomes of the above stated steps, if successful, will pave the 
way for human based experimentations targeted at correcting a particular tissue defect 
through the design of efficient therapeutic procedures that will isolate cells from muscle 
and apply them to the body.  
  
 164 
 
 
 
 
 
 
 
 
 
 
 
7. References  
 
 
165 
 
References 
Adewumi, O., Aflatoonian, B., Ahrlund-Richter, L., Amit, M., Andrews, P. W., 
Beighton, G., Bello, P. A., Benvenisty, N., Berry, L. S., Bevan S, Blum B, Brooking J, 
Chen KG, Choo AB, Churchill GA, Corbel M, Damjanov I, Draper JS, Dvorak P, 
Emanuelsson K, Fleck RA, Ford A, Gertow K, Gertsenstein M, Gokhale PJ, Hamilton 
RS, Hampl A, Healy LE, Hovatta O, Hyllner J, Imreh MP, Itskovitz-Eldor J, Jackson J, 
Johnson JL, Jones M, Kee K, King BL, Knowles BB, Lako M, Lebrin F, Mallon BS, 
Manning D, Mayshar Y, McKay RD, Michalska AE, Mikkola M, Mileikovsky M, 
Minger SL, Moore HD, Mummery CL, Nagy A, Nakatsuji N, O'Brien CM, Oh SK, 
Olsson C, Otonkoski T, Park KY, Passier R, Patel H, Patel M, Pedersen R, Pera MF, 
Piekarczyk MS, Pera RA, Reubinoff BE, Robins AJ, Rossant J, Rugg-Gunn P, Schulz 
TC, Semb H, Sherrer ES, Siemen H, Stacey GN, Stojkovic M, Suemori H, Szatkiewicz 
J, Turetsky T, Tuuri T, van den Brink S, Vintersten K, Vuoristo S, Ward D, Weaver 
TA, Young LA, Zhang W. (2007). Characterization of human embryonic stem cell lines 
by the International Stem Cell Initiative. Nature Biotechnology, 25 (7), pp.803-816. 
Aho, H.J., Aro, H., Juntunen, S., Strengell, L. & Michelsson, J.E. (1988) Bone 
formation in experimental myositis ossificans. Light and electron microscopy study. 
APMIS: Acta Pathologica, Microbiologica, Et Immunologica Scandinavica, 96 (10), 
pp.933-940. 
Alhadlaq, A. & Mao, J.J. (2004) Mesenchymal stem cells: isolation and therapeutics. 
Stem Cells and Development, 13 (4), pp.436-448. 
Alison, M.R., Poulsom, R., Forbes, S. & Wright, N.A. (2002) An introduction to stem 
cells. The Journal of Pathology, 197 (4), pp.419-423. 
Ambrosio, F., Ferrari, R.J., Fitzgerald, G.K., Carvell, G., Boninger, M.L. & Huard, 
Johnny (2009) Functional overloading of dystrophic mice enhances muscle-derived 
stem cell contribution to muscle contractile capacity. Archives of Physical Medicine and 
Rehabilitation, 90 (1), pp.66-73. 
Arnett, T.R. & Henderson, B. (1998) Methods in bone biology. 1st ed. London, 
Chapman and Hall. 
Aro, H.T., Viljanto, J., Aho, H.J. & Michelsson, J.E. (1991) Macrophages in trauma-
induced myositis ossificans. APMIS: Acta Pathologica, Microbiologica, Et 
Immunologica Scandinavica, 99 (5), pp.482-486. 
Arriero, M., Brodsky, S.V., Gealekman, O., Lucas, P.A. & Goligorsky, M.S. (2004) 
Adult skeletal muscle stem cells differentiate into endothelial lineage and ameliorate 
renal dysfunction after acute ischemia. American Journal of Physiology. Renal 
Physiology, 287 (4), pp.F621-627. 
 
 
 
166 
 
References 
Asakura, A, Komaki, M. & Rudnicki, M (2001) Muscle satellite cells are multipotential 
stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. 
Differentiation; Research in Biological Diversity, 68 (4-5), pp.245-253. 
Asakura, A & Rudnicki, M  (2002) Side population cells from diverse adult tissues are 
capable of in vitro hematopoietic differentiation. Experimental Hematology, 30 (11), 
pp.1339-1345. 
Asakura, A, Seale, P, Girgis-Gabardo, A & Rudnicki, M A (2002) Myogenic 
specification of side population cells in skeletal muscle. The Journal of Cell Biology, 
159 (1), pp.123-134. 
Baddoo, M., Hill, K., Wilkinson, R., Gaupp, D., Hughes, C., Kopen, G.C. & Phinney, 
D.G. (2003) Characterization of mesenchymal stem cells isolated from murine bone 
marrow by negative selection. Journal of Cellular Biochemistry, 89 (6), pp.1235-1249. 
Beauchamp, J.R., Heslop, L., Yu, D.S., Tajbakhsh, S, Kelly, R G, Wernig, A, 
Buckingham, M.E., Partridge, T.A. & Zammit, P S (2000) Expression of CD34 and 
Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. The Journal 
of Cell Biology, 151 (6), pp.1221-1234. 
Blais, A., Tsikitis, M., Acosta-Alvear, D., Sharan, R., Kluger, Y. & Dynlacht, B.D. 
(2005) An initial blueprint for myogenic differentiation. Genes & Development, 19 (5), 
pp.553-569. 
Blau, H M, Brazelton, T.R. & Weimann, J.M. (2001) The evolving concept of a stem 
cell: entity or function? Cell, 105 (7), pp.829-841. 
Bober, E., Brand-Saberi, B., Ebensperger, C., Wilting, J., Balling, R., Paterson, B.M., 
Arnold, H.H. & Christ, B. (1994) Initial steps of myogenesis in somites are independent 
of influence from axial structures. Development (Cambridge, England), 120 (11), 
pp.3073-3082. 
Bosch, P., Musgrave, D.S., Lee, J Y, Cummins, J, Shuler, T., Ghivizzani, T.C., Evans, 
T., Robbins, T.D. & Huard (2000) Osteoprogenitor cells within skeletal muscle. Journal 
of Orthopaedic Research: Official Publication of the Orthopaedic Research Society, 18 
(6), pp.933-944. 
Braun, T. & Arnold, H.H. (1996) Myf-5 and myoD genes are activated in distinct 
mesenchymal stem cells and determine different skeletal muscle cell lineages. The 
EMBO Journal, 15 (2), pp.310-318. 
 
 
 
167 
 
References 
Braun, T., Rudnicki, M A, Arnold, H.H. & Jaenisch, R. (1992) Targeted inactivation of 
the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal 
death. Cell, 71 (3), pp.369-382. 
Brown, C.B., Engleka, K.A., Wenning, J., Min Lu, M. & Epstein, J.A. (2005) 
Identification of a hypaxial somite enhancer element regulating Pax3 expression in 
migrating myoblasts and characterization of hypaxial muscle Cre transgenic mice. 
Genesis (New York, N.Y.: 2000), 41 (4), pp.202-209. 
Bruder, S.P. & Caplan, A.I. (1989) Cellular and molecular events during embryonic 
bone development. Connective Tissue Research, 20 (1-4), pp.65-71. 
Buckingham, M (2001) Skeletal muscle formation in vertebrates. Current Opinion in 
Genetics & Development, 11 (4), pp.440-448. 
Buckingham, Margaret, Bajard, L., Chang, T., Daubas, P., Hadchouel, J., Meilhac, S., 
Montarras, D., Rocancourt, Didier & Relaix, F. (2003) The formation of skeletal 
muscle: from somite to limb. Journal of Anatomy, 202 (1), pp.59-68. 
Burdzińska, A., Gala, K. & Paczek, L. (2008) Myogenic stem cells. Folia Histochemica 
Et Cytobiologica / Polish Academy of Sciences, Polish Histochemical and 
Cytochemical Society, 46 (4), pp.401-412. 
Burry, R.W. (2010) Immunocytochemistry: A Practical Guide for Biomedical Research. 
1st ed. Springer, New York. 
Butler-Browne, G.S., Eriksson, P.O., Laurent, C. & Thornell, L.E. (1988) Adult human 
masseter muscle fibers express myosin isozymes characteristic of development. Muscle 
& Nerve, 11 (6), pp.610-620. 
Buxton, P.G., Bitar, M., Gellynck, K., Parkar, M., Brown, R.A., Young, A.M., 
Knowles, J.C. & Nazhat, S.N. (2008) Dense collagen matrix accelerates osteogenic 
differentiation and rescues the apoptotic response to MMP inhibition. Bone, 43 (2), 
pp.377-385. 
Canalis, E., Economides, A.N. & Gazzerro, E. (2003) Bone morphogenetic proteins, 
their antagonists, and the skeleton. Endocrine Reviews, 24 (2), pp.218-235. 
Cao, B & Huard, J (2004) Muscle-derived stem cells. Cell Cycle (Georgetown, Tex.), 3 
(2), pp.104-107. 
 
 
 
168 
 
References 
Caplan, A.I. (1991) Mesenchymal stem cells. Journal of Orthopaedic Research: Official 
Publication of the Orthopaedic Research Society, 9 (5), pp.641-650. 
Chen, Di, Zhao, M. & Mundy, G.R. (2004) Bone morphogenetic proteins. Growth 
Factors (Chur, Switzerland), 22 (4), pp.233-241. 
Chen, J., Shapiro, H.S. & Sodek, J. (1992) Development expression of bone sialoprotein 
mRNA in rat mineralized connective tissues. Journal of Bone and Mineral Research: 
The Official Journal of the American Society for Bone and Mineral Research, 7 (8), 
pp.987-997. 
Cheng, G., Merriam, A.P., Gong, B., Leahy, P., Khanna, S. & Porter, J.D. (2004) 
Conserved and muscle-group-specific gene expression patterns shape postnatal 
development of the novel extraocular muscle phenotype. Physiological Genomics, 18 
(2), pp.184-195. 
 
Christ, B. & Ordahl, C.P. (1995) Early stages of chick somite development. Anatomy 
and Embryology, 191 (5), pp.381-396. 
Cikos, S., Bukovská, A. & Koppel, J. (2007) Relative quantification of mRNA: 
comparison of methods currently used for real-time PCR data analysis. BMC Molecular 
Biology, 8, p.113. 
Clemmons, D.R. (2009) Role of IGF-I in skeletal muscle mass maintenance. Trends in 
Endocrinology and Metabolism: TEM, 20 (7), pp.349-356. 
Cooper, W.G. & Konigsberg, I.R. (1961) Dynamics of myogenesis in vitro. The 
Anatomical Record, 140, pp.195-205. 
Cornelison, D.D. & Wold, B.J. (1997) Single-cell analysis of regulatory gene 
expression in quiescent and activated mouse skeletal muscle satellite cells. 
Developmental Biology, 191 (2), pp.270-283. 
Corsi, K.A., Pollett, Jonathan B, Phillippi, J.A., Usas, Arvydas, Li, G. & Huard, Johnny 
(2007) Osteogenic potential of postnatal skeletal muscle-derived stem cells is 
influenced by donor sex. Journal of Bone and Mineral Research: The Official Journal of 
the American Society for Bone and Mineral Research, 22 (10), pp.1592-1602. 
Cossu, G & Borello, U. (1999) Wnt signaling and the activation of myogenesis in 
mammals. The EMBO Journal, 18 (24), pp.6867-6872. 
 
 
 
169 
 
References 
Cossu, Giulio, Tajbakhsh, Shahragim & Buckingham, Margaret (1996) How is 
myogenesis initiated in the embryo? Trends in Genetics, 12 (6), pp.218-223. 
Davies, L.C., Locke, M., Webb, R.D.J., Roberts, J.T., Langley, M., Thomas, D.W., 
Archer, C.W. & Stephens, P. (2010) A multipotent neural crest-derived progenitor cell 
population is resident within the oral mucosa lamina propria. Stem cells and 
development, 19 (6), pp.819–830. 
Deasy, B M, Gharaibeh, B.M., Pollett, J B, Jones, M.M., Lucas, M.A., Kanda, Y. & 
Huard, J (2005) Long-term self-renewal of postnatal muscle-derived stem cells. 
Molecular Biology of the Cell, 16 (7), pp.3323-3333. 
Deasy, B M, Qu-Peterson, Z., Greenberger, J.S. & Huard, J (2002) Mechanisms of 
muscle stem cell expansion with cytokines. Stem Cells (Dayton, Ohio), 20 (1), pp.50-
60. 
Deasy, B M., Jankowski, R J. & Huard, J (2001) Muscle-Derived Stem Cells: 
Characterization and Potential for Cell-Mediated Therapy. Blood Cells, Molecules, and 
Diseases, 27 (5), pp.924-933. 
Dell’Agnola, C., Rabascio, C., Mancuso, P., Capillo, M., Pruneri, G., Gobbi, A., 
Minucci, S., Ronzoni, S., Volorio, S., Calabrese, L., Tradati, N., Martinelli, G., Shultz, 
L. & Bertolini, F. (2002) In vitro and in vivo hematopoietic potential of human stem 
cells residing in muscle tissue. Experimental Hematology, 30 (8), pp.905-914. 
Dietrich, S, Schubert, F.R., Healy, C., Sharpe, P.T. & Lumsden, A. (1998) Specification 
of the hypaxial musculature. Development (Cambridge, England), 125 (12), pp.2235-
2249. 
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L. & Karsenty, G. (1997) Osf2/Cbfa1: A 
Transcriptional Activator of Osteoblast Differentiation. Cell, 89 (5), pp.747-754. 
Dupin, E., Calloni, G., Real, C., Gonçalves-Trentin, A. & Le Douarin, N.M. (2007) 
Neural crest progenitors and stem cells. Comptes Rendus Biologies, 330 (6-7), pp.521-
529. 
Ehnert, S., Glanemann, M., Schmitt, A., Vogt, S., Shanny, N., Nussler, N.C., Stöckle, 
U. & Nussler, A. (2009) The possible use of stem cells in regenerative medicine: dream 
or reality? Langenbeck’s archives of surgery / Deutsche Gesellschaft für Chirurgie, 394 
(6), pp.985–997. 
Evans, D.J.R. & Noden, Drew M (2006) Spatial relations between avian craniofacial 
neural crest and paraxial mesoderm cells. Developmental Dynamics: An Official 
Publication of the American Association of Anatomists, 235 (5), pp.1310-1325. 
 
 
170 
 
References 
Farhadieh, R.D., Gianoutsos, M.P., Yu, Y. & Walsh, W.R. (2004) The role of bone 
morphogenetic proteins BMP-2 and BMP-4 and their related postreceptor signaling 
system (Smads) in distraction osteogenesis of the mandible. The Journal of Craniofacial 
Surgery, 15 (5), pp.714-718. 
Fernandes, K.J.L., McKenzie, I.A., Mill, P., Smith, K.M., Akhavan, M., Barnabé-
Heider, F., Biernaskie, J., Junek, A., Kobayashi, N.R., Toma, J.G., Kaplan, D.R., 
Labosky, P.A., Rafuse, V., Hui, C.-C. & Miller, F.D. (2004) A dermal niche for 
multipotent adult skin-derived precursor cells. Nature cell biology, 6 (11), pp.1082–
1093. 
Gharaibeh, B., Lu, Aiping, Tebbets, J., Zheng, Bo, Feduska, J., Crisan, M., Peault, B., 
Cummins, James & Huard, Johnny (2008) Isolation of a slowly adhering cell fraction 
containing stem cells from murine skeletal muscle by the preplate technique. Nat. 
Protocols, 3 (9), pp.1501-1509. 
Gilbert, S.F. & Singer, S.R. (2006) Developmental biology. Sinauer Associates, Inc. 
Sunderland, USA. 
Golub, E.E. & Boesze-Battaglia, K. (2007) The role of alkaline phosphatase in 
mineralization. Current Opinion in Orthopaedics, 18, pp.444-448. 
Grefte, S., Kuijpers-Jagtman, A.M., Torensma, R. & Von den Hoff, J.W. (2007) 
Skeletal muscle development and regeneration. Stem Cells and Development, 16 (5), 
pp.857-868. 
Grenier, J., Teillet, M.-A., Grifone, R., Kelly, Robert G & Duprez, Delphine (2009) 
Relationship between neural crest cells and cranial mesoderm during head muscle 
development. PloS One, 4 (2), p.e4381. 
Gronthos, S, Mankani, M., Brahim, J, Robey, P G & Shi, S (2000) Postnatal human 
dental pulp stem cells (DPSCs) in vitro and in vivo. Proceedings of the National 
Academy of Sciences of the United States of America, 97 (25), pp.13625–13630. 
Gros, J., Scaal, M. & Marcelle, C. (2004) A two-step mechanism for myotome 
formation in chick. Developmental Cell, 6 (6), pp.875-882. 
Gussoni, E, Soneoka, Y., Strickland, C.D., Buzney, E.A., Khan, M.K., Flint, A.F., 
Kunkel, L M & Mulligan, R.C. (1999) Dystrophin expression in the mdx mouse 
restored by stem cell transplantation. Nature, 401 (6751), pp.390-394. 
Hall, B.K. (1988) The Embryonic Development of Bone. American Scientist, 76 (2), 
pp.174-181. 
 
 
171 
 
References 
Ham, R.G., St Clair, J.A., Webster, C. & Blau, H M (1988) Improved media for normal 
human muscle satellite cells: serum-free clonal growth and enhanced growth with low 
serum. In Vitro Cellular & Developmental Biology: Journal of the Tissue Culture 
Association, 24 (8), pp.833-844. 
Hashimoto, N., Kiyono, T., Wada, M.R., Umeda, R., Goto, Y.-ichi, Nonaka, I., 
Shimizu, S., Yasumoto, S. & Inagawa-Ogashiwa, M. (2008) Osteogenic properties of 
human myogenic progenitor cells. Mechanisms of Development, 125 (3-4), pp.257-269. 
Hatori, M., Klatte, K.J., Teixeira, C.C. & Shapiro, I.M. (1995) End labeling studies of 
fragmented DNA in the avian growth plate: evidence of apoptosis in terminally 
differentiated chondrocytes. Journal of Bone and Mineral Research: The Official 
Journal of the American Society for Bone and Mineral Research, 10 (12), pp.1960-
1968. 
Hawke, T.J. & Garry, D.J. (2001) Myogenic satellite cells: physiology to molecular 
biology. Journal of Applied Physiology, 91 (2), pp.534 -551. 
Ho, M.M., Ng, A.V., Lam, S. & Hung, J.Y. (2007) Side Population in Human Lung 
Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells. Cancer 
Research, 67 (10), pp.4827 -4833. 
Huard, J, Yokoyama, T., Pruchnic, R., Qu, Z., Li, Y., Lee, J Y, Somogyi, G.T., de 
Groat, W.C. & Chancellor, M.B. (2002) Muscle-derived cell-mediated ex vivo gene 
therapy for urological dysfunction. Gene therapy, 9 (23), pp.1617–1626. 
Ito, Y. & Miyazono, K. (2003) RUNX transcription factors as key targets of TGF-beta 
superfamily signaling. Current Opinion in Genetics & Development, 13 (1), pp.43-47. 
Jackson, Kathyjo Ann, Mi, T. & Goodell, M.A. (1999) Hematopoietic potential of stem 
cells isolated from murine skeletal muscle. Proceedings of the National Academy of 
Sciences, 96 (25), pp.14482 -14486. 
Jankowski, R J, Deasy, B M & Huard, J (2002) Muscle-derived stem cells. Gene 
Therapy, 9 (10), pp.642-647. 
Jankowski, R J, Haluszczak, C., Trucco, M. & Huard, J (2001) Flow cytometric 
characterization of myogenic cell populations obtained via the preplate technique: 
potential for rapid isolation of muscle-derived stem cells. Human Gene Therapy, 12 (6), 
pp.619-628. 
Jiang, Y., Vaessen, B., Lenvik, T., Blackstad, M., Reyes, M. & Verfaillie, C.M. (2002) 
Multipotent progenitor cells can be isolated from postnatal murine bone marrow, 
muscle, and brain. Experimental Hematology, 30 (8), pp.896-904. 
 
 
172 
 
References 
Jonason, J.H., Xiao, G., Zhang, M., Xing, L. & Chen, D (2009) Post-translational 
Regulation of Runx2 in Bone and Cartilage. Journal of Dental Research, 88 (8), pp.693-
703. 
Jonker, J.W., Freeman, J., Bolscher, E., Musters, S., Alvi, A.J., Titley, I., Schinkel, A.H. 
& Dale, T.C. (2005) Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the 
side population phenotype in mammary gland and bone marrow of mice. Stem Cells 
(Dayton, Ohio), 23 (8), pp.1059-1065. 
Kafadar, K.A., Yi, L., Ahmad, Y., So, L., Rossi, F. & Pavlath, Grace K (2009) Sca-1 
expression is required for efficient remodeling of the extracellular matrix during skeletal 
muscle regeneration. Developmental Biology, 326 (1), pp.47-59. 
Kan, L., Hu, M., Gomes, W.A. & Kessler, J.A. (2004) Transgenic mice overexpressing 
BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. The 
American Journal of Pathology, 165 (4), pp.1107-1115. 
Kaplan, F S & Smith, R.M. (1997) Fibrodysplasia ossificans progressiva (FOP). Journal 
of Bone and Mineral Research: The Official Journal of the American Society for Bone 
and Mineral Research, 12 (5), p.855. 
Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., 
Wozney, J.M., Fujisawa-Sehara, A. & Suda, T. (1994) Bone morphogenetic protein-2 
converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. 
The Journal of Cell Biology, 127 (6 Pt 1), pp.1755-1766. 
Katz, B. (1961) The Terminations of the Afferent Nerve Fibre in the Muscle Spindle of 
the Frog. Philosophical Transactions of the Royal Society of London. Series B, 
Biological Sciences, 243 (703), pp.221 -240. 
Kelly, Robert G, Jerome-Majewska, L.A. & Papaioannou, V.E. (2004) The del22q11.2 
candidate gene Tbx1 regulates branchiomeric myogenesis. Human Molecular Genetics, 
13 (22), pp.2829-2840. 
Khouri, R.K., Koudsi, B. & Reddi, H. (1991) Tissue transformation into bone in vivo. A 
potential practical application. JAMA: The Journal of the American Medical 
Association, 266 (14), pp.1953-1955. 
Kim, K.S., Lee, J.H., Ahn, H.H., Lee, Ju Young, Khang, G., Lee, B., Lee, H.B. & Kim, 
M.S. (2008) The osteogenic differentiation of rat muscle-derived stem cells in vivo 
within in situ-forming chitosan scaffolds. Biomaterials, 29 (33), pp.4420-4428. 
 
 
 
173 
 
References 
Kim, M., Turnquist, H., Jackson, J., Sgagias, M., Yan, Y., Gong, M., Dean, M., Sharp, 
J.G. & Cowan, K. (2002) The Multidrug Resistance Transporter ABCG2 (Breast Cancer 
Resistance Protein 1) Effluxes Hoechst 33342 and Is Overexpressed in Hematopoietic 
Stem Cells. Clinical Cancer Research, 8 (1), pp.22 -28. 
Knudsen, K.A., McElwee, S.A. & Myers, L. (1990) A role for the neural cell adhesion 
molecule, NCAM, in myoblast interaction during myogenesis. Developmental Biology, 
138 (1), pp.159-168. 
Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, 
Y., Bronson, R.T., Gao, Y.H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, 
S. & Kishimoto, T. (1997) Targeted disruption of Cbfa1 results in a complete lack of 
bone formation owing to maturational arrest of osteoblasts. Cell, 89 (5), pp.755-764. 
Krebsbach, P.H. & Robey, P.G. (2002) Dental and skeletal stem cells: potential cellular 
therapeutics for craniofacial regeneration. Journal of Dental Education, 66 (6), pp.766-
773. 
Kubo, S., Cooper, G.M., Matsumoto, T., Phillippi, J.A., Corsi, K.A., Usas, Arvydas, Li, 
G., Fu, Freddie H & Huard, Johnny (2009) Blocking vascular endothelial growth factor 
with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-
derived stem cells. Arthritis and Rheumatism, 60 (1), pp.155-165. 
Kuratani, S. (2005) Developmental studies on the vertebrate head evolution. Zoological 
Science, 22 (12), pp.1361-1366. 
Kuroda, R., Usas, Arvydas, Kubo, S., Corsi, K., Peng, Hairong, Rose, T., Cummins, 
James, Fu, Freddie H & Huard, Johnny (2006) Cartilage repair using bone 
morphogenetic protein 4 and muscle-derived stem cells. Arthritis and Rheumatism, 54 
(2), pp.433-442. 
Lavker, R.M. & Sun, T.T. (2000) Epidermal stem cells: properties, markers, and 
location. Proceedings of the National Academy of Sciences of the United States of 
America, 97 (25), pp.13473–13475. 
Lee, J Y, Peng, H., Usas, A., Musgrave, D., Cummins, J., Pelinkovic, D., Jankowski, R., 
Ziran, B., Robbins, P. & Huard, Johnny (2002) Enhancement of bone healing based on 
ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic 
protein 2. Human gene therapy, 13 (10), pp.1201–1211. 
Lee, J Y, Qu-Petersen, Z, Cao, B, Kimura, S, Jankowski, R, Cummins, J, Usas, A, 
Gates, C, Robbins, P., Wernig, A & Huard, J (2000) Clonal isolation of muscle-derived 
cells capable of enhancing muscle regeneration and bone healing. The Journal of Cell 
Biology, 150 (5), pp.1085-1100. 
 
 
174 
 
References 
Levy, M.M., Joyner, C.J., Virdi, A.S., Reed, A., Triffitt, J.T., Simpson, A.H., 
Kenwright, J., Stein, H. & Francis, M.J. (2001) Osteoprogenitor cells of mature human 
skeletal muscle tissue: an in vitro study. Bone, 29 (4), pp.317-322. 
Li, Y. & Huard, J (2002) Differentiation of muscle-derived cells into myofibroblasts in 
injured skeletal muscle. The American Journal of Pathology, 161 (3), pp.895-907. 
Linker, C., Lesbros, C., Stark, M.R. & Marcelle, C. (2003) Intrinsic signals regulate the 
initial steps of myogenesis in vertebrates. Development (Cambridge, England), 130 
(20), pp.4797-4807. 
Liu, R., Schindeler, A. & Little, D.G. (2010) The potential role of muscle in bone 
repair. Journal of Musculoskeletal & Neuronal Interactions, 10 (1), pp.71-76. 
Livak, K.J. & Schmittgen, T.D. (2001) Analysis of relative gene expression data using 
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, 
Calif.), 25 (4), pp.402-408. 
Lu, J.-R., Bassel-Duby, R., Hawkins, A., Chang, P., Valdez, R., Wu, H., Gan, L., 
Shelton, J.M., Richardson, J.A. & Olson, E.N. (2002) Control of facial muscle 
development by MyoR and capsulin. Science (New York, N.Y.), 298 (5602), pp.2378-
2381. 
Lu, S.-H., Yang, A.-H., Wei, C.-F., Chiang, H.S. & Chancellor, M.B. (2009) Multi-
potent differentiation of human purified muscle-derived cells: potential for tissue 
regeneration. BJU International. Available from: 
<http://www.ncbi.nlm.nih.gov/pubmed/19712114> [Accessed 8 January 2012]. 
Mahboubi, S., Glaser, D L, Shore, E M & Kaplan, F S (2001) Fibrodysplasia ossificans 
progressiva. Pediatric Radiology, 31 (5), pp.307-314. 
Majka, S.M., Jackson, Kathyjo A, Kienstra, K.A., Majesky, M.W., Goodell, M.A. & 
Hirschi, K.K. (2003) Distinct progenitor populations in skeletal muscle are bone 
marrow derived and exhibit different cell fates during vascular regeneration. The 
Journal of Clinical Investigation, 111 (1), pp.71-79. 
Martini, F. & Ober, W.C. (2006) Fundamentals of anatomy & physiology. 7
th
 ed. 
Pearson Benjamin Cummings. 
Mastrogiacomo, M., Derubeis, A.R. & Cancedda, R. (2005) Bone and cartilage 
formation by skeletal muscle derived cells. Journal of Cellular Physiology, 204 (2), 
pp.594-603. 
 
 
175 
 
References 
Mauro, A. (1961) Satellite cell of skeletal muscle fibers. The Journal of Biophysical and 
Biochemical Cytology, 9, pp.493-495. 
McKinney-Freeman, S.L., Jackson, Kathyjo A, Camargo, F.D., Ferrari, G., Mavilio, F. 
& Goodell, M.A. (2002) Muscle-derived hematopoietic stem cells are hematopoietic in 
origin. Proceedings of the National Academy of Sciences of the United States of 
America, 99 (3), pp.1341-1346. 
McKinney-Freeman, S.L., Majka, S.M., Jackson, Kathyjo A, Norwood, K., Hirschi, 
K.K. & Goodell, M.A. (2003) Altered phenotype and reduced function of muscle-
derived hematopoietic stem cells. Experimental Hematology, 31 (9), pp.806-814. 
McLoon, L.K., Thorstenson, K.M., Solomon, A. & Lewis, M P (2007) Myogenic 
precursor cells in craniofacial muscles. Oral Diseases, 13 (2), pp.134-140. 
Meeson, A.P., Hawke, T.J., Graham, S., Jiang, N., Elterman, J., Hutcheson, K., Dimaio, 
J.M., Gallardo, T.D. & Garry, D.J. (2004) Cellular and molecular regulation of skeletal 
muscle side population cells. Stem Cells (Dayton, Ohio), 22 (7), pp.1305-1320. 
Menasché, P. (2008) Skeletal myoblasts and cardiac repair. Journal of molecular and 
cellular cardiology, 45 (4), pp.545–553. 
Menetrey, J., Kasemkijwattana, C., Day, C.S., Bosch, P., Vogt, M., Fu, F H, Moreland, 
M.S. & Huard, J (2000) Growth factors improve muscle healing in vivo. The Journal of 
Bone and Joint Surgery. British Volume, 82 (1), pp.131-137. 
Menko, A.S. & Boettiger, D. (1987) Occupation of the extracellular matrix receptor, 
integrin, is a control point for myogenic differentiation. Cell, 51 (1), pp.51-57. 
Mitchell, P.J., Timmons, P.M., Hébert, J.M., Rigby, P.W. & Tjian, R. (1991) 
Transcription factor AP-2 is expressed in neural crest cell lineages during mouse 
embryogenesis. Genes & Development, 5 (1), pp.105-119. 
Mitchell, P.O., Mills, T., O’Connor, R.S., Kline, E.R., Graubert, T., Dzierzak, E. & 
Pavlath, Grace K (2005) Sca-1 negatively regulates proliferation and differentiation of 
muscle cells. Developmental Biology, 283 (1), pp.240-252. 
Mootoosamy, R.C. & Dietrich, Susanne (2002) Distinct regulatory cascades for head 
and trunk myogenesis. Development (Cambridge, England), 129 (3), pp.573-583. 
 
 
 
 
176 
 
References 
Münsterberg, A.E., Kitajewski, J., Bumcrot, D.A., McMahon, A.P. & Lassar, A B 
(1995) Combinatorial signaling by Sonic hedgehog and Wnt family members induces 
myogenic bHLH gene expression in the somite. Genes & Development, 9 (23), 
pp.2911-2922. 
Musgrave, D.S., Pruchnic, R, Bosch, P., Ziran, B.H., Whalen, J. & Huard, J (2002) 
Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic 
protein-2. The Journal of Bone and Joint Surgery. British Volume, 84 (1), pp.120-127. 
Nilsson, O.S., Urist, M.R., Dawson, E.G., Schmalzried, T.P. & Finerman, G.A. (1986) 
Bone repair induced by bone morphogenetic protein in ulnar defects in dogs. The 
Journal of Bone and Joint Surgery. British Volume, 68 (4), pp.635-642. 
Noden, D M (1983) The role of the neural crest in patterning of avian cranial skeletal, 
connective, and muscle tissues. Developmental Biology, 96 (1), pp.144-165. 
Noden, D M & Francis-West, P. (2006) The differentiation and morphogenesis of 
craniofacial muscles. Developmental Dynamics: An Official Publication of the 
American Association of Anatomists, 235 (5), pp.1194-1218. 
Noden, D M & Schneider, R.A. (2006) Neural crest cells and the community of plan for 
craniofacial development: historical debates and current perspectives. Advances in 
Experimental Medicine and Biology, 589, pp.1-23. 
Noden, D M & Trainor, P.A. (2005) Relations and interactions between cranial 
mesoderm and neural crest populations. Journal of Anatomy, 207 (5), pp.575-601. 
Nolazco, G., Kovanecz, I., Vernet, D., Gelfand, R.A., Tsao, J., Ferrini, M.G., Magee, 
T., Rajfer, J. & Gonzalez-Cadavid, N.F. (2008) Effect of muscle-derived stem cells on 
the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat. 
BJU International, 101 (9), pp.1156-1164. 
Ogata, Y. (2008) Bone sialoprotein and its transcriptional regulatory mechanism. 
Journal of Periodontal Research, 43 (2), pp.127-135. 
Ojima, K., Uezumi, A., Miyoshi, H., Masuda, S., Morita, Y., Fukase, A., Hattori, A., 
Nakauchi, H., Miyagoe-Suzuki, Y. & Takeda, S. (2004) Mac-1(low) early myeloid cells 
in the bone marrow-derived SP fraction migrate into injured skeletal muscle and 
participate in muscle regeneration. Biochemical and Biophysical Research 
Communications, 321 (4), pp.1050-1061. 
Ono, Y., Boldrin, L., Knopp, P., Morgan, J.E. & Zammit, Peter S (2010) Muscle 
satellite cells are a functionally heterogeneous population in both somite-derived and 
branchiomeric muscles. Developmental Biology, 337 (1), pp.29-41. 
 
 
177 
 
References 
Otto, F., Thornell, A.P., Crompton, T., Denzel, A., Gilmour, K.C., Rosewell, I.R., 
Stamp, G.W., Beddington, R.S., Mundlos, S., Olsen, B.R., Selby, P.B. & Owen, M.J. 
(1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for 
osteoblast differentiation and bone development. Cell, 89 (5), pp.765-771. 
Paulin, D & Li, Z (2004) Desmin: a major intermediate filament protein essential for the 
structural integrity and function of muscle. Experimental Cell Research, 301 (1), pp.1-7. 
Pavlath, G K, Thaloor, D., Rando, T A, Cheong, M., English, A.W. & Zheng, B (1998) 
Heterogeneity among muscle precursor cells in adult skeletal muscles with differing 
regenerative capacities. Developmental Dynamics: An Official Publication of the 
American Association of Anatomists, 212 (4), pp.495-508. 
Peng, H & Huard, J (2004) Muscle-derived stem cells for musculoskeletal tissue 
regeneration and repair. Transplant Immunology, 12 (3-4), pp.311-319. 
Pownall, M.E. & Emerson, C.P., Jr (1992) Sequential activation of three myogenic 
regulatory genes during somite morphogenesis in quail embryos. Developmental 
Biology, 151 (1), pp.67-79. 
Price, N., Hunt, N P & Lewis, M P (1998) Expression of an embryonic fibronectin 
splicing variant in human masseter muscle. Archives of Oral Biology, 43 (11), pp.911-
915. 
Qu, Z., Balkir, L., van Deutekom, J.C., Robbins, P.D., Pruchnic, R & Huard, J (1998) 
Development of approaches to improve cell survival in myoblast transfer therapy. The 
Journal of Cell Biology, 142 (5), pp.1257-1267. 
Qu-Petersen, Zhuqing, Deasy, B., Jankowski, Ron, Ikezawa, Makato, Cummins, James, 
Pruchnic, Ryan, Mytinger, J., Cao, Baohong, Gates, Charley, Wernig, Anton & Huard, 
Johnny (2002) Identification of a novel population of muscle stem cells in mice: 
potential for muscle regeneration. The Journal of Cell Biology, 157 (5), pp.851-864. 
Rando, T A & Blau, H M (1994) Primary mouse myoblast purification, 
characterization, and transplantation for cell-mediated gene therapy. The Journal of Cell 
Biology, 125 (6), pp.1275-1287. 
Reilly, T.M., Seldes, R., Luchetti, W. & Brighton, C.T. (1998) Similarities in the 
phenotypic expression of pericytes and bone cells. Clinical Orthopaedics and Related 
Research, (346), pp.95-103. 
Renault, V., Rolland, E., Thornell, L.-E., Mouly, V. & Butler-Browne, G. (2002) 
Distribution of satellite cells in the human vastus lateralis muscle during aging. 
Experimental Gerontology, 37 (12), pp.1513-1514. 
 
 
178 
 
References 
Richler, C. & Yaffe, D. (1970) The in vitro cultivation and differentiation capacities of 
myogenic cell lines. Developmental Biology, 23 (1), pp.1-22. 
Rinon, A., Lazar, S., Marshall, H., Büchmann-Møller, S., Neufeld, A., Elhanany-Tamir, 
H., Taketo, M.M., Sommer, L., Krumlauf, R. & Tzahor, E. (2007) Cranial neural crest 
cells regulate head muscle patterning and differentiation during vertebrate 
embryogenesis. Development (Cambridge, England), 134 (17), pp.3065-3075. 
Romero-Ramos, M., Vourc’h, P., Young, H.E., Lucas, P.A., Wu, Y., Chivatakarn, O., 
Zaman, R., Dunkelman, N., el-Kalay, M.A. & Chesselet, M.-F. (2002) Neuronal 
differentiation of stem cells isolated from adult muscle. Journal of Neuroscience 
Research, 69 (6), pp.894-907. 
Rouger, K., Fornasari, B., Armengol, V., Jouvion, G., Leroux, I., Dubreil, L., Feron, M., 
Guevel, L. & Cherel, Y. (2007) Progenitor cell isolation from muscle-derived cells 
based on adhesion properties. The Journal of Histochemistry and Cytochemistry: 
Official Journal of the Histochemistry Society, 55 (6), pp.607-618. 
Royer, C.L., Howell, J.C., Morrison, P.R., Srour, E.F. & Yoder, M.C. (2002) Muscle-
derived CD45-SCA-1+c-kit- progenitor cells give rise to skeletal muscle myotubes in 
vitro. In Vitro Cellular & Developmental Biology. Animal, 38 (9), pp.512-517. 
Rudnicki, M A, Braun, T., Hinuma, S. & Jaenisch, R. (1992) Inactivation of MyoD in 
mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently 
normal muscle development. Cell, 71 (3), pp.383-390. 
Sambasivan, R. & Tajbakhsh, S. (2007) Skeletal muscle stem cell birth and properties. 
Seminars in Cell & Developmental Biology, 18 (6), pp.870-882. 
Sawyer, J.R., Myers, M.A., Rosier, R.N. & Puzas, J.E. (1991) Heterotopic ossification: 
clinical and cellular aspects. Calcified Tissue International, 49 (3), pp.208-215. 
Schmittgen, T.D., Zakrajsek, B.A., Mills, A.G., Gorn, V., Singer, M.J. & Reed, M.W. 
(2000) Quantitative reverse transcription-polymerase chain reaction to study mRNA 
decay: comparison of endpoint and real-time methods. Analytical Biochemistry, 285 
(2), pp.194-204. 
Schor, A.M., Canfield, A.E., Sutton, A.B., Arciniegas, E. & Allen, T.D. (1995) Pericyte 
differentiation. Clinical Orthopaedics and Related Research, (313), pp.81-91. 
Seale, P & Rudnicki, M A (2000) A new look at the origin, function, and “stem-cell” 
status of muscle satellite cells. Developmental Biology, 218 (2), pp.115-124. 
 
 
179 
 
References 
Seale, Patrick, Ishibashi, J., Holterman, C. & Rudnicki, Michael A (2004) Muscle 
satellite cell-specific genes identified by genetic profiling of MyoD-deficient myogenic 
cell. Developmental Biology, 275 (2), pp.287-300. 
Seo, B.-M., Miura, M., Gronthos, Stan, Bartold, P.M., Batouli, S., Brahim, Jaime, 
Young, M., Robey, Pamela Gehron, Wang, C.-Y. & Shi, Songtao (2004) Investigation 
of multipotent postnatal stem cells from human periodontal ligament. Lancet, 364 
(9429), pp.149–155. 
Shen, H.-C., Peng, Hairong, Usas, Arvydas, Gearhart, B., Cummins, James, Fu, Freddie 
H & Huard, Johnny (2004) Ex vivo gene therapy-induced endochondral bone 
formation: comparison of muscle-derived stem cells and different subpopulations of 
primary muscle-derived cells. Bone, 34 (6), pp.982-992. 
Sherwood, R.I., Christensen, J.L., Conboy, I.M., Conboy, M.J., Rando, Thomas A, 
Weissman, I.L. & Wagers, A.J. (2004) Isolation of adult mouse myogenic progenitors: 
functional heterogeneity of cells within and engrafting skeletal muscle. Cell, 119 (4), 
pp.543-554. 
Sherwood, R.I., Christensen, J.L., Weissman, I.L. & Wagers, A.J. (2004) Determinants 
of skeletal muscle contributions from circulating cells, bone marrow cells, and 
hematopoietic stem cells. Stem Cells (Dayton, Ohio), 22 (7), pp.1292-1304. 
Sinanan, A.C.M., Buxton, Paul G & Lewis, Mark P (2006) Muscling in on stem cells. 
Biology of the Cell / Under the Auspices of the European Cell Biology Organization, 98 
(4), pp.203-214. 
Sinanan, A.C.M., Hunt, Nigel P & Lewis, Mark P (2004) Human adult craniofacial 
muscle-derived cells: neural-cell adhesion-molecule (NCAM; CD56)-expressing cells 
appear to contain multipotential stem cells. Biotechnology and Applied Biochemistry, 
40 (Pt 1), pp.25-34. 
Smith, R. & Triffitt, J.T. (1986) Bones in muscles: the problems of soft tissue 
ossification. The Quarterly Journal of Medicine, 61 (235), pp.985-990. 
Sperber, G.H. (1989) Craniofacial Embryology. 4th ed. Oxford, Butterworth-
Heinemann Ltd. 
Stewart, C.E.H. & Rittweger, J. (2006) Adaptive processes in skeletal muscle: 
molecular regulators and genetic influences. Journal of Musculoskeletal & Neuronal 
Interactions, 6 (1), pp.73-86. 
Strauer, B.E. and Kornowski, R. (2003) Stem Cell Therapy in Perspective. Circulation, 
107 (7), pp.929–934. 
 
 
180 
 
References 
Summer, R., Kotton, D.N., Sun, X., Ma, B., Fitzsimmons, K. & Fine, A. (2003) Side 
population cells and Bcrp1 expression in lung. American Journal of Physiology. Lung 
Cellular and Molecular Physiology, 285 (1), pp.L97-104. 
Tajbakhsh, S (2009) Skeletal muscle stem cells in developmental versus regenerative 
myogenesis. Journal of Internal Medicine, 266 (4), pp.372-389. 
Tajbakhsh, S & Buckingham, M (2000) The birth of muscle progenitor cells in the 
mouse: spatiotemporal considerations. Current Topics in Developmental Biology, 48, 
pp.225-268. 
Tajbakhsh, S, Borello, U., Vivarelli, E., Kelly, R., Papkoff, J., Duprez, D, Buckingham, 
M & Cossu, G (1998) Differential activation of Myf5 and MyoD by different Wnts in 
explants of mouse paraxial mesoderm and the later activation of myogenesis in the 
absence of Myf5. Development (Cambridge, England), 125 (21), pp.4155-4162. 
Tajbakhsh, S, Rocancourt, D, Cossu, G & Buckingham, M (1997) Redefining the 
genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of 
MyoD. Cell, 89 (1), pp.127-138. 
Torrente, Y, Tremblay, J P, Pisati, F., Belicchi, M., Rossi, B., Sironi, M., Fortunato, F., 
El Fahime, M., D’Angelo, M.G., Caron, N.J., Constantin, G., Paulin, D, Scarlato, G. & 
Bresolin, N. (2001) Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem 
cells restores dystrophin in mdx mice. The Journal of Cell Biology, 152 (2), pp.335-
348. 
Tortora, G.J. & Derrickson, B. (2009) Principles of anatomy and physiology. 12th ed. 
Hoboken, NJ, John Wiley & Sons, Inc. 
Tzahor, E., Kempf, H., Mootoosamy, R.C., Poon, A.C., Abzhanov, A., Tabin, C.J., 
Dietrich, Susanne & Lassar, Andrew B (2003) Antagonists of Wnt and BMP signaling 
promote the formation of vertebrate head muscle. Genes & Development, 17 (24), 
pp.3087-3099. 
Uchida, N., Buck, D.W., He, D., Reitsma, M.J., Masek, M., Phan, T.V., Tsukamoto, 
A.S., Gage, F.H. & Weissman, I.L. (2000) Direct isolation of human central nervous 
system stem cells. Proceedings of the National Academy of Sciences of the United 
States of America, 97 (26), pp.14720–14725. 
Uezumi, A., Ojima, K., Fukada, S.-ichiro, Ikemoto, M., Masuda, S., Miyagoe-Suzuki, 
Y. & Takeda, S. (2006) Functional heterogeneity of side population cells in skeletal 
muscle. Biochemical and Biophysical Research Communications, 341 (3), pp.864-873. 
 
 
 
181 
 
References 
Urist, M.R. (1965) Bone: formation by autoinduction. Science (New York, N.Y.), 150 
(698), pp.893-899. 
Urist, M.R. & Strates, B.S. (1971) Bone morphogenetic protein. Journal of Dental 
Research, 50 (6), pp.1392-1406. 
Urist, M.R., DeLange, R.J. & Finerman, G.A. (1983) Bone cell differentiation and 
growth factors. Science (New York, N.Y.), 220 (4598), pp.680-686. 
Urist, M.R., Jurist, J.M., Jr, Dubuc, F.L. & Strates, B.S. (1970) Quantitation of new 
bone formation in intramuscular implants of bone matrix in rabbits. Clinical 
Orthopaedics and Related Research, 68, pp.279-293. 
Usas, Arvydas, Ho, A.M., Cooper, G.M., Olshanski, A., Peng, Hairong & Huard, 
Johnny (2009) Bone regeneration mediated by BMP4-expressing muscle-derived stem 
cells is affected by delivery system. Tissue Engineering. Part A, 15 (2), pp.285-293. 
Van de Putte, K.A. & Urist, M.R. (1965) Osteogenesis in the interior of intramuscular 
implants of decalcified bone matrix. Clinical Orthopaedics and Related Research, 43, 
pp.257-270. 
Vessey, C.J. & de la Hall, P.M. (2001) Hepatic stem cells: a review. Pathology, 33 (2), 
pp.130–141. 
Vogel, G. (2001) Stem cell policy. Can adult stem cells suffice? Science, 292 (5523), 
pp.1820–1822. 
Wagers, A.J., Christensen, J.L. & Weissman, I.L. (2002) Cell fate determination from 
stem cells. Gene therapy, 9 (10), pp.606–612. 
Widera, D., Zander, C., Heidbreder, M., Kasperek, Y., Noll, T., Seitz, O., Saldamli, B., 
Sudhoff, H., Sader, R., Kaltschmidt, C. & Kaltschmidt, B. (2009) Adult palatum as a 
novel source of neural crest-related stem cells. Stem cells (Dayton, Ohio), 27 (8), 
pp.1899–1910. 
Williams, T. & Tjian, R. (1991) Analysis of the DNA-binding and activation properties 
of the human transcription factor AP-2. Genes & Development, 5 (4), pp.670-682. 
Yaffe, D. (1968) Retention of differentiation potentialities during prolonged cultivation 
of myogenic cells. Proceedings of the National Academy of Sciences of the United 
States of America, 61 (2), pp.477-483. 
 
 
 
182 
 
References 
Yamane, A. (2005) Embryonic and postnatal development of masticatory and tongue 
muscles. Cell and Tissue Research, 322 (2), pp.183-189. 
Yan, Z., Lin, Y., Jiao, X., Li, Zhiyong, Wu, L., Jing, W., Qiao, J., Liu, L., Tang, W., 
Zheng, X. & Tian, W. (2006) Characterization of ectomesenchymal cells isolated from 
the first branchial arch during multilineage differentiation. Cells, Tissues, Organs, 183 
(3), pp.123-132. 
 183 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8. Appendices  
 
 184 
 
Appendix A. Materials 
 
 
 
 
 
 
 
 
 
 
Appendix A. Materials 
 
 
 185 
 
Appendix A. Materials 
Materials used for RNA extraction and quality control 
 
Experimental step Materials Supplying company 
RNase inhibition 
-Clean surfaces 
 
-Tips 
-Centrifuge tubes  
 
-Water 
 
-RNaseZap® wipes 
-RNase® Zap spray 
-Eppendorf® epT.I.P.S, 
-RNase/ DNase free 
centrifuge tubes 
-RNase free water 
 
-Ambion (Europe) Ltd, Applied 
Biosystems, Warrington, UK 
            -Sigma-Aldrich Ltd, Dorset, UK. 
-Qiagen, West Sussex, UK 
 
-Qiagen, West Sussex, UK 
Purification and elution 
-selective binding 
 
-Elusion 
 
-Ethanol 
 
-RNeasy®  mini kit 
 
-Fisher Scientific UK Ltd, 
Loughborough, UK 
             -Qiagen, West Sussex, UK 
RNA quantity and purity 
-Spectrophotometer  
 
 
-Ultrospec 2000 
machine 
 
- Tecan M200 
 
-Amersham Pharmacia Biotech, GE 
Healthcare Ltd, Buckinghamshire, 
UK 
-TECAN group Ltd 
Switzerland 
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Materials used for quantitative RT-PCR (qRT-PCR) 
 
Experimental step Materials  Supplying 
company 
cDNA synthesis  
-High-capacity cDNA reverse 
transcription kit  
- PTC-100 Thermocycler machine,  
 
* 
-MJ Research Inc, 
Genetic research 
instrumentation 
Ltd, Essex, UK 
qRT-PCR  
-File builder software (to design LOC 
gene assay) 
-TaqMan® universal PCR master mix 
-MicroAmp® optical 96-well reaction 
plates 
-MicroAmp® optical adhesive cover 
-7300 Real time PCR machine* 
-7300 system software*  
-Large centrifuge 
 
* 
* 
* 
* 
* 
* 
-Jouan CR4.12, 
DJB labcare Ltd, 
Buckinghamshire, 
UK. 
 *Supplied by Applied 
Biosystems, Warrington, UK. 
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Appendix B. Protocols 
Isolation and differentiation of isolated muscle mononuclear cells protocol 
 
Materials for muscle and cells isolation: 
70% ethanol in a squirt bottle 
Sterile phosphate buffered saline (PBS) 
Collagenase/Dispase/CaCl2 solution 
DMEM medium  
Neonatal mice, preferably 1-3 days old 
Sharp curved surgical scissors 
2 pairs of fine forceps 
Low power stereo dissecting microscope 
Sterile razor blade 
70 μm nylon mesh  
Small sterile funnel 
Humidified 37°C, 5% CO2 incubator 
Inverted microscope 
T75 flask 
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Solutions for muscle and cells isolation:  
Collagenase D  
(Roche #1 088 858) >0.15 U/mg 
Reconstitute 100 mg in 10 ml D-PBS = 1.5 U/ml = 10 mg/ml 
Filter sterilize. Store –20 C in 1 ml aliquots 
 
Dispase II 
(Roche #295 825) 2.4 U/ml 
Liquid 1x (working conc. 0.6–2.4 U/ml) 
Sterile. Store –20 C in aliquots 
1. Dissolve 10 mg dispase in 1 ml PBS (without calcium and magnesium). This 
concentration is 10mg/ml. It is also 10 U/ml.  
2. Dilute that stock 1:5 by adding 4 ml PBS to 1 ml stock (10 U/ml dispase). The 
concentration is now 2 U/ml. 
 
100 mM CaCl2   
1.47 g/100 ml 
Filter sterilize 
 
Collagenase/Dispase/CaCl2 solution 
1 ml 1.5 U/ml collagenase (Final conc. 0.75 U/ml) 
1 ml 2.4 U/ml dispase (Final conc. 1.2 U/ml) 
50 μl 100 mM CaCl2 (Final conc. 2.5 mM) 
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DMEM medium 
500 ml DMEM Low Glucose (1g/l) with L-Glutamine.   
50 ml foetal bovine serum (10% final) 
5 ml 100x penicillin/streptomycin (GIBCO BRL; final concentration is 100 U/ml and 
100 µg/ml, respectively) 
Store at 8
°
C  
 
Phosphate buffered saline (PBS) 
Store at room temperature. 
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Primary Culture preparation:  
The primary culture will compose of Craniofacial and hind limb muscles of neonate 
mice.  
All muscle samples will be isolated using enzymatic dissociation technique previously 
described by Rando and Blau, (1994).  
 
Isolate craniofacial muscle  
Sacrifice 10 neonatal mice by decapitation.  
Rinse the head with 70% ethanol and remove the skin with sterile scissors. Dissect the 
muscle (Masseter) bilaterally away from the skin and bone with sterile forceps.  
Dissection is easier if done under a stereo dissecting microscope. Store the muscle 
tissue in a culture dish on ice in a drop of sterile PBS as successive muscles are being 
processed, maintaining sterility in the accumulated tissue.  
 
Dissociate muscle cells  
All subsequent steps should be done in a sterile tissue culture hood 
Add enough PBS to keep the tissue moist, and mince to slurry with razor blades in the 
culture dish.  
Transfer to 50 ml tube with 10 ml PBS and let sit to allow fat to float in the buffer. 
Discard buffer carefully 
Add approximately 2 ml of collagenase/dispase/CaCl2 solution per gram or per 250mg 
of tissue and continue mincing for several minutes.  
Transfer the minced tissue to a sterile tube and incubate at 37°C until the mixture is fine 
slurry, usually about 20-30 min. in shaking water bath. (Gently triturate with a plastic 
pipette to break up clumps 2-3 times while incubation with collagenase solution).  
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If desired, the slurry can be filtered through a piece of 70 µm nylon mesh in a sterile 
funnel to remove large pieces of tissue. (You may need to add equal amount of the 
growth medium to the solution)  
Centrifuge the cells for 5 min at 1000 rpm. Re-suspend the pellet in 10 ml of DMEM 
medium supplemented with 10% FBS and 1% P/S, and plate in T75 culture flask.   
It is common to see a great deal of debris and very few recognizable cells; however, 
after two days, many cells will be evident and the debris will be rinsed away during the 
first change of medium.  
Incubate in a 37°C 5% CO2 incubator for 1hr. transfer the supernatant from the original 
flask (Pre-plate 1 (PP1)) into new flask. The original flask will be replenished with a 
fresh medium.  
The supernatant from flask 2 (Pre-plate 2 (PP2)) will be transferred to new flask (PP3) 
after incubation for 48h. The PP2 flask will be replenished with a fresh medium. 
The cells in PP3 will be allowed to settle for about 5 d  
Medium will be changed every 2-3 days for all pre-plates.  
When the cells are ready to be split, remove the cells from the dish using Trypsin as 
Follows:  
View cultures using an inverted microscope to assess the degree of confluency and 
confirm the absence of bacterial and fungal contaminants.  
Remove spent medium.  
Wash the cell monolayer with PBS without Ca2
+
/Mg2
+
 using a volume equivalent to half 
the volume of culture medium. Repeat this wash step if the cells are known to adhere 
strongly.  
Pipette trypsin/EDTA onto the washed cell monolayer using 1ml per 25 cm
2
 of surface 
area. Rotate flask to cover the monolayer with trypsin. Decant the excess trypsin.  
Return flask to the incubator and leave for 2-10 min  
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Examine the cells using an inverted microscope to ensure that all/majority of the cells 
are detached and floating. The side of the flasks may be gently tapped to release any 
remaining attached cells.  
Resuspended the cells in a small volume of fresh serum-containing medium (approx 3-4 
x the volume of trypsin) to inactivate the trypsin. Centrifuge cells at 1000rpm for 3-5 
minutes and resuspended before performing a cell count.   
Transfer the required number of cells to a new labelled flask containing pre-warmed 
medium. Incubate in a 37ºC, 5% CO2 incubator until confluent.  
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In vitro cell differentiation: 
Media used: 
Osteogenic: DMEM+ 10%FBS+ 1%P/S+ 100ng/ml BMP-2, 50ug/ml ascorbic acid 
(AsAc) and 8mM β-glycerophosphate.  
Myogenic: DMEM high Glu+ 2%FBS+ 1%P/S+ 10ng/ml IGF-1. 
GM: DMEM+ 10%FBS+ 1%P/S.  
 
Cells from each plate were plated in 24-well plate. Three repeats for each differentiation 
method (Figure 1). 
 
Cells will be stimulated to differentiate into osteogenic lineage by application of BMP-2 
as follows:  
Stimulate cells with 100 ng/ml of BMP-2, 50ug/ml ascorbic acid (AsAc) and 8mM β-
glycerophosphate in general medium . 
 
AsAc stock solution [1000X]:  
1. Dissolve 50 mg ascorbic acid-2 phosphate in 10 ml DMEM/15 mM HEPES.  
2. In the tissue culture hood, filter it through a 0.22 μm pore size membrane.  
3. Store the solution in a closed flask at 4
o
C. It should be stable for several months.  
 
β-glycerophosphate stock solution [10X]:  
1. Dissolve 630 mg β-glycerophosphate in 20 ml DMEM.  
2. In the tissue culture hood, filter it through a 0.22 μm pore size membrane.  
3. Store the solution in a closed flask at 4
o
C. It should be stable for at least two months.  
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Osteogenic induction procedure:  
• Reserve a confluent culture to perform the differentiation.  
• The osteogenic induction consists of switching from complete culture medium to 
osteogenic induction medium, and performing medium changes twice a week for 4 
weeks.  
 
• Generally, mineralised extracellular matrix deposition can be observed after 2-3 weeks 
week after the onset of differentiation, and becomes more evident along time.  
 
Myogenic Differentiation: 
Stimulate wells with low serum containing medium supplemented with 10ng/ml IGF-1.  
Medium changed every 2 days. 
Analyse cells after 2-3 weeks. 
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Figure 1: The differentiation set up for myogenic and osteogenic differentiation 
experiments. This setup was repeated for all isolates  
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Final RNA extraction protocol 
Laboratory steps Materials  Volume  Settings 
i) Prior to start 
Clean the working bench, pipettes and 
all plastic ware used 
 
-RNaseZap® wipes 
-RNaseZap spray 
 
 
 
 
ii) Handling the sample 
 Transfer the cell lysate to the working 
bench 
 
 
  
iii) Disruption and homogenisation 
 
 
 
Total 
 
RLT buffer 
 
Measure lysate 
70% ethanol 
 
~ 
 
~350 µl  
~350 µl * 
~700 µl 
 
iv) Purification** 
-Use the lysate from the previous step 
 
Spin column 
 
RW1 buffer 
RW1 buffer 
RPE buffer 
RPE buffer 
New tube open cap 
 
~700 µl 
 
350µl 
350µl 
500 µl 
500 µl 
- 
 
Centrifuge   15s 10,000 rpm*** 
 
Centrifuge   15s 10,000 rpm 
Centrifuge   15s 10,000 rpm 
Centrifuge   15s 10,000 rpm 
Centrifuge   2m maximum speed 
Centrifuge   1m maximum speed 
v) Elution** 
 
 
RNase free water 
 
30 µl 
 
Keep          5m at room T 
Centrifuge   1m maximum speed 
*Measure the remaining lysate after homogenisation and add equal volume of ethanol. ** Following the RNeasy® 
mini kit manual. ***Capacity of the spin column is only 700 µl, hence the spinning can be conducted more than once.  
T, temperature. 
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qRT-PCR laboratory protocol  
Laboratory steps Materials  Volume  Settings 
i) cDNA synthesis 
 -Adjusting RNA concentration 
(equal volume to the cDNA MM) 
 
Total 
 
  -Preparation of cDNA MM  
 
 
 
 
 
Total 
   
   -cDNA synthesis 
 
Total 
 
RNA sample (total 
concentration 5ng/reaction)  
RNase free water 
Adjusted RNA sample 
 
10X RT Buffer  
25X dNTP mix (100mM) 
10X RT Random primers  
MultiScribe Reverse 
transcriptase enzyme  
RNase free water 
cDNA MM/reaction 
 
cDNA MM 
Adjusted RNA sample 
cDNA mixture  
 
 
Variable 
Variable 
10µl 
 
2µl 
0.8µl 
2µl 
 
1µl 
4.2µl 
10µl 
 
10µl 
10µl 
20µl 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T/ cycle (35 cycles used) 
25°C 10m  
37°C 120m  
85°C 5s 
4°C ∞ 
ii) qRT-PCR 
   -Preparation of qRT-PCR mix 
 
 
 
 
Total 
   
   -Loading each well and cover 
    the whole plate 
   -Applying the 96-well plate 
   into the relative quantification 
   real-time PCR machine 
 
TaqMan Universal PCR MM 
RNase free water 
cDNA mixture 
Gene of interest assay 
qRT-PCR mixture/well 
 
qRT-PCR mixture 
 
 
 
 
12.5µl 
8.75µl 
2.5µl 
1.25µl 
25µl 
 
25µl 
 
 
 
 
 
 
 
 
 
 
 
Centrifuge 15s maximum speed 
in a large centrifuge 
T/ cycle (40 cycles used) 
50°C 2m  
95°C 10m  
95°C 15s 
60°C 1m 
MM: Master mix.  T: Temperature. M: minutes. S: seconds 
 199 
 
Appendix C. Publications 
 
 
 
 
 
 
 
 
Appendix C. Publications 
 
 200 
 
Appendix C. Publications 
Publications: 
Mulhall H, Patel M, Alqahtani K, Mason C, Lewis MP, Wall I. (2011) Effect of 
capillary shear stress on recovery and osteogenic differentiation of muscle-derived 
precursor cell populations. Journal of Tissue Engineering and Regenerative Medicine, 
5(8):629-35 
 
Patel M, Mulhall H, Al-Qahtani K, Lewis M, Wall I. (2011) Muscle-derived 
precursor cells isolated on the basis of differential adhesion properties respond 
differently to capillary flow. Biotechnology Letters. 33(7):1481-6. 
 
Lewis MP, Smith A, Shah R, Al-Qahtani K, Carlqvist K, Sinanan AC, Mudera V, 
(2009) A little bit of this and a little bit of that! 3D tissue engineered skeletal muscle-
Generating basic mechanisms in maintenance and turnover. Comparative Biochemistry 
and Physiology A-Molecular and Integrative Physiology 153 (2): 73.  
 
 
Posters and Oral presentations: 
Alqahtani, K., Buxton, P., Parkar, M., Lewis, M.P. Osteoprogenitor cells within skeletal 
muscle tissue. TCES, Glasgow, UK, 2009.  
 
Alqahtani, K., Buxton, P., Parkar, M., Lewis, M.P. Isolation of Progenitor Cells from 
Craniofacial Skeletal Muscle based on Adhesion Properties. Presented at UCL stem cell 
day, December 2007. 
 
Alqahtani, K., Buxton, P., Parkar, M., Lewis, M.P. Isolation of Progenitor Cells from 
Craniofacial Skeletal Muscle based on Adhesion Properties. Presented at 20th head 
group meeting held at ICH, January 2008. 
 
 201 
 
Appendix C. Publications 
Alqahtani, K., Buxton, P., Parkar, M., Lewis, M.P. Isolation of Progenitor Cells from 
Craniofacial Skeletal Muscle based on Adhesion Properties. Presented at Eastman 60
th
 
anniversary meeting, April 2008.  
 
Alqahtani, K., Buxton, P., Parkar, M., Lewis, M.P. Isolation of Craniofacial Muscle 
Progenitor Cells Based on Adhesion Properties. Presented at PEF IDAR meeting, 
London 2008.  
 
Carlqvist K, Alqahtani K, Sinanan ACM, Aggrewal S, Mudera V, Lewis M.P, 2008, 
craniofacial Muscle Derived Stem Cells. Presented at PEF IDAR meeting, London 
2008.  
 
 
 
